var title_f42_37_43600="Cromolyn sodium: Patient drug information";
var content_f42_37_43600=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"14\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Cromolyn sodium: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block note\" id=\"F12804545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12804546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?0/12/197?source=see_link\">",
"       Cromolyn sodium (nasal): Patient drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?16/46/17124?source=see_link\">",
"       Cromolyn sodium (ophthalmic): Patient drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/53/29524?source=see_link\">",
"       Cromolyn sodium (systemic therapy and oral inhalation): Patient drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12342 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-218.28.111.102-8C7B610DBC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_37_43600=[""].join("\n");
var outline_f42_37_43600=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?0/12/197?source=related_link\">",
"      Cromolyn sodium (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?16/46/17124?source=related_link\">",
"      Cromolyn sodium (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/53/29524?source=related_link\">",
"      Cromolyn sodium (systemic therapy and oral inhalation): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_37_43601="Extracranial aneurysm of the internal carotid artery";
var content_f42_37_43601=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F80873&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F80873&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 498px\">",
"   <div class=\"ttl\">",
"    Extracranial aneurysm of the internal carotid artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 478px; height: 470px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Arteriography of an extracranial aneurysm of the internal carotid artery at the skull base resulting from carotid dissection in a 34-year-old man.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Meairs S, Hennerici M. Long-term follow-up of aneurysms developed during extracranial internal carotid artery dissection. Neurology 2000; 54:2190. Copyright &copy; 2000 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_37_43601=[""].join("\n");
var outline_f42_37_43601=null;
var title_f42_37_43602="PVNS knee MRI";
var content_f42_37_43602=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F54059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F54059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pigmented villonodular synovitis (PVNS) of the knee",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 399px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sagittal T1-weighted MR image of the knee demonstrates suprapatellar (long arrow) and intra-articular (short arrows) nodular masses, which show low signal intensity (dark) from hemosiderin deposition.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Shahla Modarresi, MD and Cecilia M Jude, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_37_43602=[""].join("\n");
var outline_f42_37_43602=null;
var title_f42_37_43603="Halobetasol: Pediatric drug information";
var content_f42_37_43603=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"14\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Halobetasol: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?9/44/9925?source=see_link\">",
"    see \"Halobetasol: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?23/35/24116?source=see_link\">",
"    see \"Halobetasol: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F178409\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Halonate&trade;;",
"     </li>",
"     <li>",
"      Ultravate&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F178410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ultravate&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1053110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Adrenal Corticosteroid",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anti-inflammatory Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Corticosteroid, Topical",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Glucocorticoid",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1053103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?9/44/9925?source=see_link\">",
"      see \"Halobetasol: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &lt;12 years: Use not recommended (high risk of systemic adverse effects, eg, HPA axis suppression, Cushing's syndrome)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &ge;12 years and Adults: Topical: Steroid-responsive dermatoses: Apply sparingly once or twice daily; maximum dose: 50 g/week; do not treat for &gt;2 weeks.",
"     <b>",
"      Note:",
"     </b>",
"     To decrease risk of systemic effects, only treat small areas at any one time; discontinue therapy when control is achieved; reassess diagnosis if no improvement is seen in 2 weeks.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F178393\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical, as propionate: 0.05% (15 g, 50 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ultravate&reg;: 0.05% (15 g [DSC], 50 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment, topical, as propionate: 0.05% (15 g, 50 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Halonate&trade;: 0.05% (50 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ultravate&reg;: 0.05% (15 g [DSC], 50 g)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F178380\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1053114\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Topical: Apply sparingly to affected area, gently rub in until disappears; do not use on open skin; do not apply to face, underarms, or groin area; avoid contact with eyes; do not occlude affected area.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1053106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store between 59&deg;F to 86&deg;F (15&deg;C to 30&deg;C)",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1053113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of inflammation and pruritus associated with corticosteroid-response dermatoses",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F178429\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Ultravate&reg; may be confused with Cutivate&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F178427\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Central nervous system: Intracranial hypertension (systemic effect reported in children treated with topical corticosteroids)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Acneiform eruptions, allergic contact dermatitis, dry skin, erythema, folliculitis, hypertrichosis, hypopigmentation, itching, leukoderma, miliaria, perioral dermatitis, pruritus, pustulation, rash, skin atrophy, skin infection (secondary), striae, telangiectasia, vesicles, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine: Glycosuria, HPA axis suppression, metabolic effects (hyperglycemia, hypokalemia)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Burning, stinging",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Paresthesia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1053117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to halobetasol propionate, other corticosteroids, or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1053102\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid using higher than recommended doses; suppression of HPA axis, suppression of linear growth (ie, reduction of growth velocity), reduced bone mineral, or hypercorticism (Cushing's syndrome) may occur. Discontinue treatment if local irritation develops. Use appropriate antibacterial or antifungal agents to treat concomitant skin infections; discontinue halobetasol treatment if infection does not resolve promptly.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1053101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypothalamic-pituitary-adrenal (HPA) axis suppression may occur with topical corticosteroid use; acute adrenal insufficiency may occur with abrupt withdrawal after long-term use or with stress; withdrawal or discontinuation should be done carefully; patients with HPA axis suppression may require increased doses of systemic glucocorticosteroids prior to, during, and after unusual stress (eg, surgery). Adverse systemic effects (including HPA axis suppression) may occur when topical steroids are used on large areas of the body, denuded areas, for prolonged periods of time, with an occlusive dressing, and/or in infants or small children; infants and small children may be more susceptible to HPA axis suppression or other systemic toxicities due to a larger skin surface area to body mass ratio; use with caution in pediatric patients; safety and efficacy have not been established in children &lt;12 years of age (use is not recommended)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Do not use topical halobetasol for the treatment of rosacea or perioral dermatitis; do not apply to the face, groin, or axillae. Do not exceed maximum recommended dose or duration of therapy due to the potential development of HPA axis suppression.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299435\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F178389\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aldesleukin: Corticosteroids may diminish the antineoplastic effect of Aldesleukin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticorelin: Corticosteroids may diminish the therapeutic effect of Corticorelin. Specifically, the plasma ACTH response to corticorelin may be blunted by recent or current corticosteroid therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Corticosteroids may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Corticosteroids may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving corticosteroids (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: Corticosteroids may decrease the serum concentration of Telaprevir. Telaprevir may increase the serum concentration of Corticosteroids.  Management: Concurrent use of telaprevir and systemic corticosteroids is not recommended.  When possible, consider alternatives.  If used together, employ extra caution and monitor closely for excessive corticosteroid effects and diminished telaprevir effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F178390\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F178402\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects have been observed in animal reproduction studies. Topical products are not recommended for extensive use, in large quantities, or for long periods of time in pregnant women (Reed, 1997).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1053109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Assess HPA axis suppression in patients using potent topical steroids applied to a large surface area or to areas under occlusion (eg, ACTH stimulation test, morning plasma cortisol test, urinary free cortisol test)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1053100\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not well defined topically; possesses anti-inflammatory, antipruritic, antiproliferative, vasoconstrictive, and immunosuppressive properties",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1053116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Percutaneous absorption varies and depends on many factors including vehicle used, integrity of epidermis, dose, and use of occlusive dressing; absorption is increased by occlusive dressings or with decreased integrity of skin (eg, inflammation or skin disease)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cream: &lt;6% of topically applied dose enters circulation within 96 hours following application",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Renal",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1053108\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?23/35/24116?source=see_link\">",
"      see \"Halobetasol: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid contact with eyes; do not apply to face, underarms, or groin area; do not bandage, cover, or wrap affected area unless directed by physician; do not use for longer than directed; notify physician if condition being treated persists or worsens. Do not use tight-fitting diapers or plastic pants on a child being treated in diaper area. Wash hands after applying.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1053118\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Considered to be a super high potency topical corticosteroid; patients with psoriasis who were treated with halobetasol cream or ointment in divided doses of 7 g/day for one week developed HPA axis suppression",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12934 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-4A54400AA2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_37_43603=[""].join("\n");
var outline_f42_37_43603=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178409\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178410\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053110\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053103\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178393\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178380\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053114\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053106\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053113\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178429\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178427\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053117\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053102\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053101\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299435\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178389\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178390\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178402\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053109\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053100\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053116\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053108\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053118\">",
"      Additional Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12934\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12934|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?9/44/9925?source=related_link\">",
"      Halobetasol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?23/35/24116?source=related_link\">",
"      Halobetasol: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_37_43604="Microgranular APL variant peripheral smear";
var content_f42_37_43604=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F82867&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F82867&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Peripheral smear from a patient with the microgranular (or hypogranular) variant of acute promyelocytic leukemia (APL)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 404px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The white blood cell count in the microgranular (or hypogranular)&nbsp;type of APL is usually elevated, and the cells are identified by their bi-lobed, dumbbell-shaped, or reniform nuclei. The cells have no recognizable granules, but granules are in fact present and can be seen by electron microscopy. Despite the sub-light microscopic nature of the granules, the cells are still strongly positive for the myeloperoxidase reaction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_37_43604=[""].join("\n");
var outline_f42_37_43604=null;
var title_f42_37_43605="Radical vulvectomy4";
var content_f42_37_43605=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61321&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61321&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Radical vulvectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 425px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The right crus has been clamped ready for transection and suture.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of C. William Helm, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_37_43605=[""].join("\n");
var outline_f42_37_43605=null;
var title_f42_37_43606="Tear drop cells";
var content_f42_37_43606=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F55274&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F55274&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Teardrop-shaped red blood cells (dacrocytes)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 305px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This peripheral smear from a patient with bone marrow fibrosis shows numerous teardrop-shaped red cells (arrows). Note that the teardrops are pointed in several different directions, ruling out an artifact due to preparation of the smear.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_37_43606=[""].join("\n");
var outline_f42_37_43606=null;
var title_f42_37_43607="Pelvic organ prolapse in women: Obliterative procedures (colpocleisis)";
var content_f42_37_43607=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pelvic organ prolapse in women: Obliterative procedures (colpocleisis)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/37/43607/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/37/43607/contributors\">",
"     Kimberly Kenton, MD, MS, FACOG, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/37/43607/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/37/43607/contributors\">",
"     Linda Brubaker, MD, FACS, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/37/43607/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/37/43607/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/37/43607/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H3586030\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic organ prolapse (POP) affects millions of women; approximately 200,000 inpatient surgical procedures for prolapse are performed annually in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. One in nine women will undergo surgery for prolapse or incontinence by age 80 years, and 30 percent of these women will require an additional prolapse surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reconstructive surgery corrects the prolapsed vagina and aims to restore normal anatomy, while obliterative surgery corrects prolapse by removing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    closing off all or a portion of the vaginal canal (colpocleisis) to reduce the viscera back into the pelvis. Most women with symptomatic POP are treated with a reconstructive procedure. However, obliterative procedures are an effective option for women who cannot tolerate more extensive surgery and who are not planning future vaginal intercourse. In addition, obliterative procedures are consistently associated with high rates of satisfaction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Obliterative procedures for POP are reviewed here. Evaluation of women with POP, conservative management, and choosing a primary surgical procedure are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/33/40473?source=see_link\">",
"     \"An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/7/17530?source=see_link\">",
"     \"Vaginal pessary treatment of prolapse and incontinence\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/7/9337?source=see_link\">",
"     \"Pelvic organ prolapse in women: Choosing a primary surgical procedure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20396416\">",
"    <span class=\"h1\">",
"     CANDIDATES FOR SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for obliterative prolapse repair are generally the same as for other POP repair procedures, ie, symptomatic prolapse in women who decline or fail conservative therapy. However, obliterative procedures are less invasive and better tolerated by frail, older women than reconstructive procedures. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/7/9337?source=see_link&amp;anchor=H2327205#H2327205\">",
"     \"Pelvic organ prolapse in women: Choosing a primary surgical procedure\", section on 'Candidates for surgical treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Obliterative procedures are reserved for women who are not candidates for more extensive surgery or do not plan future vaginal intercourse. A study that surveyed older adults on their sexuality reported that the prevalence of sexual activity decreased with aging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/5\">",
"     5",
"    </a>",
"    ]. Sexual activity amongst women ages 57 to 64 was 62 percent and decreased to 17 percent in women ages 75 to 85.",
"   </p>",
"   <p>",
"    In the appropriate population, the advantages of obliterative procedures compared with other types of POP surgery are that such procedures typically have a shorter operative duration, decreased perioperative morbidity, and an extremely low risk of prolapse recurrence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/6-13\">",
"     6-13",
"    </a>",
"    ]. A retrospective cohort study of older women (median age 80) reported similar rates of patient satisfaction after obliterative versus reconstructive surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The obvious disadvantages are the elimination of the potential for vaginal intercourse, as well as the inability to evaluate the cervix or uterus via a vaginal route (eg, cervical cytology or endometrial biopsy).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20396939\">",
"    <span class=\"h1\">",
"     PREOPERATIVE EVALUATION AND PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;POP often coexists with other pelvic floor symptoms. Similar to other reconstructive procedures, prior to recommending an obliterative procedure, surgeons should obtain a thorough pelvic floor history, including assessment of bothersome urinary symptoms (incontinence and voiding difficulties)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    defecatory problems. In addition, the symptoms specific to prolapse (eg, sensation of a vaginal bulge, irritation from ulceration of prolapse vaginal tissue) should be elicited. During the history and physical examination, the presence and severity of each of these disorders should be assessed, as this information may alter surgical decision making.",
"   </p>",
"   <p>",
"    Aspects of preoperative evaluation and preparation that are specific to obliterative POP surgery are discussed in this section. General principles of evaluation of women undergoing POP repair are discussed in detail separately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20396946\">",
"    <span class=\"h2\">",
"     Informed consent and patient goals",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to discuss with the patient each symptom that is present and the effect on her quality of life. This helps to set goals for reconstructive surgery and assess postoperative improvement. Studies have demonstrated that patient satisfaction after POP surgery correlates highly with achievement of self-described preoperative surgical goals, but poorly with objective outcome measures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/15-17\">",
"     15-17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Informed consent for obliterative POP surgery should include a discussion of the risks of surgery and loss of the ability to have future vaginal intercourse. Since many women develop stress urinary incontinence (SUI) following correction of apical prolapse, it is particularly important to discuss this risk and whether preventive surgery should be performed. (See",
"    <a class=\"local\" href=\"#H25884270\">",
"     'Concomitant stress urinary incontinence surgery'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1546?source=see_link&amp;anchor=H9#H9\">",
"     \"Pelvic organ prolapse and stress urinary incontinence in women: Combined surgical treatment\", section on 'Detecting occult incontinence'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20396953\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms should be reviewed that are related to POP and to associated urinary or anal incontinence. Women with POP may experience a bulge or protrusion from the vagina. Protrusion of the vagina may result in chronic discharge, vaginal discharge",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bleeding from ulceration. Other symptoms may include pelvic pressure, urinary retention, or constipation; some women have the need to reduce the prolapse using a finger in the vagina (ie, splint) to urinate or defecate.",
"   </p>",
"   <p>",
"    Medical comorbidities should be reviewed and preoperative medical consultation obtained if appropriate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/48/41735?source=see_link\">",
"     \"Overview of the principles of medical consultation and perioperative medicine\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20396960\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough speculum and bimanual pelvic examination are performed. The findings of the examination should be recorded using a quantitative and reproducible method for recording POP. The system currently recommended by the International Continence Society and the American Urogynecologic Society is the pelvic organ prolapse quantitation (POP-Q) system (",
"    <a class=\"graphic graphic_figure graphicRef74368 \" href=\"mobipreview.htm?14/54/15202\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef57450 \" href=\"mobipreview.htm?3/1/3100\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/46/8937?source=see_link&amp;anchor=H2#H2\">",
"     \"Pelvic organ prolapse in women: Diagnostic evaluation\", section on 'Speculum and bimanual examination'",
"    </a>",
"    .) Prolapse assessment should be done with the prolapse maximally everted and all vaginal compartments assessed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20396967\">",
"    <span class=\"h2\">",
"     Evaluation of urinary dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;POP frequently coexists with urinary incontinence or urinary retention, and women planning apical prolapse repair should be evaluated for these conditions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7777852\">",
"    <span class=\"h3\">",
"     Urinary incontinence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many women with stage II or greater apical prolapse remain continent despite loss of anterior vaginal and",
"    <span class=\"nowrap\">",
"     bladder/urethral",
"    </span>",
"    support. However, 13 to 65 percent of continent women develop symptoms of SUI after surgical correction of the prolapse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. A retrospective study of women who underwent colpocleisis reported that 8 of 30 developed de novo SUI postoperatively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/10\">",
"     10",
"    </a>",
"    ]. This likely occurs because the prolapse kinks and obstructs the urethra; this obstruction is alleviated when the prolapse is repaired. This is referred to as \"occult\" or \"potential\" stress incontinence. The decision to perform a prophylactic continence procedure at the time of colpocleisis remains unclear; however, several small case series suggest that concomitant midurethral sling at the time of colpocleisis is safe and does not result in high rates of urinary retention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Continent women undergoing colpocleisis should be counseled regarding the risks and benefits of prophylactic continence procedures versus staged procedures. Consideration should be given to evaluating these women preoperatively with reduced stress testing, although reduction testing does not accurately predict postoperative SUI (approximately 40 percent of women with negative testing will develop postoperative stress incontinence) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/25\">",
"     25",
"    </a>",
"    ]. This testing may impact surgical decision making, particularly for women undergoing transvaginal apical prolapse repair. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1546?source=see_link&amp;anchor=H9#H9\">",
"     \"Pelvic organ prolapse and stress urinary incontinence in women: Combined surgical treatment\", section on 'Detecting occult incontinence'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women with bothersome SUI should be counseled regarding a concomitant procedure for SUI, regardless of preoperative urinary retention. In a case series of 38 women with POP and SUI undergoing colpocleisis and midurethral sling, 11 women had preoperative urinary retention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/23\">",
"     23",
"    </a>",
"    ]. Ten of 11 women with preoperative retention had resolution of retention and no women experienced prolonged retention requiring sling release after surgery, suggesting it is reasonable to offer women with POP and bothersome SUI midurethral sling at the time of colpocleisis. In contrast, rectus fascial sling is associated with a three-fold increase in reoperation for postoperative retention when performed at the time of colpocleisis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7777859\">",
"    <span class=\"h3\">",
"     Urinary retention",
"    </span>",
"    &nbsp;&mdash;&nbsp;A postvoid residual (PVR) urine volume should be determined within 10 minutes of voiding. In general, a PVR of less than 50 mL is considered adequate emptying, and a PVR of greater than 200 mL is considered inadequate. Older women with advanced POP are at increased risk for urinary retention, which, in rare cases, may result in hydronephrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25884254\">",
"    <span class=\"h1\">",
"     SURGICAL PLANNING",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25884299\">",
"    <span class=\"h2\">",
"     Choosing a type of obliterative procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;All colpocleisis procedures remove vaginal epithelium and then appose the anterior and posterior vaginal muscularis. Apposing the anterior and posterior vaginal walls inverts the prolapsed apex and the sutured tissue forms a column of pelvic support [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/7\">",
"     7",
"    </a>",
"    ]. The two most common techniques for obliterative surgery for POP are [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Partial colpocleisis (Le Fort colpocleisis) &ndash; Partial (Le Fort) colpocleisis is done in patients in whom the uterus is left in situ and includes removal of strips of anterior and posterior vaginal epithelium, leaving a small strip of lateral epithelium on each side. The primary purpose for leaving the lateral strips of epithelium is to provide an outlet for cervical or uterine bleeding or drainage in patients where the uterus is left in situ. However, some surgeons leave the lateral epithelium to help orient junior surgeons when learning the procedure.",
"     </li>",
"     <li>",
"      Total colpocleisis &ndash; Total colpocleisis is generally reserved for vaginal vault prolapse and refers to removal of the majority of the vaginal epithelium. This procedure is also referred to as complete colpocleisis, colpectomy, or vaginectomy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Whether performing a partial or total colpocleisis, 3 to 4 cm of distal vaginal epithelium should be left in place to avoid placing traction on the posterior urethra when suturing the anterior and posterior vaginal muscularis. This distal traction on the posterior urethral and bladder neck may increase SUI postoperatively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25884262\">",
"    <span class=\"h2\">",
"     Concomitant hysterectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Concomitant hysterectomy is often performed at the time of POP surgery, despite case series data that suggest that hysterectomy performed at the time of colpocleisis increases operative duration and morbidity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/12,27\">",
"     12,27",
"    </a>",
"    ]. Obliterative surgery is highly effective, regardless of whether hysterectomy is performed. In a retrospective study of 92 women who underwent total colpocleisis, concomitant hysterectomy was associated with significant increases in operative duration (an average of 52 minutes longer) and transfusion rate (35 versus 13 percent) compared with no hysterectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some surgeons routinely recommend concomitant hysterectomy because obliterative procedures preclude future evaluation of the cervix or uterus (eg, cervical cytology or endometrial biopsy). Hysterectomy also prevents future pyometra, but this complication is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/28-32\">",
"     28-32",
"    </a>",
"    ]. However, the increased morbidity associated with concomitant hysterectomy does not offset rare",
"    <span class=\"nowrap\">",
"     uterine/cervical",
"    </span>",
"    complications. Women with a uterus",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cervix should undergo preoperative evaluation of the cervix and endometrium (cervical cytology and endometrial sampling",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    transvaginal ultrasound) prior to obliterative procedures without concomitant hysterectomy.",
"   </p>",
"   <p>",
"    Hysterectomy may be advisable in women with risk factors for cervical cancer (eg, current or recent high risk human papillomavirus infection or cervical intraepithelial neoplasia) or endometrial cancer (eg, obesity,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    use, Lynch syndrome), although there are no studies evaluating obliterative procedures in these groups. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38744?source=see_link&amp;anchor=H7#H7\">",
"     \"Evaluation of the endometrium for malignant or premalignant disease\", section on 'Transvaginal ultrasound'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/55/28537?source=see_link&amp;anchor=H3#H3\">",
"     \"Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis\", section on 'Epidemiology and risk factors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/27/18874?source=see_link&amp;anchor=H2#H2\">",
"     \"Endometrial carcinoma: Epidemiology and risk factors\", section on 'Risk factors'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    For women who are undergoing colpocleisis and are at an average risk of cervical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    endometrial cancer, we suggest not performing concomitant hysterectomy.",
"   </p>",
"   <p>",
"    A detailed discussion of hysterectomy at the time of surgery for POP can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/7/9337?source=see_link&amp;anchor=H2327312#H2327312\">",
"     \"Pelvic organ prolapse in women: Choosing a primary surgical procedure\", section on 'Concomitant hysterectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25884270\">",
"    <span class=\"h2\">",
"     Concomitant stress urinary incontinence surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women undergoing obliterative POP surgery often have symptomatic or occult SUI. Concomitant continence surgery is appropriate in some women, depending upon their symptoms and goals for treatment. (See",
"    <a class=\"local\" href=\"#H20396967\">",
"     'Evaluation of urinary dysfunction'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Historically, a Kelly suburethral plication was done at the time of colpocleisis to treat or prevent SUI; however, this procedure is often unsuccessful. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/10/43177?source=see_link&amp;anchor=H9#H9\">",
"     \"Stress urinary incontinence in women: Choosing a primary surgical procedure\", section on 'Procedures no longer recommended'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The outcomes of combined surgical treatment of POP and SUI were best illustrated in the Outcomes Following Vaginal Prolapse Repair and Midurethral Sling (OPUS) trial, which evaluated the addition of a concomitant prophylactic midurethral sling procedure in continent women at the time of vaginal prolapse surgery, including women who underwent colpocleisis (24 women; 8 percent of participants) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/33\">",
"     33",
"    </a>",
"    ]. Women who had a concomitant sling had lower rates of incontinence or treatment for incontinence one year after surgery, but had an increased risk of complications (eg, voiding dysfunction). A detailed discussion of the OPUS trial can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1546?source=see_link&amp;anchor=H15#H15\">",
"     \"Pelvic organ prolapse and stress urinary incontinence in women: Combined surgical treatment\", section on 'POP with no symptoms of SUI'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, several small case series suggest that concomitant midurethral sling at the time of colpocleisis is safe and does not result in high rates of urinary retention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. A retrospective study of 30 women who underwent colpocleisis and midurethral sling placement reported one perioperative complication (a myocardial infarction); only two women (6.6 percent) had mild postoperative SUI (not requiring a pad) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Combined treatment for POP and SUI is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1546?source=see_link\">",
"     \"Pelvic organ prolapse and stress urinary incontinence in women: Combined surgical treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1523239\">",
"    <span class=\"h1\">",
"     ANESTHESIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colpocleisis can be performed under general or regional anesthesia. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3586400\">",
"    <span class=\"h1\">",
"     PROCEDURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Using sharp and blunt dissection, the vaginal epithelium is dissected off the underlying muscularis (",
"    <a class=\"graphic graphic_figure graphicRef51734 \" href=\"mobipreview.htm?24/43/25272\">",
"     figure 3",
"    </a>",
"    ). A total colpocleisis removes all of the vaginal epithelium, while a partial colpocleisis leaves a small portion of vaginal epithelium on each side to provide drainage tracts in women with a uterus, as noted above. (See",
"    <a class=\"local\" href=\"#H25884299\">",
"     'Choosing a type of obliterative procedure'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The leading edge of the prolapse is identified and successive interrupted delayed absorbable sutures are used to reduce the prolapse until it lies above the levator plate, effectively obliterating the vaginal canal. Approximately 3 to 4 cm of epithelium on the distal anterior vaginal wall should be left in place to avoid pulling the posterior urethra down when suturing the anterior and posterior vagina. The urethrovaginal junction can be easily identified by placing gentle traction on the Foley catheter and palpating the balloon. The urethrovesical junction can then be marked with a sterile skin marker to prevent over dissection of the epithelium in this area.",
"   </p>",
"   <p>",
"    Finally, a wide perineorrhaphy is created by removing a large diamond shaped area of perineal skin and distal vaginal epithelium. The levator muscles are then approximated with nonabsorbable sutures. Typically, the genital hiatus is reduced to allow passage of one finger.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23451733\">",
"    <span class=\"h1\">",
"     FOLLOW-UP",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23451747\">",
"    <span class=\"h2\">",
"     Routine postoperative care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most women will experience a small amount of vaginal bleeding, as well as incisional pain following obliterative POP surgery. These symptoms typically resolve within one week postoperatively and can be treated with nonsteroidal antiinflammatory medications. Narcotics are often unnecessary. Patients should be advised to call their surgeon in case of severe or persistent bleeding or abdominal pain or the development of increasing incisional pain, vaginal discharge, dysuria, or fever. Routine postoperative clinical evaluation should occur within the first two to four weeks.",
"   </p>",
"   <p>",
"    A detailed discussion of postoperative care after gynecologic surgery can be found separately. (See",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/27/28083?source=see_link\">",
"     \"Patient information: Care after gynecologic surgery (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23451754\">",
"    <span class=\"h2\">",
"     Sexual function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaginal intercourse is precluded following colpocleisis, but other sexual activities are possible. There are few data regarding sexual function following colpocleisis. In one prospective study, women reported differing impacts on sexual function, including worse (3 percent), unchanged (87 percent), and improved (10 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3586416\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Significant postoperative complications are often related to comorbidities in an elderly population; postoperative cardiac, thromboembolic, pulmonary, or cerebrovascular events occur in approximately two percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/8,34\">",
"     8,34",
"    </a>",
"    ]. A review of published reports of colpocleisis since 1980 calculated a surgical mortality rate of 1 in 400 cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Four percent of patients experience complications related to the procedure itself, eg, transfusion or pyelonephritis; these events occur mostly when concomitant hysterectomy is performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/8,27\">",
"     8,27",
"    </a>",
"    ]. Less frequently, complications include ongoing vaginal bleeding, fever and intraoperative ureteral injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23451578\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colpocleisis is highly effective for treating prolapse; success rates range from 90 to 100 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/4,9-13,35\">",
"     4,9-13,35",
"    </a>",
"    ]. As an example, a large retrospective study (n = 310) found that 93 percent of women who underwent colpocleisis reported their symptoms were cured or greatly improved. The complication rate was 15 percent; most complications were minor, but four deaths occurred (two cases of postoperative pulmonary embolisms, one myocardial infarction 42 days after surgery, one case of sepsis related to a bowel injury during a concomitant procedure) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/36\">",
"     36",
"    </a>",
"    ]. In over 90 percent of women with urinary retention undergoing colpocleisis, urinary retention resolves after surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Colpocleisis does not appear to alter body image and regret after the procedure is uncommon (ranging from than 0 to 13 percent) and not related to patient age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43607/abstract/6,9,12,27,38-40\">",
"     6,9,12,27,38-40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3586365\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obliterative surgery treats pelvic organ prolapse (POP) by removing",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      closing off all or a portion of the vaginal canal (colpocleisis) to reduce the vagina and viscera back into the pelvis. While most women with symptomatic POP are treated with a reconstructive procedure, obliterative procedures are an effective option for women who cannot tolerate more extensive surgery and who are not planning future vaginal intercourse. (See",
"      <a class=\"local\" href=\"#H20396416\">",
"       'Candidates for surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Partial (Le Fort) colpocleisis is done in patients in whom the uterus is left in situ and involves removal of strips of anterior and posterior vaginal epithelium. The remaining lateral portions of epithelium are left in place, providing drainage tracts for uterine bleeding or discharge. Total colpocleisis (colpectomy) is typically done for vaginal vault prolapse, and the majority of the vaginal epithelium is removed. (See",
"      <a class=\"local\" href=\"#H25884299\">",
"       'Choosing a type of obliterative procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women with a uterus or cervix who are undergoing colpocleisis, we suggest partial colpocleisis (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For women without a cervix or uterus, either partial or total colpocleisis may be performed. (See",
"      <a class=\"local\" href=\"#H25884299\">",
"       'Choosing a type of obliterative procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women who are undergoing colpocleisis and are at an average risk of cervical",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      endometrial cancer, we suggest NOT performing concomitant hysterectomy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Concomitant hysterectomy at the time of colpocleisis increases operative duration and morbidity. (See",
"      <a class=\"local\" href=\"#H25884262\">",
"       'Concomitant hysterectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women undergoing obliterative POP surgery often have symptomatic or occult stress urinary incontinence (SUI). Concomitant midurethral sling is appropriate in some women and does not seem to increase postoperative rates of urinary retention. (See",
"      <a class=\"local\" href=\"#H25884270\">",
"       'Concomitant stress urinary incontinence surgery'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1546?source=see_link&amp;anchor=H15#H15\">",
"       \"Pelvic organ prolapse and stress urinary incontinence in women: Combined surgical treatment\", section on 'POP with no symptoms of SUI'",
"      </a>",
"      .). &nbsp;",
"     </li>",
"     <li>",
"      Significant postoperative complications of colpocleisis are often related to comorbidities in an elderly population. The most common complications related to the procedure itself are transfusion and pyelonephritis. (See",
"      <a class=\"local\" href=\"#H3586416\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Colpocleisis",
"      <strong>",
"      </strong>",
"      is highly effective for treating prolapse; success rates range from 90 to 100 percent. Colpocleisis does not appear to alter body image and regret after the procedure is uncommon (ranging from 0 to 13 percent). (See",
"      <a class=\"local\" href=\"#H23451578\">",
"       'Outcome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/1\">",
"      Jones KA, Shepherd JP, Oliphant SS, et al. Trends in inpatient prolapse procedures in the United States, 1979-2006. Am J Obstet Gynecol 2010; 202:501.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/2\">",
"      Boyles SH, Weber AM, Meyn L. Procedures for pelvic organ prolapse in the United States, 1979-1997. Am J Obstet Gynecol 2003; 188:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/3\">",
"      Olsen AL, Smith VJ, Bergstrom JO, et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997; 89:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/4\">",
"      Fitzgerald MP, Richter HE, Bradley CS, et al. Pelvic support, pelvic symptoms, and patient satisfaction after colpocleisis. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:1603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/5\">",
"      Lindau ST, Schumm LP, Laumann EO, et al. A study of sexuality and health among older adults in the United States. N Engl J Med 2007; 357:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/6\">",
"      Barber MD, Amundsen CL, Paraiso MF, et al. Quality of life after surgery for genital prolapse in elderly women: obliterative and reconstructive surgery. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/7\">",
"      Abbasy S, Kenton K. Obliterative procedures for pelvic organ prolapse. Clin Obstet Gynecol 2010; 53:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/8\">",
"      FitzGerald MP, Richter HE, Siddique S, et al. Colpocleisis: a review. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/9\">",
"      DeLancey JO, Morley GW. Total colpocleisis for vaginal eversion. Am J Obstet Gynecol 1997; 176:1228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/10\">",
"      FitzGerald MP, Brubaker L. Colpocleisis and urinary incontinence. Am J Obstet Gynecol 2003; 189:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/11\">",
"      Hanson GE, Keettel WC. The Neugebauer-Le Fort operation. A review of 288 colpocleises. Obstet Gynecol 1969; 34:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/12\">",
"      Hoffman MS, Cardosi RJ, Lockhart J, et al. Vaginectomy with pelvic herniorrhaphy for prolapse. Am J Obstet Gynecol 2003; 189:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/13\">",
"      Gutman RE, Bradley CS, Ye W, et al. Effects of colpocleisis on bowel symptoms among women with severe pelvic organ prolapse. Int Urogynecol J 2010; 21:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/14\">",
"      Murphy M, Sternschuss G, Haff R, et al. Quality of life and surgical satisfaction after vaginal reconstructive vs obliterative surgery for the treatment of advanced pelvic organ prolapse. Am J Obstet Gynecol 2008; 198:573.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/15\">",
"      Elkadry EA, Kenton KS, FitzGerald MP, et al. Patient-selected goals: a new perspective on surgical outcome. Am J Obstet Gynecol 2003; 189:1551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/16\">",
"      Hullfish KL, Bovbjerg VE, Steers WD. Patient-centered goals for pelvic floor dysfunction surgery: long-term follow-up. Am J Obstet Gynecol 2004; 191:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/17\">",
"      Mahajan ST, Elkadry EA, Kenton KS, et al. Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am J Obstet Gynecol 2006; 194:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/18\">",
"      Brubaker, L, Norton, P. Current Clinical Nomenclature for Description of Pelvic Organ Prolapse. Journal of Pelvic Surgery 1996; 2:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/19\">",
"      Ellerkmann RM, Cundiff GW, Melick CF, et al. Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol 2001; 185:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/20\">",
"      Gutman RE, Ford DE, Quiroz LH, et al. Is there a pelvic organ prolapse threshold that predicts pelvic floor symptoms? Am J Obstet Gynecol 2008; 199:683.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/21\">",
"      Swift S, Woodman P, O'Boyle A, et al. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol 2005; 192:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/22\">",
"      Mouritsen L, Larsen JP. Symptoms, bother and POPQ in women referred with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/23\">",
"      Abbasy S, Lowenstein L, Pham T, et al. Urinary retention is uncommon after colpocleisis with concomitant mid-urethral sling. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/24\">",
"      Moore RD, Miklos JR. Colpocleisis and tension-free vaginal tape sling for severe uterine and vaginal prolapse and stress urinary incontinence under local anesthesia. J Am Assoc Gynecol Laparosc 2003; 10:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/25\">",
"      Visco AG, Brubaker L, Nygaard I, et al. The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/26\">",
"      Beverly CM, Walters MD, Weber AM, et al. Prevalence of hydronephrosis in patients undergoing surgery for pelvic organ prolapse. Obstet Gynecol 1997; 90:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/27\">",
"      von Pechmann WS, Mutone M, Fyffe J, Hale DS. Total colpocleisis with high levator plication for the treatment of advanced pelvic organ prolapse. Am J Obstet Gynecol 2003; 189:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/28\">",
"      Kohli N, Sze E, Karram M. Pyometra following Le Fort colpocleisis. Int Urogynecol J Pelvic Floor Dysfunct 1996; 7:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/29\">",
"      Shayya RF, Weinstein MM, Lukacz ES. Pyometra after Le Fort colpocleisis resolved with interventional radiology drainage. Obstet Gynecol 2009; 113:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/30\">",
"      Toglia MR, Fagan MJ. Pyometra complicating a LeFort colpocleisis. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/31\">",
"      Carberry CL, Hampton BS, Aguilar VC. Pyometra necessitating hysterectomy after colpocleisis in an extremely elderly patient. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/32\">",
"      Roth TM. Pyometra and recurrent prolapse after Le Fort colpocleisis. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/33\">",
"      Wei JT, Nygaard I, Richter HE, et al. A midurethral sling to reduce incontinence after vaginal prolapse repair. N Engl J Med 2012; 366:2358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/34\">",
"      Stepp KJ, Barber MD, Yoo EH, et al. Incidence of perioperative complications of urogynecologic surgery in elderly women. Am J Obstet Gynecol 2005; 192:1630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/35\">",
"      Misrai V, Gosseine PN, Costa P, et al. [Colpocleisis: indications, technique and results]. Prog Urol 2009; 19:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/36\">",
"      Zebede S, Smith AL, Plowright LN, et al. Obliterative LeFort colpocleisis in a large group of elderly women. Obstet Gynecol 2013; 121:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/37\">",
"      Fitzgerald MP, Kulkarni N, Fenner D. Postoperative resolution of urinary retention in patients with advanced pelvic organ prolapse. Am J Obstet Gynecol 2000; 183:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/38\">",
"      Harmanli OH, Dandolu V, Chatwani AJ, Grody MT. Total colpocleisis for severe pelvic organ prolapse. J Reprod Med 2003; 48:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/39\">",
"      Lu, YX, Hu, ML, Wang, WY, et al. [Colpocleisis in elderly patients with severe pelvic organ prolapse]. Zhonghua Fu Chan Ke Za Zhi 2010; 45:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43607/abstract/40\">",
"      Hullfish KL, Bovbjerg VE, Steers WD. Colpocleisis for pelvic organ prolapse: patient goals, quality of life, and satisfaction. Obstet Gynecol 2007; 110:341.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15268 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-617C8121F3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_37_43607=[""].join("\n");
var outline_f42_37_43607=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3586365\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3586030\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20396416\">",
"      CANDIDATES FOR SURGERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20396939\">",
"      PREOPERATIVE EVALUATION AND PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20396946\">",
"      Informed consent and patient goals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20396953\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20396960\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20396967\">",
"      Evaluation of urinary dysfunction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7777852\">",
"      - Urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7777859\">",
"      - Urinary retention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25884254\">",
"      SURGICAL PLANNING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25884299\">",
"      Choosing a type of obliterative procedure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25884262\">",
"      Concomitant hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25884270\">",
"      Concomitant stress urinary incontinence surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1523239\">",
"      ANESTHESIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3586400\">",
"      PROCEDURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23451733\">",
"      FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23451747\">",
"      Routine postoperative care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23451754\">",
"      Sexual function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3586416\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23451578\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3586365\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/15268\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/15268|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?14/54/15202\" title=\"figure 1\">",
"      Sites pelvic organ support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/1/3100\" title=\"figure 2\">",
"      Three by three grid POP-Q",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/43/25272\" title=\"figure 3\">",
"      Partial colpocleisis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/33/40473?source=related_link\">",
"      An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/27/18874?source=related_link\">",
"      Endometrial carcinoma: Epidemiology and risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38744?source=related_link\">",
"      Evaluation of the endometrium for malignant or premalignant disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/55/28537?source=related_link\">",
"      Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/48/41735?source=related_link\">",
"      Overview of the principles of medical consultation and perioperative medicine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/27/28083?source=related_link\">",
"      Patient information: Care after gynecologic surgery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1546?source=related_link\">",
"      Pelvic organ prolapse and stress urinary incontinence in women: Combined surgical treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/7/9337?source=related_link\">",
"      Pelvic organ prolapse in women: Choosing a primary surgical procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/46/8937?source=related_link\">",
"      Pelvic organ prolapse in women: Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/10/43177?source=related_link\">",
"      Stress urinary incontinence in women: Choosing a primary surgical procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/7/17530?source=related_link\">",
"      Vaginal pessary treatment of prolapse and incontinence",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_37_43608="Ischemic stroke in children: Evaluation, initial management, and prognosis";
var content_f42_37_43608=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ischemic stroke in children: Evaluation, initial management, and prognosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/37/43608/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/37/43608/contributors\">",
"     Sabrina E Smith, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/37/43608/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/37/43608/contributors\">",
"     Scott E Kasner, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/37/43608/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/37/43608/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/37/43608/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/37/43608/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 30, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;While more common in older adults, stroke also occurs in neonates, infants, children, and young adults, resulting in significant morbidity and mortality.",
"   </p>",
"   <p>",
"    An overview of the evaluation, initial management, and prognosis of arterial ischemic stroke in children one month of age or older is provided here. Other aspects of ischemic stroke in children and young adults are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/61/23513?source=see_link\">",
"     \"Ischemic stroke in children and young adults: Etiology and clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/27/27063?source=see_link\">",
"     \"Ischemic stroke in children: Secondary prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/2/27690?source=see_link\">",
"     \"Stroke in the newborn\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/26/7594?source=see_link\">",
"     \"Etiology, clinical features, and diagnosis of cerebral venous thrombosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urgent neuroimaging is important for confirming the diagnosis of acute arterial ischemic stroke because there are numerous conditions that can mimic ischemic stroke, particularly with regard to children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because the causes of stroke in children and young adults are varied, and because the presence of multiple risk factors for stroke increases recurrence risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/2\">",
"     2",
"    </a>",
"    ], clinicians should conduct a thorough investigation for possible cardiac, vascular, and hematologic risk factors in all patients.",
"   </p>",
"   <p>",
"    Stroke in children is a multifactorial disease, so the full diagnostic evaluation should be completed even if one risk factor is identified. In support of this, a case-control study of 38 children with underlying cardiac disease and ischemic stroke found more than one hemostatic abnormality consistent with a prothrombotic state in 10.5 percent of cases and in none of the 100 age-matched controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children, head CT is generally considered inadequate to diagnose stroke, since MRI may be required to reliably exclude stroke mimics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. Brain MRI is more sensitive for acute ischemia than CT, particularly with use of diffusion weighted imaging in the hyperacute time period. In addition, brain MRI provides better visualization of the posterior fossa.",
"   </p>",
"   <p>",
"    Current UK guidelines from the Royal College of Physicians (RCP) recommend brain MRI for the investigation of children presenting with clinical stroke, and further suggest that brain MRI be obtained as soon as possible after admission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/4\">",
"     4",
"    </a>",
"    ]. Head CT is considered an acceptable initial alternative only if brain MRI is not available within 48 hours of admission.",
"   </p>",
"   <p>",
"    In adults, either a noncontrast head CT or a brain MRI is considered acceptable as the initial imaging study, as noted in current guidelines from the American Heart",
"    <span class=\"nowrap\">",
"     Association/American",
"    </span>",
"    Stroke Association [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. The choice between these methods depends mainly on local preference, expertise and availability. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/56/17290?source=see_link\">",
"     \"Neuroimaging of acute ischemic stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In agreement with the RCP guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/4\">",
"     4",
"    </a>",
"    ], we obtain a brain MRI with diffusion weighted imaging as the initial study in children with suspected ischemic stroke. MRI with gadolinium contrast may be helpful in identifying conditions that can mimic stroke clinically, but gadolinium is not necessary for the diagnosis of ischemic stroke. Head CT can be substituted if MRI is not tolerated or will not be available within 48 hours after stroke onset. In young adults, either CT or MRI may be used as the initial study, but we prefer brain MRI with diffusion imaging if available because it is more sensitive for the diagnosis of acute stroke than CT.",
"   </p>",
"   <p>",
"    In addition to brain imaging, we suggest the following neurovascular evaluation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Magnetic resonance angiography (MRA) of the head to evaluate the intracranial large arteries. Computed tomography angiography (CTA) can be substituted depending on availability and local expertise.",
"     </li>",
"     <li>",
"      MRA of the neck to evaluate the extracranial large arteries. CTA can be substituted depending on availability and local expertise.",
"     </li>",
"     <li>",
"      Axial T1 MRI of the neck with fat saturation to evaluate for dissection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation for stroke in children should include the following studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Electrocardiogram",
"     </li>",
"     <li>",
"      Complete blood count including platelets",
"     </li>",
"     <li>",
"      Electrolytes, urea nitrogen, creatinine",
"     </li>",
"     <li>",
"      Serum glucose",
"     </li>",
"     <li>",
"      Prothrombin time (PT) and international normalized ratio (INR)",
"     </li>",
"     <li>",
"      Partial thromboplastin time (PTT)",
"     </li>",
"     <li>",
"      Oxygen saturation",
"     </li>",
"     <li>",
"      Transthoracic echocardiography with agitated saline study to evaluate for possible cardiac source of embolism, including right to left shunt",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In selected patients, additional studies may be useful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiac enzymes and troponin if there is clinical suspicion of myocardial ischemia",
"     </li>",
"     <li>",
"      Electroencephalogram if seizures are suspected",
"     </li>",
"     <li>",
"      Transesophageal echocardiography (TEE) if TTE is nondiagnostic, or if there is a high index of suspicion for a cardioembolic source",
"     </li>",
"     <li>",
"      Transcranial Doppler when MRA or CTA are nondiagnostic and there is a high index of clinical suspicion for intracranial large artery disease",
"     </li>",
"     <li>",
"      Holter monitor if there is suspicion for cardiac arrhythmia, particularly atrial fibrillation",
"     </li>",
"     <li>",
"      Hemoglobin electrophoresis in patients with possible sickle cell disease",
"     </li>",
"     <li>",
"      Liver function tests",
"     </li>",
"     <li>",
"      Toxicology screen",
"     </li>",
"     <li>",
"      Blood alcohol level",
"     </li>",
"     <li>",
"      Pregnancy test in women of child-bearing potential",
"     </li>",
"     <li>",
"      Lumbar puncture, if there is clinical suspicion for subarachnoid hemorrhage and head CT scan is negative for blood, or if there is suspicion for an infectious etiology of stroke",
"     </li>",
"     <li>",
"      Hypercoagulable evaluation (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Hypercoagulable state evaluation'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Vasculitis evaluation (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Vasculitis evaluation'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Hypercoagulable state evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous prothrombotic conditions are risk factors for ischemic stroke in children. However, since the precise role of prothrombotic states in stroke pathophysiology remains unclear, clinical practice regarding screening for prothrombotic states and subsequent treatment varies by center. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/30/14825?source=see_link\">",
"     \"Screening for inherited thrombophilia in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/61/23513?source=see_link&amp;anchor=H7#H7\">",
"     \"Ischemic stroke in children and young adults: Etiology and clinical features\", section on 'Hematologic'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We screen for a hypercoagulable state in all children with ischemic stroke except those with sickle cell disease. Our approach is in agreement with current guidelines from the Royal College of Physicians and the American Heart Association Stroke council, which recommend prothrombotic testing for all children with arterial ischemic stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/4,7\">",
"     4,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In our clinical experience, this approach is especially important for children with congenital heart disease. These children undergo frequent instrumentation and line placement. While the cardiac defect is a strong risk factor for stroke, identification of a prothrombotic abnormality that may be a second risk factor for stroke can influence management. As an example, anticoagulation may be instituted in children with congenital heart disease and a prothrombotic state to prevent clot formation and possible stroke during high risk periods.",
"   </p>",
"   <p>",
"    However, the evidence supporting this approach is limited, and some experts reserve hypercoagulable testing only for children who do not have an obvious alternative explanation for the stroke.",
"   </p>",
"   <p>",
"    The following studies are suggested as part of the evaluation for a hypercoagulable state in children:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Protein C functional",
"     </li>",
"     <li>",
"      Protein S free and total or protein S functional",
"     </li>",
"     <li>",
"      Antithrombin III activity",
"     </li>",
"     <li>",
"      Lipoprotein (a)",
"     </li>",
"     <li>",
"      Homocysteine",
"     </li>",
"     <li>",
"      Prothrombin gene mutations",
"     </li>",
"     <li>",
"      Factor V Leiden gene mutation",
"     </li>",
"     <li>",
"      Anticardiolipin antibodies (IgG and IgM)",
"     </li>",
"     <li>",
"      Beta2-glycoprotein I antibodies (IgG and IgM)",
"     </li>",
"     <li>",
"      Lupus anticoagulant tests, including dilute Russell viper venom time and dilute activated PTT",
"     </li>",
"     <li>",
"      Factor VIII activity",
"     </li>",
"     <li>",
"      D-dimer",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Vasculitis evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following studies are suggested whenever there is clinical suspicion of vasculitis, inflammation, or infection as the cause of ischemic stroke in children:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cerebral digital subtraction angiography",
"     </li>",
"     <li>",
"      Erythrocyte sedimentation rate and C-reactive protein level",
"     </li>",
"     <li>",
"      Antinuclear antibody assay",
"     </li>",
"     <li>",
"      Varicella titers",
"     </li>",
"     <li>",
"      Human immunodeficiency virus testing (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/44/35525?source=see_link\">",
"       \"Diagnostic testing for HIV infection in infants and children younger than 18 months\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/55/20345?source=see_link\">",
"       \"Diagnostic assays for HIV infection\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/17/22808?source=see_link\">",
"       \"Acute and early HIV infection: Treatment\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Serum nontreponemal tests (eg, Venereal Disease Research Laboratory [VDRL] or Rapid Plasma Reagin [RPR])",
"     </li>",
"     <li>",
"      When there is suspicion for late forms of neurosyphilis, serum treponemal tests (eg, fluorescent treponemal antibody absorption [FTA-ABS] or Treponema pallidum particle agglutination assay [TPPA]) should be performed (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/44/26312?source=see_link&amp;anchor=H15#H15\">",
"       \"Neurosyphilis\", section on 'Diagnosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Lumbar puncture and cerebrospinal fluid (CSF) examination with cell count, differential, protein concentration, and acid-fast bacilli testing; in patients with suspected neurosyphilis, testing should include determination of the CSF-VDRL titer",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     MELAS evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the diagnosis of MELAS is suspected on clinical grounds, the evaluation includes, in part:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lactate levels from serum and cerebrospinal fluid",
"     </li>",
"     <li>",
"      Molecular genetic testing (of blood leukocytes, cultured skin fibroblast, skeletal muscle, urine sediment",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      cheek mucosa)",
"     </li>",
"     <li>",
"      Muscle biopsy, particularly if genetic testing is nondiagnostic",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These studies are not always abnormal in patients with MELAS because of heteroplasmy for mitochondrial mutations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/35/12853?source=see_link&amp;anchor=H8#H8\">",
"     \"Mitochondrial structure, function, and genetics\", section on 'Heteroplasmy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    At least 29 different point mutations in mitochondrial DNA have been associated with MELAS. However, approximately 80 percent of cases are related to the A3243G transfer RNA mutation and 8 percent to the T3271C transfer RNA mutation.",
"   </p>",
"   <p>",
"    The evaluation of mitochondrial disorders including MELAS is discussed in greater detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/12/7370?source=see_link&amp;anchor=H16#H16\">",
"     \"Mitochondrial myopathies: Clinical features and diagnosis\", section on 'Evaluation and diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     INITIAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;No randomized controlled trials of treatment in acute childhood stroke have been performed. In general, treatment of pediatric stroke is largely adapted from treatment of adult stroke. However, the treatment of children with stroke diverges from that of adults with regard to the use of acute anticoagulation and the use of recombinant tissue plasminogen activator (t-PA or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?12/2/12328?source=see_link\">",
"     alteplase",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Our management recommendations for pediatric stroke are based on the clinical experience of experts, as reflected in consensus guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/4,7,8\">",
"     4,7,8",
"    </a>",
"    ], clinical trials in adults, and the clinical experience of the author.",
"   </p>",
"   <p>",
"    The treatment of ischemic stroke in adults is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/29/33242?source=see_link\">",
"     \"Initial assessment and management of acute stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/8/41098?source=see_link\">",
"     \"Reperfusion therapy for acute ischemic stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/60/31688?source=see_link\">",
"     \"Antithrombotic treatment of acute ischemic stroke and transient ischemic attack\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment for adults with transient cerebral ischemia (transient ischemic attack or TIA) or ischemic stroke where the potential cause has been identified is also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/33/32281?source=see_link\">",
"     \"Secondary prevention for specific causes of ischemic stroke and transient ischemic attack\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Supportive measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;For most patients with suspected acute arterial ischemic stroke, the following supportive measures are recommended:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Maintain airway, breathing, and circulation (ABCs)",
"     </li>",
"     <li>",
"      Maintain normoglycemia and normothermia; start normal saline intravenously at maintenance rate",
"     </li>",
"     <li>",
"      Allow modest hypertension",
"     </li>",
"     <li>",
"      Perform frequent neurologic checks",
"     </li>",
"     <li>",
"      Begin respiratory and oxygen saturation monitoring, along with oxygen supplementation to keep oxygen saturation &gt;95 percent",
"     </li>",
"     <li>",
"      Utilize cardiac monitoring for the first 24 hours after stroke onset to look for atrial fibrillation or other potentially serious cardiac arrhythmias",
"     </li>",
"     <li>",
"      Start venous thromboembolism prophylaxis with pneumatic compression device for patients restricted to bed with paralysis or diminished consciousness",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most patients with acute ischemic stroke should be positioned as flat as possible in bed for at least the first 24 hours from stroke onset, ideally with head-of-bed elevation kept between 0 and 15 degrees. Exacerbation of elevated intracranial pressure (ICP) may occur with flat head-of-bed positioning. Significant aggravation of elevated ICP is unlikely in the first 24 hours after ischemic stroke onset, but can occur after 24 hours. Thus, patients with large ischemic infarction of unknown onset or &gt;24 hours since onset should be maintained at 30 degrees in bed, once hypovolemia has been excluded.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Thrombolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?12/2/12328?source=see_link\">",
"     Alteplase",
"    </a>",
"    (rt-PA) is not approved in the United States by the Food and Drug Administration for use in children less than 18 years of age with ischemic stroke. There are case reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/9-16\">",
"     9-16",
"    </a>",
"    ], national registry data from the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/17\">",
"     17",
"    </a>",
"    ], and international registry data [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/18\">",
"     18",
"    </a>",
"    ] of intravenous or intraarterial thrombolysis use in small numbers of children. However, the effectiveness, safety and dose of alteplase for the treatment of children with arterial ischemic stroke have not been established.",
"   </p>",
"   <p>",
"    For children with acute ischemic stroke, consensus guidelines recommend not using thrombolysis or mechanical thrombectomy outside of specific research protocols or clinical trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Similarly, until additional studies are performed, we suggest",
"    <strong>",
"     not",
"    </strong>",
"    using thrombolytics for children (age 14 and younger) with stroke outside of a clinical trial or a rigorous research protocol.",
"   </p>",
"   <p>",
"    There was no consensus regarding the use of thrombolysis for older adolescents in the",
"    <span class=\"nowrap\">",
"     AHA/ASA",
"    </span>",
"    guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/7\">",
"     7",
"    </a>",
"    ]. However, recognizing that safety and efficacy data are lacking in patients younger than 18 years of age, it may be reasonable to consider thrombolytic treatment on an individual basis for older adolescents (age 15 and older) with acute arterial ischemic stroke. Strict adherence to the accepted time limits and other eligibility criteria used in adults should be observed if thrombolytic therapy is employed for older adolescents. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/26/6570?source=see_link&amp;anchor=H548320#H548320\">",
"     \"Intravenous fibrinolytic (thrombolytic) therapy in acute ischemic stroke: Therapeutic use\", section on 'Patient selection and eligibility'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/8/41098?source=see_link\">",
"     \"Reperfusion therapy for acute ischemic stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Initial antithrombotic treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, there are no randomized controlled trials examining the effectiveness of antiplatelet or anticoagulation therapy for the treatment of acute arterial ischemic stroke in children.",
"   </p>",
"   <p>",
"    Limited data suggest anticoagulation therapy in children has an acceptable safety profile, although efficacy remains uncertain. In a nonrandomized observational study of children with arterial ischemic stroke, 123 were treated with various forms of anticoagulant therapy within seven days after diagnosis; new or increased intracerebral hemorrhage developed in 11 percent and was symptomatic in 4 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/19\">",
"     19",
"    </a>",
"    ]. A similar rate of new or increased intracerebral hemorrhage (16 percent) was observed among 75 children who were not treated with anticoagulant therapy. Another nonrandomized study of 135 children with a first episode of ischemic stroke due to various mechanisms found no statistically significant difference in risk of stroke recurrence between those who were treated with",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/10/19624?source=see_link\">",
"     aspirin",
"    </a>",
"    versus those treated with low-dose low molecular weight",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/39/7801?source=see_link\">",
"     heparin",
"    </a>",
"    and followed for a median duration of 36 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/20\">",
"     20",
"    </a>",
"    ]. No major bleeding or drug-related adverse events were observed in either group.",
"   </p>",
"   <p>",
"    In adults with acute ischemic stroke, the best available evidence suggests that anticoagulation has no net benefit compared with antiplatelet therapy for improving stroke outcome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/60/31688?source=see_link&amp;anchor=H6#H6\">",
"     \"Antithrombotic treatment of acute ischemic stroke and transient ischemic attack\", section on 'Parenteral anticoagulation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some clinicians have argued that children could derive benefit from anticoagulation without the risk of hemorrhage seen in adults, since the stroke etiologies most amenable to anticoagulation in adults (cardiac disease, dissection, and hypercoagulable states) are common in pediatric stroke, and atherosclerosis is uncommon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/21\">",
"     21",
"    </a>",
"    ]. However, there is no good evidence to support or refute this hypothesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are differences among consensus guidelines regarding the initial treatment of children with acute arterial ischemic stroke.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The American Academy of Chest Physicians (ACCP) recommends either unfractionated",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/39/7801?source=see_link\">",
"       heparin",
"      </a>",
"      or low molecular weight heparin (LMWH) or",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/10/19624?source=see_link\">",
"       aspirin",
"      </a>",
"      as initial therapy until dissection and embolic causes have been excluded [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The American Heart Association Stroke Council guideline states that it may be reasonable to initiate anticoagulation with LMWH or unfractionated",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/39/7801?source=see_link\">",
"       heparin",
"      </a>",
"      in children with arterial ischemic stroke pending completion of the diagnostic evaluation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Royal College of Physicians recommends initial therapy with",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/10/19624?source=see_link\">",
"       aspirin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Acute treatment for specific causes of arterial ischemic stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no controlled trials or studies examining the effectiveness of specific treatments for different causes of arterial ischemic stroke in children. Thus, all of the recommendations that follow are based mainly upon extrapolation from studies involving adults, and the clinical experience of experts, as reflected in consensus guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/4,7,8\">",
"     4,7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although data are limited and consensus opinions conflicting, we suggest",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/10/19624?source=see_link\">",
"       aspirin",
"      </a>",
"      3 to 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day rather than anticoagulation as initial therapy for most children with acute arterial ischemic stroke of unknown etiology. However, in cases with a high clinical suspicion for either arterial dissection or cardioembolism as the etiology, we suggest short-term anticoagulation with low molecular weight",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/39/7801?source=see_link\">",
"       heparin",
"      </a>",
"      or unfractionated heparin until vascular imaging and echocardiography are obtained. Anticoagulation should then be stopped and aspirin initiated if no indication (eg, a confirmed cardioembolic source or arterial dissection) is identified by these investigations. Exceptions to the use of any acute antithrombotic treatment (ie, aspirin or anticoagulation) are children with sickle cell disease and those with evidence of intracranial hemorrhage. Children who are already anticoagulated at the time of ischemic stroke onset should not be treated acutely with aspirin.",
"     </li>",
"     <li>",
"      For children with arterial stroke due to a confirmed cardioembolic source, arterial dissection, or hypercoagulable state, we suggest initial anticoagulation treatment (rather than",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/10/19624?source=see_link\">",
"       aspirin",
"      </a>",
"      ) with intravenous unfractionated",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/39/7801?source=see_link\">",
"       heparin",
"      </a>",
"      (goal PTT 60 to 85) or subcutaneous low molecular weight heparin (eg,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?41/55/42872?source=see_link\">",
"       enoxaparin",
"      </a>",
"      [1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      dose every 12 hours] to achieve a goal anti-factor Xa level of 0.5 to 1.0",
"      <span class=\"nowrap\">",
"       U/mL)",
"      </span>",
"      for five to seven days, followed by treatment with low molecular weight heparin or",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?21/4/21578?source=see_link\">",
"       warfarin",
"      </a>",
"      . Aspirin (3 to 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day) should be given if there is a contraindication to anticoagulation. The duration of long-term anticoagulation is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/27/27063?source=see_link\">",
"       \"Ischemic stroke in children: Secondary prevention\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For children with acute ischemic stroke resulting from sickle cell disease, we suggest urgent intravenous hydration, and further suggest hydration with normal saline rather than hypotonic saline to avoid the potential worsening of cytotoxic cerebral edema that may occur with infusion of hypotonic fluid. In addition, we recommend urgent exchange transfusion in experienced centers with routine availability of this therapy to reduce the hemoglobin S fraction to &lt;30 percent of total hemoglobin [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/4,7\">",
"       4,7",
"      </a>",
"      ]. Exchange transfusion rather than simple transfusion is recommended for acute emergencies in part because it avoids the risk of transfusion-associated",
"      <span class=\"nowrap\">",
"       volume/circulatory",
"      </span>",
"      overload (TACO) syndrome and associated pulmonary edema. In addition, exchange transfusion avoids the theoretical risk of increased blood viscosity associated with simple transfusion. UK guidelines, however, recommend urgent simple transfusion of packed red blood cells if the patient has severe anemia (ie, in the setting of splenic sequestration or aplastic crisis) or if there will be a delay of greater than four hours to initiation of exchange transfusion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/4\">",
"       4",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/11/31930?source=see_link\">",
"       \"Cerebrovascular complications of sickle cell disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For children with arterial ischemic stroke related to vasculopathy (excluding dissection), lacunar disease, or cryptogenic etiology, we suggest treatment with",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/10/19624?source=see_link\">",
"       aspirin",
"      </a>",
"      (3 to 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day) rather than anticoagulation. Immunosuppression may be indicated for confirmed inflammatory vasculitis.",
"     </li>",
"     <li>",
"      For children with large \"malignant\" middle cerebral artery territory stroke associated with mass effect, elevated intracranial pressure, midline shift, and deterioration of consciousness, we suggest decompressive hemicraniectomy. Published data for this procedure in children are limited but encouraging [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/22,23\">",
"       22,23",
"      </a>",
"      ]. In the author's experience, decompressive hemicraniectomy is both life-saving and associated with good outcome in children. In adults undergoing decompressive hemicraniectomy, the best outcomes were achieved in patients younger than 50 years old. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/35/569?source=see_link\">",
"       \"Decompressive hemicraniectomy for malignant middle cerebral artery territory infarction\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A study of national registry data from the United States reported that in-hospital mortality after ischemic stroke in children ages 1 to 17 years was 3.4 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/17\">",
"     17",
"    </a>",
"    ]. Similarly, among 612 children with arterial ischemic stroke in an international database, the mortality rate prior to hospital discharge was 3 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/24\">",
"     24",
"    </a>",
"    ]. In young adults, mortality is approximately 4 to 6 percent in the first year after ischemic stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Disability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the neural plasticity present in children, the majority of children with stroke have persistent disability.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 90 children with ischemic stroke followed for a median duration of three years, disability that interfered with daily life was present in 60 percent, while a good outcome was present in 40 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a report of 67 children with arterial ischemic stroke and follow-up of one year or more, there was no residual disability in 17 patients (25 percent), mild residual disability in 17 patients (25 percent), and severe residual disability in 33 patients (49 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another study of 123 children with ischemic stroke followed for a mean duration of two years, 37 percent were normal, 20 percent had mild deficits, 26 percent had moderate deficits, 16 percent had severe deficits, and 13 percent developed epilepsy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In various reports of children with ischemic stroke, predictors of poor outcome have included the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Young age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/28\">",
"       28",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Altered consciousness at presentation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/24,30,31\">",
"       24,30,31",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Fever at presentation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/28\">",
"       28",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Middle cerebral artery territory stroke volume greater than 10 percent of the intracranial volume [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/32\">",
"       32",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Right middle cerebral artery territory infarction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/28\">",
"       28",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Bilateral ischemia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/24\">",
"       24",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Arteriopathy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/24\">",
"       24",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In an observational study of 29 children with unilateral stroke in the middle cerebral artery territory, abnormal signal in the descending corticospinal tract (DCST) was seen on diffusion weighted MRI in 20 (69 percent) within two weeks of stroke onset, and correlated with poor motor outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/33\">",
"     33",
"    </a>",
"    ]. In seven children with poor motor outcome, the abnormal DCST signal was either contralateral to the acute stroke or was bilateral, an unexpected and unexplained finding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Recurrent ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent cerebral ischemia, including stroke and TIA, is common after childhood arterial ischemic stroke, with estimates of stroke recurrence ranging from 6.6 to 20 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/2,34-36\">",
"     2,34-36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a cohort of 212 children (median age 5 years at the time of the first arterial ischemic stroke) from the United Kingdom followed for a median of 2.2 years, the following observations were reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/35\">",
"     35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recurrent cerebral ischemia manifesting clinically as stroke, TIA, and death occurred in 14, 22, and 2 percent, respectively. Independent risk factors for clinical recurrence were a vascular diagnosis of moyamoya and low birth weight.",
"     </li>",
"     <li>",
"      In a subgroup of 115 patients without a medical diagnosis before the first arterial ischemic stroke, the presence of a genetic prothrombotic mutation was associated with a decreased time to clinical recurrence, independent of the presence of moyamoya.",
"     </li>",
"     <li>",
"      In a subgroup of 179 patients who had repeat neuroimaging, radiologic reinfarction occurred in 34 percent and was clinically silent in 11 percent. Independent risk factors for radiologic reinfarction were previous TIA, bilateral infarction at initial presentation, known medical diagnosis before first arterial ischemic stroke, and leukocytosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of vasculopathy may be a risk factor for recurrent stroke in children, but data are limited and not entirely consistent. In a retrospective cohort study with cerebrovascular imaging available for 52 children with later childhood stroke, the cumulative five-year stroke recurrence rate for children with abnormal vascular imaging was 66 percent, while children with normal vascular imaging had no recurrences [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/36\">",
"     36",
"    </a>",
"    ]. A subsequent small retrospective report noted that children with cryptogenic arterial ischemic stroke, most of whom were treated with",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/10/19624?source=see_link\">",
"     aspirin",
"    </a>",
"    , had no recurrent episodes of brain ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43608/abstract/37\">",
"     37",
"    </a>",
"    ]. The cryptogenic group included children with focal cerebral arteriopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest MRI of the brain with diffusion weighted imaging rather than CT for children with suspected ischemic stroke. In addition, all children should have a complete investigation for cardiac, vascular, and hematologic risk factors. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      As in adults, supportive care is important for children with ischemic stroke. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Initial management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children with acute arterial ischemic stroke, we suggest",
"      <strong>",
"       not",
"      </strong>",
"      treating with intravenous tPA (",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?12/2/12328?source=see_link\">",
"       alteplase",
"      </a>",
"      ) outside of a clinical trial or a rigorous research protocol (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For children with arterial ischemic stroke of unknown etiology, we suggest initial therapy with",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/10/19624?source=see_link\">",
"       aspirin",
"      </a>",
"      (3 to 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day) rather than anticoagulation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). However, in cases with a high clinical suspicion for either arterial dissection or cardioembolism, we suggest short-term anticoagulation with low molecular weight",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/39/7801?source=see_link\">",
"       heparin",
"      </a>",
"      or unfractionated heparin, rather than aspirin, until vascular imaging and echocardiography are obtained (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Exceptions are children with sickle cell disease, those with evidence of intracranial hemorrhage, and those already anticoagulated at stroke onset.",
"     </li>",
"     <li>",
"      For children with acute arterial ischemic stroke due to a confirmed cardioembolic source, arterial dissection, or hypercoagulable state, we suggest anticoagulation treatment with intravenous unfractionated",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/39/7801?source=see_link\">",
"       heparin",
"      </a>",
"      or subcutaneous low molecular weight heparin for five to seven days rather than",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/10/19624?source=see_link\">",
"       aspirin",
"      </a>",
"      , followed by treatment with low molecular weight heparin or",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?21/4/21578?source=see_link\">",
"       warfarin",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Aspirin (3 to 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day) should be given if there is a contraindication to anticoagulation. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Acute treatment for specific causes of arterial ischemic stroke'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children with arterial ischemic stroke and sickle cell disease, we suggest urgent intravenous hydration (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We also suggest hydration with intravenous normal saline rather than hypotonic saline (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We recommend urgent exchange transfusion in experienced centers with routine availability of this therapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). The goal of exchange transfusion is to achieve a hemoglobin S fraction &lt;30 percent of total hemoglobin. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Acute treatment for specific causes of arterial ischemic stroke'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children with arterial ischemic stroke related to vasculopathy (excluding dissection), lacunar disease, or cryptogenic etiology, we suggest treatment with",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/10/19624?source=see_link\">",
"       aspirin",
"      </a>",
"      3 to 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day rather than anticoagulation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Acute treatment for specific causes of arterial ischemic stroke'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Despite the neural plasticity present in children, most children with stroke have persistent disability. Recurrent cerebral ischemia is common after childhood arterial ischemic stroke. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/1\">",
"      Shellhaas RA, Smith SE, O'Tool E, et al. Mimics of childhood stroke: characteristics of a prospective cohort. Pediatrics 2006; 118:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/2\">",
"      Lanthier S, Carmant L, David M, et al. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 2000; 54:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/3\">",
"      Str&auml;ter R, Vielhaber H, Kassenb&ouml;hmer R, et al. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey. Eur J Pediatr 1999; 158 Suppl 3:S122.",
"     </a>",
"    </li>",
"    <li>",
"     Paediatric Stroke Working Group. Stroke in childhood: Clinical guidelines for diagnosis, management and rehabilitation. November 2004. www.rcplondon.ac.uk/pubs/books/childstroke/ (Accessed on January 14, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/5\">",
"      Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38:1655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/6\">",
"      Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007; 38:2001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/7\">",
"      Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008; 39:2644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/8\">",
"      Monagle P, Chan AK, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e737S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/9\">",
"      Thirumalai SS, Shubin RA. Successful treatment for stroke in a child using recombinant tissue plasminogen activator. J Child Neurol 2000; 15:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/10\">",
"      Gruber A, Nasel C, Lang W, et al. Intra-arterial thrombolysis for the treatment of perioperative childhood cardioembolic stroke. Neurology 2000; 54:1684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/11\">",
"      Carlson MD, Leber S, Deveikis J, Silverstein FS. Successful use of rt-PA in pediatric stroke. Neurology 2001; 57:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/12\">",
"      Kirton A, Wong JH, Mah J, et al. Successful endovascular therapy for acute basilar thrombosis in an adolescent. Pediatrics 2003; 112:e248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/13\">",
"      Ortiz GA, Koch S, Wallace DM, Lopez-Alberola R. Successful intravenous thrombolysis for acute stroke in a child. J Child Neurol 2007; 22:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/14\">",
"      Tan M, Armstrong D, Birken C, et al. Bacterial endocarditis in a child presenting with acute arterial ischemic stroke: should thrombolytic therapy be absolutely contraindicated? Dev Med Child Neurol 2009; 51:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/15\">",
"      Janmaat M, Gravendeel JP, Uyttenboogaart M, et al. Local intra-arterial thrombolysis in a 4-year-old male with vertebrobasilar artery thrombosis. Dev Med Child Neurol 2009; 51:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/16\">",
"      Arnold M, Steinlin M, Baumann A, et al. Thrombolysis in childhood stroke: report of 2 cases and review of the literature. Stroke 2009; 40:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/17\">",
"      Janjua N, Nasar A, Lynch JK, Qureshi AI. Thrombolysis for ischemic stroke in children: data from the nationwide inpatient sample. Stroke 2007; 38:1850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/18\">",
"      Amlie-Lefond C, deVeber G, Chan AK, et al. Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet Neurol 2009; 8:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/19\">",
"      Schechter T, Kirton A, Laughlin S, et al. Safety of anticoagulants in children with arterial ischemic stroke. Blood 2012; 119:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/20\">",
"      Str&auml;ter R, Kurnik K, Heller C, et al. Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study. Stroke 2001; 32:2554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/21\">",
"      deVeber G, Chan A. Aspirin versus low-molecular-weight heparin for ischemic stroke in children: an unanswered question. Stroke 2002; 33:1947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/22\">",
"      Ramaswamy V, Mehta V, Bauman M, et al. Decompressive hemicraniectomy in children with severe ischemic stroke and life-threatening cerebral edema. J Child Neurol 2008; 23:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/23\">",
"      Smith SE, Kirkham FJ, Deveber G, et al. Outcome following decompressive craniectomy for malignant middle cerebral artery infarction in children. Dev Med Child Neurol 2011; 53:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/24\">",
"      Goldenberg NA, Bernard TJ, Fullerton HJ, et al. Antithrombotic treatments, outcomes, and prognostic factors in acute childhood-onset arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet Neurol 2009; 8:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/25\">",
"      Marini C, Totaro R, Carolei A. Long-term prognosis of cerebral ischemia in young adults. National Research Council Study Group on Stroke in the Young. Stroke 1999; 30:2320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/26\">",
"      Leys D, Bandu L, H&eacute;non H, et al. Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke. Neurology 2002; 59:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/27\">",
"      Ganesan V, Hogan A, Shack N, et al. Outcome after ischaemic stroke in childhood. Dev Med Child Neurol 2000; 42:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/28\">",
"      Cnossen MH, Aarsen FK, Akker SLj, et al. Paediatric arterial ischaemic stroke: functional outcome and risk factors. Dev Med Child Neurol 2010; 52:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/29\">",
"      deVeber GA, MacGregor D, Curtis R, Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol 2000; 15:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/30\">",
"      Keidan I, Shahar E, Barzilay Z, et al. Predictors of outcome of stroke in infants and children based on clinical data and radiologic correlates. Acta Paediatr 1994; 83:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/31\">",
"      Delsing BJ, Catsman-Berrevoets CE, Appel IM. Early prognostic indicators of outcome in ischemic childhood stroke. Pediatr Neurol 2001; 24:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/32\">",
"      Ganesan V, Ng V, Chong WK, et al. Lesion volume, lesion location, and outcome after middle cerebral artery territory stroke. Arch Dis Child 1999; 81:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/33\">",
"      Domi T, deVeber G, Shroff M, et al. Corticospinal tract pre-wallerian degeneration: a novel outcome predictor for pediatric stroke on acute MRI. Stroke 2009; 40:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/34\">",
"      Str&auml;ter R, Becker S, von Eckardstein A, et al. Prospective assessment of risk factors for recurrent stroke during childhood--a 5-year follow-up study. Lancet 2002; 360:1540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/35\">",
"      Ganesan V, Prengler M, Wade A, Kirkham FJ. Clinical and radiological recurrence after childhood arterial ischemic stroke. Circulation 2006; 114:2170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/36\">",
"      Fullerton HJ, Wu YW, Sidney S, Johnston SC. Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics 2007; 119:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43608/abstract/37\">",
"      Darteyre S, Chabrier S, Presles E, et al. Lack of progressive arteriopathy and stroke recurrence among children with cryptogenic stroke. Neurology 2012; 79:2342.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6214 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-4D580CFE0A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_37_43608=[""].join("\n");
var outline_f42_37_43608=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Hypercoagulable state evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Vasculitis evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - MELAS evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      INITIAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Supportive measures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Thrombolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Initial antithrombotic treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Acute treatment for specific causes of arterial ischemic stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Disability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Recurrent ischemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/17/22808?source=related_link\">",
"      Acute and early HIV infection: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/60/31688?source=related_link\">",
"      Antithrombotic treatment of acute ischemic stroke and transient ischemic attack",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/11/31930?source=related_link\">",
"      Cerebrovascular complications of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/35/569?source=related_link\">",
"      Decompressive hemicraniectomy for malignant middle cerebral artery territory infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/55/20345?source=related_link\">",
"      Diagnostic assays for HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/44/35525?source=related_link\">",
"      Diagnostic testing for HIV infection in infants and children younger than 18 months",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/26/7594?source=related_link\">",
"      Etiology, clinical features, and diagnosis of cerebral venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/29/33242?source=related_link\">",
"      Initial assessment and management of acute stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/26/6570?source=related_link\">",
"      Intravenous fibrinolytic (thrombolytic) therapy in acute ischemic stroke: Therapeutic use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/61/23513?source=related_link\">",
"      Ischemic stroke in children and young adults: Etiology and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/27/27063?source=related_link\">",
"      Ischemic stroke in children: Secondary prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/12/7370?source=related_link\">",
"      Mitochondrial myopathies: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/35/12853?source=related_link\">",
"      Mitochondrial structure, function, and genetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/56/17290?source=related_link\">",
"      Neuroimaging of acute ischemic stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/44/26312?source=related_link\">",
"      Neurosyphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/8/41098?source=related_link\">",
"      Reperfusion therapy for acute ischemic stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/30/14825?source=related_link\">",
"      Screening for inherited thrombophilia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/33/32281?source=related_link\">",
"      Secondary prevention for specific causes of ischemic stroke and transient ischemic attack",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/2/27690?source=related_link\">",
"      Stroke in the newborn",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_37_43609="Persistent diarrhea in children in developing countries";
var content_f42_37_43609=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Persistent diarrhea in children in developing countries",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/37/43609/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/37/43609/contributors\">",
"     Mary E Penny, MBChB, MRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/37/43609/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/37/43609/contributors\">",
"     William J Klish, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/37/43609/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/37/43609/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/37/43609/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The great majority of diarrhea episodes last less than one week; when diarrhea persists for more than 14 days, it is called persistent or chronic diarrhea. Persistent diarrhea may be associated with a chronic enteropathy, with impaired mucosal healing and diminished digestive and absorptive capacity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/1\">",
"     1",
"    </a>",
"    ]. Malabsorption or maldigestion result [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/2\">",
"     2",
"    </a>",
"    ]. In developing countries, persistent diarrhea is most common in children younger than two years of age, and especially in children under one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/3\">",
"     3",
"    </a>",
"    ], but can also occur in older children. These prolonged episodes are important not only because of the unpleasantness of having diarrhea but because of the association with malnutrition and increased risk of death, especially in developing countries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The major causes and the prevalence of persistent diarrhea differ between developed and developing countries. In the developing world, persistent diarrhea usually follows an acute episode and typically is associated with serial enteric infections without time to recover between episodes. Children are at risk of malnutrition and often have other intercurrent illnesses, such as respiratory infections.",
"   </p>",
"   <p>",
"    In developed countries, children are less likely to be exposed to serial enteric infections and malnutrition. In these populations, chronic diarrhea is more likely to be caused by underlying disease, such as celiac disease or other food allergy. However, enteric infections (particularly in immunocompromised patients), malnutrition, and dietary factors (eg, excessive consumption of juice or withholding feeding during diarrhea and delaying in returning to normal feeding), play a role in some cases.",
"   </p>",
"   <p>",
"    The difference in pathophysiology underlying most cases of persistent diarrhea in developing countries as compared to those in developed countries calls for different approaches to diagnosis and management in the two settings.",
"   </p>",
"   <p>",
"    The pathophysiology and management of persistent diarrhea in developing countries will be reviewed here. Approaches to diagnosis and treatment of diarrheal diseases in developed countries are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/43/35511?source=see_link\">",
"     \"Approach to the diagnosis of chronic diarrhea in children in developed countries\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/5/5210?source=see_link\">",
"     \"Overview of the causes of chronic diarrhea in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent diarrhea is defined as loose or watery stools occurring at least three times a day for more than 14 days; the change in stool consistency is more important than stool frequency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/4\">",
"     4",
"    </a>",
"    ]. This typically translates to a stool volume of more than 10",
"    <span class=\"nowrap\">",
"     grams/kg/day",
"    </span>",
"    in infants and toddlers, or more than 200",
"    <span class=\"nowrap\">",
"     grams/day",
"    </span>",
"    in older children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/6\">",
"     6",
"    </a>",
"    ]. Some authors make a distinction between persistent diarrhea, which they define as having a sudden onset, and chronic diarrhea, which they define as having a gradual onset. However, it is frequently difficult to identify the time of onset of the diarrhea and delineation of the two entities can be problematic. Consequently, for the purposes of this review we will not differentiate between persistent and chronic diarrhea.",
"   </p>",
"   <p>",
"    In developing countries, most cases of persistent diarrhea are triggered by enteric infections. Poor caloric and protein intake leading to malnutrition and dietary deficiency of micronutrients such as zinc and vitamin A,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    immunodeficiency, contribute to the development of chronic enteropathy and persistent diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Although the specific triggers may vary, this pattern has been termed \"syndromic persistent diarrhea\" because of the stereotypical pathophysiological disturbances and implications for treatment. Although persistent diarrhea lasting more than two weeks is regarded as a distinct entity, there is evidence that diarrhea that lasts one to two weeks is also associated with adverse outcomes, including stunting, and identifies children at risk of developing persistent diarrhea in the future [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PREVALENCE AND MORBIDITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In developing countries, persistent diarrhea is a common condition, but the extent to which diarrhea episodes become persistent is very variable. Overall, fewer than 10 percent of episodes of diarrhea persist for two or more weeks, but reports range from 1.4 to 28.4 percent, and the risk depends on many factors including the initial enteropathogen, nutritional status, geographical location, and socioeconomic conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. It is estimated that diarrhea lasting more than two weeks occurs in up to 3 to 5 percent of the infant population worldwide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One report estimated that one million deaths could be averted annually by scaling up well established measures for diarrhea, including preventive measures such as breastfeeding, vitamin A supplementation, handwashing with soap, improved sanitation, safe drinking water, and rotavirus vaccination, and treatment measures including oral rehydration solutions (ORS) and zinc, and antibiotics for dysentery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/12\">",
"     12",
"    </a>",
"    ]. Many of these deaths are attributable to persistent diarrhea, because persistent diarrhea accounts for more than half of diarrheal deaths, and 30 to 50 percent of deaths overall among children younger than five years of age in the developing world [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/13-15\">",
"     13-15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The basic pathophysiology underlying all diarrheas is incomplete absorption of water from the intestinal lumen, either because of a reduced rate of net water absorption (related to impaired electrolyte absorption or excessive electrolyte secretion) or because of osmotic retention of water in the lumen. Reduction of net water absorption by as little as 1 percent may be sufficient to cause diarrhea. Consequently, even relatively modest compromise of absorptive function can lead to loose stools [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diarrhea may have secretory",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    osmotic components. Secretory diarrhea occurs when pathogens produce toxins that inhibit absorption and result in unopposed large fluxes of fluid and electrolytes into the small intestine that overwhelm the absorptive capacity of the more distal gut. The classic example is cholera and enterotoxigenic E. coli (ETEC) infections. Pathogens that directly damage the small intestinal mucosa, such as norovirus, have a similar effect. Diarrhea may be severe, especially in the first two to three days.",
"   </p>",
"   <p>",
"    Osmotic diarrhea occurs when unabsorbed nutrients, especially carbohydrates and sugars, cause an osmotic gradient, drawing water into the intestine. This may occur in the small or large intestine. Diarrhea typically is exacerbated by eating, and stools may be acidic and contain reducing substances. Unabsorbed dietary fat does not exert the same osmotic effect and steatorrhea is not necessarily associated with diarrhea. The colon is important, as much of the fluid secreted by the small intestine is reabsorbed in the colon. Additionally, small chain fatty acids produced by bacteria are important in this process. Pathogens that cause inflammation of colonic mucosa classically cause frequent small diarrheal stools with blood and mucus. Inflammatory cells may be seen on microscopy of stools. All these processes may occur together.",
"   </p>",
"   <p>",
"    In developing countries, most cases of persistent diarrhea are triggered by infection. The figure illustrates different mechanisms for persistence of an infectious episode (",
"    <a class=\"graphic graphic_figure graphicRef64008 \" href=\"mobipreview.htm?35/55/36734\">",
"     figure 1",
"    </a>",
"    ). In some cases, the original infectious agent may be particularly virulent and difficult to clear. Some bacteria such as shigella spp. contain plasmids that are capable of downregulating the host cell expression of antibacterial peptides, thus delaying clearance of the bacteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/17\">",
"     17",
"    </a>",
"    ]. Alternatively, the infection may cause intestinal damage that leads to continuing diarrhea (",
"    <a class=\"graphic graphic_figure graphicRef81123 \" href=\"mobipreview.htm?38/4/38991\">",
"     figure 2",
"    </a>",
"    ). The most common example of this is lactose intolerance resulting from destruction of the villus tips where the enzyme",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    is found. Studies have also shown that intestinal damage leads to a decrease in intestinal absorptive surface area, which in turn interferes with the absorption of nutrients, particularly sugars [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Disturbance of the intestinal flora, such as occurs in antibiotic-associated diarrhea, is another example of a secondary effect, as is irritable bowel syndrome developing in susceptible travelers following acute traveler's diarrhea.",
"   </p>",
"   <p>",
"    The third mechanism is delayed healing of the intestine. In this scenario, host factors such as zinc or vitamin A deficiency, or generalized malnutrition affect the host response to the infection, resulting in longer duration. Host factors affecting immunity and delaying recovery also occur in immune deficiency conditions, including HIV AIDS.",
"   </p>",
"   <p>",
"    Finally, exposure to enteropathogens may be so common that new infections with different pathogens occur before the child has had a chance to recover and these sequential acute episodes merge into one episode of persistent diarrhea.",
"   </p>",
"   <p>",
"    These mechanisms are not exclusive, and probably often exacerbate each other; for instance, delayed recovery makes it more likely that a new infection will lead to continuing symptoms.",
"   </p>",
"   <p>",
"    Infection, malnutrition, and impaired immunity interact and exacerbate one another (",
"    <a class=\"graphic graphic_figure graphicRef81123 \" href=\"mobipreview.htm?38/4/38991\">",
"     figure 2",
"    </a>",
"    ). Infection, anorexia, and food withdrawal or dilution reduce nutrient intake, causing increased net loss of nutrients, altered permeability, immune dysregulation, mucosal injury, altered intestinal microflora, and nutritional deficits, and contribute to the vicious cycle that leads to chronic diarrhea, increasing malnutrition, and possible death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Enteric pathogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;A large variety of bacterial pathogens have been isolated from stools of children with persistent diarrhea in developing countries. Some pathogens have been associated with more prolonged episodes, although results of studies are not always consistent. Among the most commonly cited culprits are enteroaggregative E. coli (also known as enteroadherent E. coli, EAEC) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/13,21,22\">",
"     13,21,22",
"    </a>",
"    ], enteropathogenic E. coli (EPEC) in infants younger than six months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/4,23-25\">",
"     4,23-25",
"    </a>",
"    ], Shigella, Cryptosporidium, Yersinia, and Campylobacter. Intestinal parasites such as Cyclospora, Isospora, Microsporidium, Entamoeba histolytica, and Strongyloides may also play a role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/13\">",
"     13",
"    </a>",
"    ]. Among the intestinal parasites, Cryptosporidium has been found in chronic episodes of diarrhea in Bangladesh but not in Peru, while Giardia lamblia showed similar incidence rates in acute and chronic diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/20,26-28\">",
"     20,26-28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/4/37960?source=see_link\">",
"     \"Pathogenic Escherichia coli\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/17/6424?source=see_link\">",
"     \"Treatment and prevention of giardiasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, serial stool cultures during episodes of chronic diarrhea suggest that sequential infections with the same or a different pathogen are more often responsible for prolonged diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/26,27\">",
"     26,27",
"    </a>",
"    ] than persistence of a single etiological agent. When complete analyses are undertaken, multiple pathogens often are identified. Studies in developing countries where fecal contamination is common show high rates of enteropathogens in stools of children without diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/21\">",
"     21",
"    </a>",
"    ]. Therefore, the presence of a particular bacteria, virus, or parasite does not mean it is the causal agent, perhaps explaining some apparent treatment failures. On the other hand, no enteropathogens are detected in many cases of persistent diarrhea, despite extensive tests [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/13,21\">",
"     13,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Viral pathogens such as rotavirus and cytomegalovirus also have been associated with protracted diarrhea usually following particularly severe episodes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/26,29,30\">",
"     26,29,30",
"    </a>",
"    ]. Rotavirus is the principal cause of severe acute dehydrating diarrhea in young children, but most episodes of rotavirus infection are short lived and self limiting. Nevertheless, rotavirus has been implicated in protracted diarrhea syndrome in both immunodeficient and immunocompetent hosts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. The reduction in diarrheal episodes associated with introduction of a vaccine against rotavirus in the infant vaccine schedules of many countries will allow a better estimate of the importance of this virus in persistent diarrhea. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/48/26376?source=see_link\">",
"     \"Clinical presentation and diagnosis of rotavirus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/56/14216?source=see_link\">",
"     \"Epidemiology, pathogenesis, clinical presentation and diagnosis of viral gastroenteritis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Torovirus and astrovirus also have been associated with chronic diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Some viral infections such as measles or HIV cause chronic diarrhea through immunosuppression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Immunosuppressed children are more likely to have enteric infections with multiple pathogens",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    with opportunistic pathogens such as Mycobacterium avium complex, Isospora, and microsporidia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/3/3130?source=see_link&amp;anchor=H18840561#H18840561\">",
"     \"Natural history and classification of pediatric HIV infection\", section on 'Other'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recent advances in genetics are increasing understanding of the interaction between the virulence mechanisms of enteropathogens and the host immune response, and are likely to explain why some children have persistent diarrhea, whereas others harboring the same pathogens remain symptom-free [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Malnutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic and acute under-nutrition impair the development and function of the immune system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/39\">",
"     39",
"    </a>",
"    ]. This leads to immune responses that are less effective but are also associated with a generalized increase in inflammatory mediators, which can contribute to the tissue damage caused by enteric infection. Malnutrition also impairs tissue repair mechanisms so that infections tend to be more severe and of longer duration.",
"   </p>",
"   <p>",
"    Specific nutrient deficiencies, such as vitamin A and zinc deficiencies, are associated with persistent diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. Randomized controlled studies in a variety of populations have shown that zinc supplementation given during an episode of diarrhea reduces the severity and duration of acute and persistent diarrhea in children over 6 months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/43\">",
"     43",
"    </a>",
"    ]. Zinc supplements given prophylactically in populations where zinc deficiency is common reduce the incidence of diarrhea, including persistent diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/3/29753?source=see_link\">",
"     \"Zinc deficiency and supplementation in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Breastfeeding, especially exclusive breastfeeding, protects against diarrhea through reduced exposure, and because breast milk contains a series of substances that have a protective effect. These include lactoferrin, lysozyme, and oligosaccharides against enteropathogens, as well as antibodies and the cellular fraction. Both acute and persistent diarrhea is less common in breastfed children. The positive effects of breastfeeding continue even after other foods are introduced; breastfeeding to 2 years old is the recommendation by the World Health Organization (WHO) and other agencies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Enteropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enteric infections, malnutrition, and impaired host defense mechanisms interact to cause chronic enteropathy (",
"    <a class=\"graphic graphic_figure graphicRef64008 \" href=\"mobipreview.htm?35/55/36734\">",
"     figure 1",
"    </a>",
"    ). The enteropathy is often associated with increased intestinal permeability, especially in children younger than 12 months, which in turn may lead to enhanced sensitization to dietary antigens and an allergic enteropathy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/52/34631?source=see_link\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chronic enteropathy is often associated with persistent diarrhea and is characterized by abnormalities of the small intestinal mucosa and altered permeability. There is evidence of an inflammatory response in the mucosa with a variety of immunological abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/13\">",
"     13",
"    </a>",
"    ]. In severe cases, the chronic enteropathy typically exhibits villous atrophy, with crypt cell hypoplasia with decreased mitotic figures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. The latter feature appears to be associated with protein malnutrition and sometimes helps to distinguish the disorder from celiac disease.",
"   </p>",
"   <p>",
"    The enteropathy contributes to malnutrition by causing malabsorption of macronutrients and micronutrients, because of the reduced surface area, reduced bile acid production and function, impaired motility, and bacterial overgrowth. Small intestinal bacterial overgrowth (SIBO) is associated with increased intestinal permeability, especially in children younger than 12 months, which in turn may lead to enhanced sensitization to dietary antigens and an allergic enteropathy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/52/34631?source=see_link\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"    </a>",
"    .) However, SIBO is very common in children living in unhygienic environments and is found in asymptomatic children as well as those with acute and persistent diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/51\">",
"     51",
"    </a>",
"    ]. Although associated with nutrient malabsorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/52\">",
"     52",
"    </a>",
"    ], it is not clear if and when SIBO per se causes diarrhea. It rapidly clears when clean food and water is given.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     HIV disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent diarrhea is commonly associated with HIV, and provides a paradigm for the complex interactions between the immunocompromised host, malnutrition, and enteric infection. Malnutrition is often an early manifestation of HIV disease, and is associated with a rapid decrease in the CD4+ cell number and an increased rate of opportunistic infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/53\">",
"     53",
"    </a>",
"    ]. Combined dysfunctions of the digestive-absorptive processes are common in children with HIV infection and may involve the intestine, the liver, and the pancreas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/54\">",
"     54",
"    </a>",
"    ]. Iron and lactose malabsorption are particularly common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several cellular mechanisms appear to be directly affected by HIV infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/56\">",
"     56",
"    </a>",
"    ]. As an example, Tat protein released by the virus can interact directly with enterocytes functioning both as a viral cytotoxin and an enterotoxin. This protein-cell interaction impairs cell growth and proliferation, and inhibits ion transport [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/57\">",
"     57",
"    </a>",
"    ]. In the setting of immunosuppression, superinfection with opportunistic agents such as Cryptosporidium, Blastocystis hominis, Candida albicans, and others can contribute to the diarrhea and mucosal injury. Consequently, HIV infection both directly and indirectly induces intestinal dysfunction, malnutrition, and immune impairment. Antiretroviral therapy may also cause persistent diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because persistent diarrhea following an acute infection is the predominant type of diarrhea seen in developing countries, and because diagnostic resources often will be limited, an algorithmic approach to diagnosis and management is practical and usually effective. This approach requires categorical assessment of the child's nutritional status and type of diarrhea, specific testing for pathogens when possible, and in some cases empiric therapy based on the clinical findings and prevalence rates.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Assess for complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step in the evaluation is to assess the child for dehydration and sepsis, as both require urgent treatment. Follow standard guidelines to diagnose and treat hypovolemia (dehydration). Children with mild or no dehydration should be given extra fluids and can be managed at home; moderate dehydration should be treated orally or by nasogastric tube, using a rehydration fluid consisting of glucose, sugar or rice flour, sodium, and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/17/11542?source=see_link\">",
"     potassium chloride",
"    </a>",
"    and a base such as bicarbonate or citrate. The recommended fluid is the low-osmolar rehydration solution made according to WHO guidelines, which has established efficacy and safety in clinical trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/59\">",
"     59",
"    </a>",
"    ]. Severe dehydration, associated with hypovolemic shock, requires intravenous rehydration, as described separately and in standard protocols. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Rehydration'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3607?source=see_link\">",
"     \"Clinical assessment and diagnosis of hypovolemia (dehydration) in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children should be weighed, measured, and examined for bilateral edema in order to recognize severe malnutrition that will require special attention. For all children with severe malnutrition (&lt;70 percent of median reference weight for height), and especially for those with edematous malnutrition, excess intravenous fluids should be avoided, and treatment always should include a low osmolar rehydration solution as well as early and frequent feeds. It is important to continue oral feeding although the diarrhea continues. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32248?source=see_link&amp;anchor=H6#H6\">",
"     \"Malnutrition in developing countries: Clinical assessment\", section on 'Assessment of severity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    All children should be evaluated for non-intestinal infections, including pneumonia, urinary tract infections, sepsis, and otitis media. Treatment of these infections should follow standard protocols.",
"   </p>",
"   <p>",
"    Clinicians should look for comorbid conditions that may be the underlying cause of the malnutrition, such as cerebral palsy, cystic fibrosis, congenital heart disease, HIV disease, and tuberculosis. These diseases may cause or complicate the child's illness and nutritional status. Tuberculosis may be difficult to diagnose in severely malnourished children. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/53/13143?source=see_link\">",
"     \"Latent tuberculosis infection in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/4/23625?source=see_link\">",
"     \"Tuberculosis disease in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies in different parts of the world have shown that the use of the",
"    <span class=\"nowrap\">",
"     WHO/UNICEF",
"    </span>",
"    protocol for the management of severe malnutrition considerably reduces mortality. This protocol should be familiar to all staff in emergency and pediatric departments and conscientiously applied by all medical, nursing, and auxiliary technical staff. Local protocols may be necessary to determine which children are admitted to the hospital depending on local conditions, but a malnourished child who also has edema, fever, dehydration, or bloody stools should be managed in a hospital. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/61/9178?source=see_link\">",
"     \"Severe malnutrition in children in developing countries: Treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32248?source=see_link\">",
"     \"Malnutrition in developing countries: Clinical assessment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Categorize the diarrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;The next step is to classify the diarrhea based on its appearance; this is not essential as a first step, but narrows the range of likely infectious triggers, and provides some estimate of risk.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Watery diarrhea &ndash; Most cases of persistent watery diarrhea in children in developing countries are caused by acute infections with enteric pathogens, usually in combination with under-nutrition. These children usually respond to interventions designed to improve nutrition and reduce the likelihood of reinfection. Because serial infections are common, enteropathogens not necessarily associated with persistent diarrhea may present as acute or chronic infections. As an example, cholera typically presents with acute onset watery diarrhea in children or adults (often with vomiting). In children younger than 2 years of age, the clinical presentation is not readily distinguishable from that of rotavirus. Cholera should be suspected in a child presenting with an acute exacerbation of watery chronic diarrhea if other cases of cholera are reported in the area.",
"     </li>",
"     <li>",
"      Bloody diarrhea &ndash; In developing countries, most cases of acute bloody diarrhea are caused by Shigella spp (45 to 67 percent of cases), and Campylobacter (35 to 37 percent of cases) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/60\">",
"       60",
"      </a>",
"      ]. Entamoeba histolytica is the most important non-bacterial pathogen, but is responsible for fewer than 3 percent of episodes. Most infections with these organisms result in acute diarrhea syndromes, and cause low-volume bloody stools, often with fever. However, in children with underlying malnutrition or immunodeficiency, these pathogens may cause chronic diarrhea and may be associated with higher volume diarrhea and dehydration. Children presenting with bloody diarrhea are at particularly high risk for morbidity and mortality [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific laboratory testing is not essential for the management of persistent diarrhea in developing countries. Essential fluid, electrolyte, and dietary management are not dependent on etiology. There are rarely facilities for a complete enteropathic screen and results of stool cultures are generally not available in time to be valuable clinically for these patients.",
"   </p>",
"   <p>",
"    Nonetheless, some simple bedside laboratory tests may be helpful. In cases where diarrhea has persisted more than two weeks, testing the stool for pH and glucose can be helpful in distinguishing those children with severe villous atrophy from other causes of persistent diarrhea. This can be done easily at the bedside with a urine dipstick if available. Glucose test tape, nitrazine paper, and clinitest tablets also have been used. A stool glucose of greater than 2+ or a pH of less than 5.0 suggests substantial villous atrophy.",
"   </p>",
"   <p>",
"    In selected cases, laboratory testing also can help identify enteropathogens that respond to antimicrobial therapy. If the diarrhea contains red blood or blood mixed with mucus, and facilities are available, the stool should be cultured for bacterial pathogens (particularly Shigella spp and Campylobacter). In these cases, antibiotic treatment for Shigella infection, based on local resistance patterns, should be started empirically. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Antimicrobials'",
"    </a>",
"    below.) In some clinical settings, laboratory testing is used as surveillance for epidemiologic reasons, such as the detection of cholera outbreaks.",
"   </p>",
"   <p>",
"    For children with persistent watery stools, stool microscopy can be performed to detect trophozoites or cysts of E. Histolytica or other parasites. However, microscopy typically over-diagnoses amebiasis because of the difficulty of distinguishing pathologic from non pathologic entamoeba. If available, fecal antigen assays also may be used to detect Giardia infection. Rotavirus should also be sought and rapid tests are now available in many locations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/28/33224?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of giardiasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/56/33671?source=see_link\">",
"     \"Intestinal Entamoeba histolytica amebiasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If cholera is suspected (eg, in a child presenting with an acute exacerbation of diarrhea, with \"rice-water\" stools and vomiting), dark-field or phase contrast microscopy can be performed to identify the organism. Antimicrobial therapy generally is not necessary for individuals with mild symptoms, so there is no benefit to specific testing for these patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/14/36073?source=see_link\">",
"     \"Overview of Vibrio cholerae infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of chronic diarrhea includes supportive measures, nutritional rehabilitation, and drug therapy. Children with moderate malnutrition, evidence of dehydration, systemic infections, or infants younger than 4 months of age should be treated in an inpatient setting if possible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/61\">",
"     61",
"    </a>",
"    ]. Children with severe malnutrition should be treated as inpatients until stable, as described separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/61/9178?source=see_link\">",
"     \"Severe malnutrition in children in developing countries: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Rehydration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Death in most instances of persistent diarrhea is caused either by hypovolemia (dehydration) or severe malnutrition. Consequently, replacement of fluid and electrolyte losses is the major early intervention. The ideal form of rehydration is through the oral or nasogastric route with low osmolarity oral rehydration solution (ORS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/62\">",
"     62",
"    </a>",
"    ]. The WHO now recommends the use of low osmolarity ORS in all diarrheal episodes except cholera (the new WHO solution contains 75",
"    <span class=\"nowrap\">",
"     mMol/L",
"    </span>",
"    of glucose, 75",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    sodium, 20",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    potassium and osmolarity 245",
"    <span class=\"nowrap\">",
"     mOsm/L).",
"    </span>",
"    Severely malnourished children are potassium depleted and additional",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/17/11542?source=see_link\">",
"     potassium chloride",
"    </a>",
"    can be added to the oral rehydration fluid to provide 40",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    of potassium. In most cases, breast feeding should be continued. The evaluation of a child for dehydration and treatment with ORS according to the degree of dehydration are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/15/18681?source=see_link\">",
"     \"Oral rehydration therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32248?source=see_link\">",
"     \"Malnutrition in developing countries: Clinical assessment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Dietary management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nutritional compromise plays a role in most cases of persistent diarrhea in developing countries, and is the primary target for treatment. Most children will respond to dietary management using locally available foods designed to provide approximately 150",
"    <span class=\"nowrap\">",
"     kcals/kg/day",
"    </span>",
"    and 10 percent of calories from protein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/63\">",
"     63",
"    </a>",
"    ]. If possible, at least half the protein should come from an animal source such as milk, egg, or chicken. Additional potassium should be added to the diet to provide at least 5",
"    <span class=\"nowrap\">",
"     mEq/kg",
"    </span>",
"    per day. Breastfeeding may provide some of these nutrients, and is continued when possible. This approach is similar to that used for nutritional rehabilitation in other children with malnutrition. However, many infants and children with chronic diarrhea have secondary disaccharidase deficiencies, caused by damage to the intestinal epithelium. Consequently, a low-lactose diet and sometimes a diet also low in sucrose or total carbohydrates may be necessary. It is usually sufficient to reduce lactose by mixing milk with cereals such as rice or noodles and giving small frequent feedings. However, a minority of children benefit from a lactose-free diet. Egg or pureed chicken have been successfully used and are palatable. Yogurt-based diets have also been used successfully [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/64\">",
"     64",
"    </a>",
"    ]. Lactose-free formulas are an alternative if available. There is no need to limit fat intake; indeed, fat can be beneficial because it provides useful calories.",
"   </p>",
"   <p>",
"    The efficacy of dietary management, with an algorithmic approach to lactose inclusion, was demonstrated in a multinational trial designed by the World Health Organization (WHO) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/63\">",
"     63",
"    </a>",
"    ]. After evaluation and treatment for acute comorbidities (including hypovolemia, sepsis, and pneumonia), all children were treated with a low-lactose diet, containing &lt;3.7 grams of",
"    <span class=\"nowrap\">",
"     lactose/150",
"    </span>",
"    kcals, as compared with about 10 grams of",
"    <span class=\"nowrap\">",
"     lactose/150",
"    </span>",
"    kcals in the standard WHO full-milk diet. The ingredients varied by region, but consisted of cereals, legumes, vegetable oil, and milk products, with added micronutrient supplements, with an energy density of 65 to 100",
"    <span class=\"nowrap\">",
"     kcals/100",
"    </span>",
"    g. Children who did not respond to this low-lactose diet within seven days were advanced to a lactose-free diet, in which the protein component was supplied by chicken or egg white.",
"   </p>",
"   <p>",
"    The overall success rate for the treatment algorithm was 80 percent (95% CI 76-84%). Sixty-five percent of children recovered with low-lactose diet alone. Among the 35 percent of children who failed the low-lactose diet and moved on to treatment with a lactose-free diet, 71 percent recovered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Micronutrients and vitamins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Micronutrient and vitamin supplementation are part of nutritional rehabilitation, especially in malnourished children from developing countries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Children with chronic diarrhea and malnutrition are often deficient in vitamin A, zinc,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?21/31/22005?source=see_link\">",
"     folic acid",
"    </a>",
"    , copper, and other vitamins and minerals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/65\">",
"     65",
"    </a>",
"    ]. Deficiencies in these micronutrients can impair the function of the immune system and have a direct effect on the structure and function of mucosa.",
"   </p>",
"   <p>",
"    The WHO recommends zinc supplementation for children with diarrhea in developing countries, at a dose of 10 mg daily for infants up to 6 months of age, and 20 mg daily for older infants and children, for 14 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/44,66\">",
"     44,66",
"    </a>",
"    ]. These recommendations are based on a variety of randomized trials in developing countries demonstrating that zinc supplementation reduced the severity and duration of acute and persistent diarrhea in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/45,46,67\">",
"     45,46,67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/3/29753?source=see_link&amp;anchor=H15#H15\">",
"     \"Zinc deficiency and supplementation in children and adolescents\", section on 'Treatment of persistent diarrhea'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The WHO also recommends providing at least two times the recommended daily allowance (RDA) for folate, vitamin A, iron, copper, and magnesium for two weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/61\">",
"     61",
"    </a>",
"    ]. Vitamin A and zinc supplementation may have synergistic effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/42\">",
"     42",
"    </a>",
"    ]. In addition, children with concomitant measles infection or ophthalmologic signs of Vitamin A deficiency should be treated with a high dose of vitamin A. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22793?source=see_link&amp;anchor=H45#H45\">",
"     \"Prevention and treatment of measles\", section on 'Vitamin A'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Antimicrobials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although nutritional rehabilitation is effective alone for most children with chronic diarrhea, specific treatment for enteric pathogens is indicated in some cases, particularly children with bloody diarrhea (usually caused by Shigella or Campylobacter, or parasites) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Extraintestinal infections (acute lower respiratory infections, urinary tract infections, sepsis, etc) commonly associated with chronic diarrhea, should be evaluated carefully and treated promptly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/63,69,70\">",
"     63,69,70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children with bloody diarrhea are likely to have Shigella or Campylobacter infection, and can be treated empirically [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/71\">",
"     71",
"    </a>",
"    ]. Empiric therapy generally should be directed against Shigella, based on the known sensitivities of local strains.",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?37/15/38128?source=see_link\">",
"     Ciprofloxacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/19/312?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    and pivmecillinam have been shown to be generally effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/72\">",
"     72",
"    </a>",
"    ]. If no improvement is seen within two days, treatment should be changed to another agent known to be effective against local strains of Shigella [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/61\">",
"     61",
"    </a>",
"    ]. Antimicrobial therapy for Campylobacter is only indicated in patients who are at increased risk or have severe disease, including patients with bloody stools, high fever, or symptoms lasting longer than one week. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/16/8457?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment and prevention of Shigella infections in children\", section on 'Antibiotic therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/19/19769?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of Campylobacter infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antibiotics are not essential for treatment of cholera, but may hasten recovery and reduce the duration of infectivity. Thus, antimicrobial therapy directed against cholera is recommended for cases of suspected or proven cholera with severe dehydration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/61\">",
"     61",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/14/36073?source=see_link\">",
"     \"Overview of Vibrio cholerae infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If enteric parasites are identified by laboratory testing, these should be treated according to standard guidelines. Empiric therapy for intestinal parasites is not recommended, except that empiric treatment for amebiasis may be considered in a child with persistent bloody diarrhea, who has failed trials of two different antimicrobials known to be effective against local strains of Shigella [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/61\">",
"     61",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/17/6424?source=see_link\">",
"     \"Treatment and prevention of giardiasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/56/33671?source=see_link\">",
"     \"Intestinal Entamoeba histolytica amebiasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/40/13961?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of cryptosporidiosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/48/31493?source=see_link\">",
"     \"Cyclospora infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Antidiarrheal drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drugs that alter intestinal motility, including",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/31/8692?source=see_link\">",
"     loperamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/30/32230?source=see_link\">",
"     codeine",
"    </a>",
"    , and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?42/61/43988?source=see_link\">",
"     paregoric",
"    </a>",
"    , are not recommended because they lack efficacy, are associated with potentially serious side effects, and possibly prolong the excretion of enteric pathogens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/14,66\">",
"     14,66",
"    </a>",
"    ]. Similarly, antiemetics cause sedation that interferes with oral rehydration therapy, and should not be given to children with diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/61\">",
"     61",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/43/35511?source=see_link&amp;anchor=H22#H22\">",
"     \"Approach to the diagnosis of chronic diarrhea in children in developed countries\", section on 'Antidiarrheal drugs'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7068392\">",
"    <span class=\"h2\">",
"     Probiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;A Cochrane review of clinical trials reported that the probiotics reduced the stool frequency and duration of persistent diarrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/37/43609/abstract/73\">",
"     73",
"    </a>",
"    ]. The authors concluded that probiotics appeared to hold promise as adjuvant therapy for persistent diarrhea but there was insufficient evidence to recommend their use at this time. The probiotics used in the trials were",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?1/5/1108?source=see_link\">",
"     lactobacillus",
"    </a>",
"    strains plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/39/25203?source=see_link\">",
"     saccharomyces boulardii",
"    </a>",
"    and lactobacillus rhamnosus GG.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persistent diarrhea is defined as loose or watery stools occurring at least three times a day for more than 14 days, where the change in stool consistency is more important than stool frequency. This typically translates to a stool volume of more than 10",
"      <span class=\"nowrap\">",
"       grams/kg/day",
"      </span>",
"      in infants and toddlers, or more than 200",
"      <span class=\"nowrap\">",
"       grams/day",
"      </span>",
"      in older children. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In developing countries, most cases of persistent diarrhea are caused by a combination of enteric infections, under-nutrition, and impaired immunity (",
"      <a class=\"graphic graphic_figure graphicRef81123 \" href=\"mobipreview.htm?38/4/38991\">",
"       figure 2",
"      </a>",
"      ). These factors interact to cause a chronic enteropathy and diarrhea. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The first step in evaluating a child with persistent diarrhea is to diagnose comorbid conditions that may cause or complicate the diarrheal illness, including dehydration, malnutrition, and associated non-enteric infections, including sepsis and HIV disease. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Assess for complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The next step is to classify the diarrhea based on its appearance. Bloody diarrhea is most likely caused by Shigella, confers a worse prognosis, and requires antimicrobial treatment. An acute exacerbation of watery diarrhea should raise the possibility of cholera in children older than 2 years of age. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Categorize the diarrhea'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory testing of stool is not essential. When available, it may be helpful to test the stools for the presence of glucose or acidic pH, to culture bloody stools for Shigella and Campylobacter, and to examine stools for parasites including Giardia and Entamoeba histolytica. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Laboratory testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The first step in treatment is to stabilize children with severe intercurrent infection or dehydration, according to standard protocols. Children with mild or moderate dehydration can be treated with oral rehydration solutions; those with severe dehydration and hypovolemic or septic shock may require intravenous repletion. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Rehydration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The main component of treatment is nutritional rehabilitation. Breastfeeding is continued when possible, and supplemented with a balanced diet of locally available foods, including an animal protein source such as yogurt, milk, chicken, or egg. Many children with chronic enteropathy have a secondary carbohydrate intolerance and respond better to a low-lactose or low-carbohydrate diet. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Dietary management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that all children with chronic diarrhea be treated with zinc supplements&nbsp;(",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Micronutrients and vitamins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In general, we suggest NOT treating the diarrhea empirically with antibiotics (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). However, in children with bloody diarrhea we suggest empiric therapy directed against Shigella (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). We also suggest antimicrobial treatment for patients with severe symptoms and suspected or proven cholera (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Antibiotics should be selected based on sensitivities of local strains. If this information is not available,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?37/15/38128?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/19/312?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      , or pivmecillinam are recommended. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Antimicrobials'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/1\">",
"      Bhutta ZA, Ghishan F, Lindley K, et al. Persistent and chronic diarrhea and malabsorption: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004; 39 Suppl 2:S711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/2\">",
"      Binder HJ. Causes of chronic diarrhea. N Engl J Med 2006; 355:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/3\">",
"      Moore SR, Lima NL, Soares AM, et al. Prolonged episodes of acute diarrhea reduce growth and increase risk of persistent diarrhea in children. Gastroenterology 2010; 139:1156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/4\">",
"      Gibbons T, Fuchs GJ. Chronic enteropathy: clinical aspects. Nestle Nutr Workshop Ser Pediatr Program 2007; 59:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/5\">",
"      Mbori-Ngacha DA, Otieno JA, Njeru EK, Onyango FE. Prevalence of persistent diarrhoea in children aged 3-36 months at the Kenyatta National Hospital, Nairobi, Kenya. East Afr Med J 1995; 72:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/6\">",
"      Vanderhoof JA. Chronic diarrhea. Pediatr Rev 1998; 19:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/7\">",
"      Karim AS, Akhter S, Rahman MA, Nazir MF. Risk factors of persistent diarrhea in children below five years of age. Indian J Gastroenterol 2001; 20:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/8\">",
"      Bhandari N, Bhan MK, Sazawal S, et al. Association of antecedent malnutrition with persistent diarrhoea: a case-control study. BMJ 1989; 298:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/9\">",
"      Andrade JA, Fagundes-Neto U. Persistent diarrhea: still an important challenge for the pediatrician. J Pediatr (Rio J) 2011; 87:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/10\">",
"      Mathai J, Raju B, Bavdekar A, Pediatric Gastroenterology Chapter, Indian Academy of Pediatrics. Chronic and persistent diarrhea in infants and young children: status statement. Indian Pediatr 2011; 48:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/11\">",
"      Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 1999; 116:1464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/12\">",
"      Fischer Walker CL, Friberg IK, Binkin N, et al. Scaling up diarrhea prevention and treatment interventions: a Lives Saved Tool analysis. PLoS Med 2011; 8:e1000428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/13\">",
"      Ochoa TJ, Salazar-Lindo E, Cleary TG. Management of children with infection-associated persistent diarrhea. Semin Pediatr Infect Dis 2004; 15:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/14\">",
"      Black RE. Persistent diarrhea in children of developing countries. Pediatr Infect Dis J 1993; 12:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/15\">",
"      Claeson M, Merson MH. Global progress in the control of diarrheal diseases. Pediatr Infect Dis J 1990; 9:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/16\">",
"      Schiller LR. Chronic diarrhea. Gastroenterology 2004; 127:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/17\">",
"      Islam D, Bandholtz L, Nilsson J, et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 2001; 7:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/18\">",
"      Klish WJ, Udall JN, Rodriguez JT, et al. Intestinal surface area in infants with acquired monosaccharide intolerance. J Pediatr 1978; 92:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/19\">",
"      Klish WJ, Udall JN, Calvin RT, Nichols BL. The effect of intestinal solute load on water secretion in infants with acquired monosaccharide intolerance. Pediatr Res 1980; 14:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/20\">",
"      Mondal D, Minak J, Alam M, et al. Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh. Clin Infect Dis 2012; 54:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/21\">",
"      Abba K, Sinfield R, Hart CA, Garner P. Pathogens associated with persistent diarrhoea in children in low and middle income countries: systematic review. BMC Infect Dis 2009; 9:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/22\">",
"      Ochoa TJ, Barletta F, Contreras C, Mercado E. New insights into the epidemiology of enteropathogenic Escherichia coli infection. Trans R Soc Trop Med Hyg 2008; 102:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/23\">",
"      Ngan PK, Khanh NG, Tuong CV, et al. Persistent diarrhea in Vietnamese children: a preliminary report. Acta Paediatr 1992; 81 Suppl 381:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/24\">",
"      Fagundes-Neto U, Scaletsky IC. The gut at war: the consequences of enteropathogenic Escherichia coli infection as a factor of diarrhea and malnutrition. Sao Paulo Med J 2000; 118:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/25\">",
"      Ahmed F, Ansaruzzaman M, Haque E, et al. Epidemiology of postshigellosis persistent diarrhea in young children. Pediatr Infect Dis J 2001; 20:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/26\">",
"      Baqui AH, Sack RB, Black RE, et al. Enteropathogens associated with acute and persistent diarrhea in Bangladeshi children less than 5 years of age. J Infect Dis 1992; 166:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/27\">",
"      Lanata CF, Black RE, Ma&uacute;rtua D, et al. Etiologic agents in acute vs persistent diarrhea in children under three years of age in peri-urban Lima, Per&uacute;. Acta Paediatr Suppl 1992; 381:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/28\">",
"      Ramakrishna BS, Venkataraman S, Mukhopadhya A. Tropical malabsorption. Postgrad Med J 2006; 82:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/29\">",
"      Khoshoo V, Bhan MK, Jayashree S, et al. Rotavirus infection and persistent diarrhoea in young children. Lancet 1990; 336:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/30\">",
"      Shimizu M, Ohta K, Wada H, et al. Cytomegalovirus-associated protracted diarrhoea in an immunocompetent boy. J Paediatr Child Health 2006; 42:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/31\">",
"      Sood M, Booth IW. Is prolonged rotavirus infection a common cause of protracted diarrhoea? Arch Dis Child 1999; 80:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/32\">",
"      Guarino A, Guandalini S, Albano F, et al. Enteral immunoglobulins for treatment of protracted rotaviral diarrhea. Pediatr Infect Dis J 1991; 10:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/33\">",
"      Unicomb LE, Banu NN, Azim T, et al. Astrovirus infection in association with acute, persistent and nosocomial diarrhea in Bangladesh. Pediatr Infect Dis J 1998; 17:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/34\">",
"      Koopmans MP, Goosen ES, Lima AA, et al. Association of torovirus with acute and persistent diarrhea in children. Pediatr Infect Dis J 1997; 16:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/35\">",
"      Feachem RG, Koblinsky MA. Interventions for the control of diarrhoeal diseases among young children: measles immunization. Bull World Health Organ 1983; 61:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/36\">",
"      Amadi B, Kelly P, Mwiya M, et al. Intestinal and systemic infection, HIV, and mortality in Zambian children with persistent diarrhea and malnutrition. J Pediatr Gastroenterol Nutr 2001; 32:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/37\">",
"      Thomas PD, Pollok RC, Gazzard BG. Enteric viral infections as a cause of diarrhoea in the acquired immunodeficiency syndrome. HIV Med 1999; 1:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/38\">",
"      Flores J, Okhuysen PC. Genetics of susceptibility to infection with enteric pathogens. Curr Opin Infect Dis 2009; 22:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/39\">",
"      Cunningham-Rundles S, McNeeley DF, Moon A. Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol 2005; 115:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/40\">",
"      Usha N, Sankaranarayanan A, Walia BN, Ganguly NK. Assessment of preclinical vitamin A deficiency in children with persistent diarrhea. J Pediatr Gastroenterol Nutr 1991; 13:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/41\">",
"      Bhan MK, Bhandari N. The role of zinc and vitamin A in persistent diarrhea among infants and young children. J Pediatr Gastroenterol Nutr 1998; 26:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/42\">",
"      Rahman MM, Vermund SH, Wahed MA, et al. Simultaneous zinc and vitamin A supplementation in Bangladeshi children: randomised double blind controlled trial. BMJ 2001; 323:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/43\">",
"      Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev 2012; 6:CD005436.",
"     </a>",
"    </li>",
"    <li>",
"     WHO/CAH Diarrhoea treatment guidelines including new recommendations for the use of ORS and zinc supplementation for clinic-based healthcare workers. UNICEF, MOST, USAID, Geneva, 2005. Available at: www.mostproject.org (Accessed on January 08, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/45\">",
"      Bhutta ZA, Bird SM, Black RE, et al. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr 2000; 72:1516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/46\">",
"      Lukacik M, Thomas RL, Aranda JV. A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea. Pediatrics 2008; 121:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/47\">",
"      Feachem RG, Koblinsky MA. Interventions for the control of diarrhoeal diseases among young children: promotion of breast-feeding. Bull World Health Organ 1984; 62:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/48\">",
"      Sazawal S, Bhan MK, Bhandari N. Type of milk feeding during acute diarrhoea and the risk of persistent diarrhoea: a case control study. Acta Paediatr Suppl 1992; 381:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/49\">",
"      Sullivan PB, Marsh MN. Small intestinal mucosal histology in the syndrome of persistent diarrhoea and malnutrition: a review. Acta Paediatr Suppl 1992; 381:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/50\">",
"      Schneider RE, Viteri FE. Morphological aspects of the duodenojejunal mucosa in protein--calorie malnourished children and during recovery. Am J Clin Nutr 1972; 25:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/51\">",
"      Penny ME, Paredes P, Brown KH, et al. Lack of a role of the duodenal microflora in pathogenesis of persistent diarrhea and diarrhea-related malabsorption in Peruvian children. Pediatr Infect Dis J 1990; 9:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/52\">",
"      Rana SV, Bhardwaj SB. Small intestinal bacterial overgrowth. Scand J Gastroenterol 2008; 43:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/53\">",
"      Tovo PA, de Martino M, Gabiano C, et al. Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children. Lancet 1992; 339:1249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/54\">",
"      Guarino A, Tarallo L, Guandalini S, et al. Impaired intestinal function in symptomatic HIV infection. J Pediatr Gastroenterol Nutr 1991; 12:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/55\">",
"      Castaldo A, Tarallo L, Palomba E, et al. Iron deficiency and intestinal malabsorption in HIV disease. J Pediatr Gastroenterol Nutr 1996; 22:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/56\">",
"      Lowery MM, Erim Z. A simulation study to examine the effect of common motoneuron inputs on correlated patterns of motor unit discharge. J Comput Neurosci 2005; 19:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/57\">",
"      Canani RB, Cirillo P, Mallardo G, et al. Effects of HIV-1 Tat protein on ion secretion and on cell proliferation in human intestinal epithelial cells. Gastroenterology 2003; 124:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/58\">",
"      Feasey NA, Healey P, Gordon MA. Review article: the aetiology, investigation and management of diarrhoea in the HIV-positive patient. Aliment Pharmacol Ther 2011; 34:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/59\">",
"      Dutta P, Mitra U, Dutta S, et al. Hypo-osmolar oral rehydration salts solution in dehydrating persistent diarrhoea in children: double-blind, randomized, controlled clinical trial. Acta Paediatr 2000; 89:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/60\">",
"      Huilan S, Zhen LG, Mathan MM, et al. Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries. Bull World Health Organ 1991; 69:549.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. The treatment of diarrhoea, a manual for physicians and other senior health workers. WHO/FCH/CAH/03.7. Geneva: World Health Organization, 2005. Available at: file://www.who.int/child_adolescent_health/documents/9241593180/en/index.html (Accessed on November 18, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/62\">",
"      Guarino A, Albano F, Working Group on Intestinal Infections of the Italian Society of Paediatric Gastroenterology and Hepatology. Guidelines for the approach to outpatient children with acute diarrhoea. Acta Paediatr 2001; 90:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/63\">",
"      Evaluation of an algorithm for the treatment of persistent diarrhoea: a multicentre study. International Working Group on Persistent Diarrhoea. Bull World Health Organ 1996; 74:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/64\">",
"      de Mattos AP, Ribeiro TC, Mendes PS, et al. Comparison of yogurt, soybean, casein, and amino acid-based diets in children with persistent diarrhea. Nutr Res 2009; 29:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/65\">",
"      Bhan MK, Bhandari N, Bahl R. Management of the severely malnourished child: perspective from developing countries. BMJ 2003; 326:146.",
"     </a>",
"    </li>",
"    <li>",
"     WHO/UNICEF Joint statement:  Clinical management of acute diarrhea. WHO/FCH/CAH/04.7. Geneva, 2004. Available at: file://www.emro.who.int/cah/pdf/who_unicef_statement.pdf (Accessed on October 19, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/67\">",
"      Bhutta ZA, Black RE, Brown KH, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. J Pediatr 1999; 135:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/68\">",
"      Farthing MJ. Diarrhoea: a significant worldwide problem. Int J Antimicrob Agents 2000; 14:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/69\">",
"      Ahmed FU, Karim E. Children at risk of developing dehydration from diarrhoea: a case-control study. J Trop Pediatr 2002; 48:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/70\">",
"      Bhatnagar S, Bhan MK, Singh KD, Shrivastav R. Prognostic factors in hospitalized children with persistent diarrhea: implications for diet therapy. J Pediatr Gastroenterol Nutr 1996; 23:151.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. The management of bloody diarrhea in young children. WHO/CDD/94.49. Geneva: World Health Organization, 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/72\">",
"      Traa BS, Walker CL, Munos M, Black RE. Antibiotics for the treatment of dysentery in children. Int J Epidemiol 2010; 39 Suppl 1:i70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/37/43609/abstract/73\">",
"      Bernaola Aponte G, Bada Mancilla CA, Carreazo Pariasca NY, Rojas Galarza RA. Probiotics for treating persistent diarrhoea in children. Cochrane Database Syst Rev 2010; :CD007401.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5878 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-2F5800EE8D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_37_43609=[""].join("\n");
var outline_f42_37_43609=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PREVALENCE AND MORBIDITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Enteric pathogens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Malnutrition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Enteropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      HIV disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSTIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Assess for complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Categorize the diarrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Rehydration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Dietary management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Micronutrients and vitamins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Antimicrobials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Antidiarrheal drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7068392\">",
"      Probiotics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5878\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5878|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/55/36734\" title=\"figure 1\">",
"      Mechanisms involved in persistent diarrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?38/4/38991\" title=\"figure 2\">",
"      Causes of persistent diarrhea",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/43/35511?source=related_link\">",
"      Approach to the diagnosis of chronic diarrhea in children in developed countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3607?source=related_link\">",
"      Clinical assessment and diagnosis of hypovolemia (dehydration) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/19/19769?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of Campylobacter infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/48/26376?source=related_link\">",
"      Clinical presentation and diagnosis of rotavirus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/48/31493?source=related_link\">",
"      Cyclospora infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/40/13961?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of cryptosporidiosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/28/33224?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of giardiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/56/14216?source=related_link\">",
"      Epidemiology, pathogenesis, clinical presentation and diagnosis of viral gastroenteritis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/52/34631?source=related_link\">",
"      Food protein-induced proctitis/colitis and enteropathy of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/56/33671?source=related_link\">",
"      Intestinal Entamoeba histolytica amebiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/53/13143?source=related_link\">",
"      Latent tuberculosis infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/31/32248?source=related_link\">",
"      Malnutrition in developing countries: Clinical assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/3/3130?source=related_link\">",
"      Natural history and classification of pediatric HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/15/18681?source=related_link\">",
"      Oral rehydration therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/14/36073?source=related_link\">",
"      Overview of Vibrio cholerae infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/5/5210?source=related_link\">",
"      Overview of the causes of chronic diarrhea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/4/37960?source=related_link\">",
"      Pathogenic Escherichia coli",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22793?source=related_link\">",
"      Prevention and treatment of measles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/61/9178?source=related_link\">",
"      Severe malnutrition in children in developing countries: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/16/8457?source=related_link\">",
"      Treatment and prevention of Shigella infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/17/6424?source=related_link\">",
"      Treatment and prevention of giardiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/4/23625?source=related_link\">",
"      Tuberculosis disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/3/29753?source=related_link\">",
"      Zinc deficiency and supplementation in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_37_43610="Contents: Patient drug information";
var content_f42_37_43610=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?32/20/33101\">",
"       Drug Information",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Patient drug information",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Patient drug information",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/61/38869\">",
"           Abacavir and lamivudine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/34/42533\">",
"           Abacavir, lamivudine, and zidovudine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/53/18261\">",
"           Abacavir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/52/1861\">",
"           Abatacept: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/52/11076\">",
"           Abciximab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/42/42660\">",
"           Abiraterone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/50/41764\">",
"           AbobotulinumtoxinA (botulinum toxin type A, Dysport): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/11/10420\">",
"           Acamprosate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/14/27876\">",
"           Acarbose: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/47/12021\">",
"           Acebutolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/32/518\">",
"           Acenocoumarol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/35/20021\">",
"           Acetaminophen (paracetamol): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/28/24005\">",
"           Acetaminophen and codeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/36/39492\">",
"           Acetaminophen and diphenhydramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/33/34324\">",
"           Acetaminophen and pamabrom: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/22/43364\">",
"           Acetaminophen and phenylephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/34/28196\">",
"           Acetaminophen and phenyltoloxamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/43/7861\">",
"           Acetaminophen and pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/57/31637\">",
"           Acetaminophen and tramadol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/23/373\">",
"           Acetaminophen, aspirin, and caffeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/43/3765\">",
"           Acetaminophen, caffeine, and dihydrocodeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/19/25909\">",
"           Acetaminophen, codeine, and doxylamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/54/5989\">",
"           Acetaminophen, dextromethorphan, and doxylamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/54/30565\">",
"           Acetaminophen, dextromethorphan, and phenylephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/8/17541\">",
"           Acetaminophen, dextromethorphan, doxylamine, and pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/38/20069\">",
"           Acetaminophen, diphenhydramine, and phenylephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/29/17876\">",
"           Acetaminophen, isometheptene, and dichloralphenazone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/25/6549\">",
"           Acetazolamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/19/1332\">",
"           Acetic acid, propylene glycol diacetate, and hydrocortisone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/37/15956\">",
"           Acetic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/45/25300\">",
"           Acetohydroxamic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/57/17299\">",
"           Acetylcholine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/12/7365\">",
"           Acetylcysteine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/53/42837\">",
"           Acitretin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/39/2677\">",
"           Acrivastine and pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/33/21012\">",
"           Activated charcoal: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/51/29492\">",
"           Activated prothrombin complex concentrates (factor VIII inhibitor bypassing activity): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/48/38660\">",
"           Acyclovir (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/60/40899\">",
"           Acyclovir (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/1/2068\">",
"           Acyclovir and hydrocortisone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/16/26881\">",
"           Acyclovir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/61/3030\">",
"           Adalimumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/2/12324\">",
"           Adapalene and benzoyl peroxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/34/2596\">",
"           Adapalene: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/27/30133\">",
"           Adefovir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/23/3444\">",
"           Adenosine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/44/9924\">",
"           Agalsidase alfa: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/56/13188\">",
"           Agalsidase beta: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/36/31300\">",
"           Albendazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/2/30755\">",
"           Albumin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/50/40741\">",
"           Albuterol (salbutamol): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/14/41187\">",
"           Alcaftadine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/51/38707\">",
"           Alclometasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/28/21957\">",
"           Aldesleukin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/55/8053\">",
"           Alemtuzumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/12/43205\">",
"           Alendronate and cholecalciferol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/29/43477\">",
"           Alendronate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/49/20245\">",
"           Alfacalcidol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/41/41620\">",
"           Alfentanil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/9/37012\">",
"           Alfuzosin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/56/3972\">",
"           Alglucosidase alfa: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/12/21701\">",
"           Aliskiren and amlodipine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/32/12806\">",
"           Aliskiren and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/11/13493\">",
"           Aliskiren and valsartan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/27/41397\">",
"           Aliskiren, amlodipine and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/43/27317\">",
"           Aliskiren: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/56/14212\">",
"           Alitretinoin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/51/30517\">",
"           All trans retinoic acid (tretinoin): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/14/2277\">",
"           Allopurinol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/4/22597\">",
"           Almotriptan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/45/14036\">",
"           Alosetron: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/57/29587\">",
"           Alpha-1 proteinase inhibitor: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/29/7637\">",
"           Alprazolam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/15/23796\">",
"           Alprostadil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/17/6420\">",
"           Alteplase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/13/17620\">",
"           Altretamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/29/38355\">",
"           Aluminum chloride hexahydrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/48/17156\">",
"           Aluminum hydroxide and magnesium carbonate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/2/24612\">",
"           Aluminum hydroxide and magnesium hydroxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/26/9636\">",
"           Aluminum hydroxide and magnesium trisilicate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/48/29444\">",
"           Aluminum hydroxide, magnesium hydroxide, and simethicone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/29/12756\">",
"           Aluminum hydroxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/45/20180\">",
"           Aluminum sulfate calcium acetate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/22/44387\">",
"           Alvimopan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/53/3925\">",
"           Amantadine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/29/15828\">",
"           Ambenonium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/29/5589\">",
"           Ambrisentan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/54/39779\">",
"           Amcinonide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/42/35491\">",
"           Amifostine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/57/6036\">",
"           Amikacin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/28/19909\">",
"           Amiloride and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/32/3589\">",
"           Amiloride: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/17/30996\">",
"           Aminocaproic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/24/29059\">",
"           Aminolevulinic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/11/16564\">",
"           Aminophylline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/35/27189\">",
"           Amiodarone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/61/15317\">",
"           Amitriptyline and chlordiazepoxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/40/35461\">",
"           Amitriptyline and perphenazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/17/32021\">",
"           Amitriptyline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/6/35939\">",
"           Amlexanox: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/8/22661\">",
"           Amlodipine and atorvastatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/47/28405\">",
"           Amlodipine and benazepril: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/36/3653\">",
"           Amlodipine and olmesartan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/39/14965\">",
"           Amlodipine and valsartan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/54/25446\">",
"           Amlodipine, olmesartan, and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/22/5478\">",
"           Amlodipine, valsartan, and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/13/4309\">",
"           Amlodipine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/53/32596\">",
"           Amobarbital: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/40/41604\">",
"           Amoxapine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/33/5653\">",
"           Amoxicillin and clavulanate potassium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/2/39972\">",
"           Amoxicillin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/30/37348\">",
"           Amphotericin B (conventional): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/59/38836\">",
"           Amphotericin B cholesteryl sulfate complex: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/21/32084\">",
"           Amphotericin B lipid complex: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/3/35891\">",
"           Ampicillin and sulbactam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/26/11685\">",
"           Ampicillin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/30/10725\">",
"           Amsacrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/55/42867\">",
"           Amyl nitrite: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/15/29940\">",
"           Anagrelide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/10/163\">",
"           Anakinra: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/3/18485\">",
"           Anastrozole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/21/34131\">",
"           Anidulafungin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/15/3316\">",
"           Anthralin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/58/2977\">",
"           Anthrax vaccine adsorbed: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/24/23940\">",
"           Antihemophilic factor concentrates (human): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/51/23348\">",
"           Antihemophilic factor/von Willebrand factor complex (human): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/61/42963\">",
"           Antipyrine and benzocaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/16/33028\">",
"           Antithrombin III: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/27/26036\">",
"           Antithymocyte globulin (equine, Atgam): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/48/19204\">",
"           Antithymocyte globulin (rabbit derived, Thymoglobulin): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/31/31220\">",
"           Apomorphine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/15/9460\">",
"           Apraclonidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/22/24932\">",
"           Aprepitant: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/0/40963\">",
"           Aprotinin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/33/22037\">",
"           Arformoterol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/17/30995\">",
"           Argatroban: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/56/35715\">",
"           Arginine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/60/17350\">",
"           Aripiprazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/31/17909\">",
"           Armodafinil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/32/25092\">",
"           Arsenic trioxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/57/8085\">",
"           Artemether and lumefantrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/48/41731\">",
"           Articaine and epinephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/46/32483\">",
"           Artificial saliva: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/31/3572\">",
"           Artificial tears: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/1/30741\">",
"           Asenapine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/33/19989\">",
"           Aspirin and diphenhydramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/57/2965\">",
"           Aspirin and extended-release dipyridamole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/12/6342\">",
"           Aspirin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/51/9013\">",
"           Atazanavir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/24/2438\">",
"           Atenolol and chlorthalidone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/27/2486\">",
"           Atenolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/2/6182\">",
"           Atomoxetine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/47/6901\">",
"           Atorvastatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/10/41124\">",
"           Atovaquone and proguanil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/24/16772\">",
"           Atovaquone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/59/34739\">",
"           Atracurium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/53/22355\">",
"           Atropine and pralidoxime: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/49/17173\">",
"           Atropine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/27/9653\">",
"           Auranofin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/19/24884\">",
"           Azacitidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/31/28149\">",
"           Azathioprine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/34/18980\">",
"           Azelaic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/54/12132\">",
"           Azelastine (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/17/38164\">",
"           Azelastine (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/22/38240\">",
"           Azelastine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/24/21893\">",
"           Azilsartan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/42/13988\">",
"           Azithromycin (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/51/33589\">",
"           Azithromycin (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/52/25409\">",
"           Azithromycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/58/23460\">",
"           Aztreonam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/39/40564\">",
"           Bacillus Calmette-Guerin (BCG) vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/37/3669\">",
"           Bacitracin and polymyxin B: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/6/3173\">",
"           Bacitracin, neomycin, and polymyxin B: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/53/30548\">",
"           Bacitracin, neomycin, polymyxin B, and hydrocortisone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/24/2436\">",
"           Bacitracin, neomycin, polymyxin B, and pramoxine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/56/1925\">",
"           Bacitracin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/48/41732\">",
"           Baclofen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/2/1060\">",
"           Balanced salt solution: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/55/31604\">",
"           Balsalazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/37/19028\">",
"           Barium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/61/10197\">",
"           Basiliximab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/37/7764\">",
"           Becaplermin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/51/16180\">",
"           Beclomethasone (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/17/26901\">",
"           Beclomethasone (oral inhalation): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/14/38112\">",
"           Beclomethasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/48/20228\">",
"           Belimumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/35/12852\">",
"           Belladonna and opium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/14/20710\">",
"           Benazepril and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/42/2726\">",
"           Benazepril: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/55/41844\">",
"           Bendamustine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/8/25731\">",
"           Bentoquatam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/32/31235\">",
"           Benzocaine, butamben, and tetracaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/58/27557\">",
"           Benzocaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/29/27091\">",
"           Benzonatate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/8/15492\">",
"           Benzoyl peroxide and hydrocortisone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/55/15221\">",
"           Benzoyl peroxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/35/3637\">",
"           Benzphetamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/44/39620\">",
"           Benztropine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/4/37955\">",
"           Benzydamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/50/23332\">",
"           Benzyl alcohol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/8/128\">",
"           Bepotastine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/28/9668\">",
"           Besifloxacin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/32/38403\">",
"           Beta-carotene: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/15/42227\">",
"           Betahistine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/26/7588\">",
"           Betaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/17/5396\">",
"           Betamethasone and clotrimazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/7/7287\">",
"           Betamethasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/14/21732\">",
"           Betaxolol (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/33/18965\">",
"           Betaxolol (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/26/38304\">",
"           Betaxolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/14/15588\">",
"           Bethanechol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/29/1494\">",
"           Bevacizumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/14/36069\">",
"           Bexarotene (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/0/12293\">",
"           Bexarotene (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/28/38336\">",
"           Bexarotene: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/44/31428\">",
"           Bezafibrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/55/12149\">",
"           Bicalutamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/57/42900\">",
"           Bimatoprost: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/49/15124\">",
"           Bisacodyl: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/28/16837\">",
"           Bismuth subsalicylate, metronidazole, and tetracycline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/44/29380\">",
"           Bismuth: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/13/7382\">",
"           Bisoprolol and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/59/22453\">",
"           Bisoprolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/23/38259\">",
"           Bivalirudin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/36/21059\">",
"           Black widow spider (Latrodectus mactans) antivenom: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/49/26388\">",
"           Bleomycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/1/20501\">",
"           Boceprevir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/23/14709\">",
"           Bortezomib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/53/13141\">",
"           Bosentan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/46/35556\">",
"           Brimonidine and timolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/40/28292\">",
"           Brimonidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/46/34532\">",
"           Brinzolamide and timolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/38/15972\">",
"           Brinzolamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/0/30724\">",
"           Bromazepam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/25/39315\">",
"           Bromfenac: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/23/35189\">",
"           Bromocriptine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/3/6197\">",
"           Brompheniramine and phenylephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/18/38180\">",
"           Brompheniramine and pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/8/10373\">",
"           Brompheniramine, pseudoephedrine, and dextromethorphan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/15/40180\">",
"           Brompheniramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/59/8116\">",
"           Budesonide (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/45/25303\">",
"           Budesonide (systemic therapy and oral inhalation): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/54/10086\">",
"           Budesonide and formoterol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/37/39504\">",
"           Budesonide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/28/29125\">",
"           Bumetanide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/10/3236\">",
"           Bupivacaine and epinephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/51/820\">",
"           Bupivacaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/13/17622\">",
"           Buprenorphine and naloxone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/30/43494\">",
"           Buprenorphine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/7/17526\">",
"           Bupropion: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/41/29333\">",
"           Buserelin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/2/21540\">",
"           Buspirone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/32/36357\">",
"           Busulfan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/23/31092\">",
"           Butabarbital: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/26/3493\">",
"           Butalbital and acetaminophen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/26/10661\">",
"           Butalbital compound and codeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/6/33892\">",
"           Butalbital compound: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/17/7445\">",
"           Butalbital, acetaminophen, and caffeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/45/21205\">",
"           Butalbital, acetaminophen, caffeine, and codeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/30/26083\">",
"           Butenafine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/56/34691\">",
"           Butoconazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/54/2917\">",
"           Butorphanol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/54/38755\">",
"           C1 inhibitor concentrate (human): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/41/34453\">",
"           Cabazitaxel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/43/6837\">",
"           Cabergoline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/51/42803\">",
"           Caffeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/17/22804\">",
"           Calcipotriol (calcipotriene) and betamethasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/0/23556\">",
"           Calcipotriol (calcipotriene): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/48/37636\">",
"           Calcitonin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/11/10421\">",
"           Calcitriol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/38/7780\">",
"           Calcium acetate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/62/41956\">",
"           Calcium and vitamin D: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/50/11044\">",
"           Calcium carbonate and magnesium hydroxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/42/3748\">",
"           Calcium carbonate and simethicone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/17/13589\">",
"           Calcium carbonate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/59/13235\">",
"           Calcium chloride: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/15/24820\">",
"           Calcium citrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/24/13700\">",
"           Calcium glubionate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/2/5157\">",
"           Calcium gluconate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/41/16020\">",
"           Calcium lactate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/7/20596\">",
"           Calcium phosphate, tribasic: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/29/19924\">",
"           Calcium polystyrene sulfonate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/62/38883\">",
"           Camphor and menthol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/52/36675\">",
"           Camphor and phenol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/53/12116\">",
"           Canakinumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/41/30357\">",
"           Candesartan and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/50/4902\">",
"           Candesartan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/44/8899\">",
"           Cantharidin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/53/14165\">",
"           Capecitabine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/56/7044\">",
"           Capreomycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/41/36500\">",
"           Capsaicin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/54/27493\">",
"           Captopril and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/49/25365\">",
"           Captopril: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/21/4436\">",
"           Carbachol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/8/13446\">",
"           Carbamazepine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/43/22196\">",
"           Carbamide peroxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/60/14275\">",
"           Carbetocin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/27/10676\">",
"           Carbidopa: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/6/31844\">",
"           Carbidopa-levodopa: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/63/40948\">",
"           Carbidopa-levodopa-entacapone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/61/4053\">",
"           Carbinoxamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/18/40228\">",
"           Carboplatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/24/41347\">",
"           Carboprost tromethamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/20/39235\">",
"           Carboxymethylcellulose: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/54/34660\">",
"           Carglumic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/62/32740\">",
"           Carisoprodol and aspirin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/42/31396\">",
"           Carisoprodol, aspirin, and codeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/1/8212\">",
"           Carisoprodol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/48/22277\">",
"           Carmustine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/42/10916\">",
"           Carteolol (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/15/37109\">",
"           Carvedilol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/3/3124\">",
"           Caspofungin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/31/29172\">",
"           Cefaclor: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/6/17508\">",
"           Cefadroxil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/26/32163\">",
"           Cefazolin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/40/17028\">",
"           Cefdinir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/21/42323\">",
"           Cefditoren: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/22/39267\">",
"           Cefepime: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/38/9828\">",
"           Cefixime: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/61/34771\">",
"           Cefotaxime: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/50/8996\">",
"           Cefotetan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/35/564\">",
"           Cefoxitin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/6/11364\">",
"           Cefpodoxime: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/19/18740\">",
"           Cefprozil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/56/26499\">",
"           Ceftaroline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/6/34915\">",
"           Ceftazidime: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/56/17284\">",
"           Ceftibuten: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/39/24180\">",
"           Ceftriaxone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/55/29556\">",
"           Cefuroxime: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/63/40949\">",
"           Celecoxib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/39/21108\">",
"           Cephalexin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/54/4966\">",
"           Certolizumab pegol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/46/13029\">",
"           Cetirizine and pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/28/28100\">",
"           Cetirizine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/15/37108\">",
"           Cetrorelix: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/62/30692\">",
"           Cetuximab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/60/7108\">",
"           Cevimeline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/21/9556\">",
"           Chenodeoxycholic acid (chenodiol): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/59/33716\">",
"           Chloral hydrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/16/25861\">",
"           Chlorambucil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/3/20532\">",
"           Chloramphenicol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/40/33412\">",
"           Chlordiazepoxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/1/40981\">",
"           Chlorhexidine gluconate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/60/43971\">",
"           Chloroprocaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/35/1589\">",
"           Chloroquine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/62/21477\">",
"           Chlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/10/43172\">",
"           Chlorpheniramine and acetaminophen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/41/21141\">",
"           Chlorpheniramine and phenylephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/14/16613\">",
"           Chlorpheniramine and pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/39/30325\">",
"           Chlorpheniramine, phenylephrine, and dextromethorphan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/49/789\">",
"           Chlorpheniramine, pseudoephedrine, and codeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/28/22981\">",
"           Chlorpheniramine, pseudoephedrine, and dextromethorphan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/24/44420\">",
"           Chlorpheniramine, pyrilamine, and phenylephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/16/37124\">",
"           Chlorpheniramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/11/20661\">",
"           Chlorpromazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/5/40020\">",
"           Chlorpropamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/21/8533\">",
"           Chlorthalidone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/23/8564\">",
"           Chlorzoxazone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/6/34917\">",
"           Cholestyramine resin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/35/42548\">",
"           Choline magnesium trisalicylate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/10/20643\">",
"           Chondroitin sulfate-sodium hyaluronate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/37/27221\">",
"           Ciclesonide (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/34/35365\">",
"           Ciclesonide (oral inhalation): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/53/38736\">",
"           Ciclesonide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/32/39428\">",
"           Ciclopirox: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/1/36884\">",
"           Cidofovir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/18/22821\">",
"           Cilazapril and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/62/8165\">",
"           Cilazapril: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/8/34948\">",
"           Cilostazol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/30/27109\">",
"           Cimetidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/43/2741\">",
"           Cinacalcet: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/39/36468\">",
"           Ciprofloxacin (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/21/15700\">",
"           Ciprofloxacin (otic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/11/17590\">",
"           Ciprofloxacin (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/1/1044\">",
"           Ciprofloxacin and dexamethasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/26/1444\">",
"           Ciprofloxacin and hydrocortisone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/15/41200\">",
"           Ciprofloxacin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/22/38244\">",
"           Cisapride (United States - available via limited-access protocol only): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/60/34755\">",
"           Cisatracurium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/20/14661\">",
"           Cisplatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/49/12054\">",
"           Citalopram: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/44/708\">",
"           Citric acid bladder mixture: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/22/19813\">",
"           Cladribine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/8/12421\">",
"           Clarithromycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/51/35636\">",
"           Clemastine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/36/30275\">",
"           Clevidipine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/50/38692\">",
"           Clidinium and chlordiazepoxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/49/35604\">",
"           Clindamycin (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/21/2389\">",
"           Clindamycin (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/6/20580\">",
"           Clindamycin and benzoyl peroxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/52/23364\">",
"           Clindamycin and tretinoin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/59/43952\">",
"           Clindamycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/0/14341\">",
"           Clioquinol and flumethasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/60/41924\">",
"           Clobazam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/34/13860\">",
"           Clobetasol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/14/30947\">",
"           Clocortolone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/11/16565\">",
"           Clodronate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/44/44740\">",
"           Clofarabine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/14/17636\">",
"           Clomiphene: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/14/26853\">",
"           Clomipramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/43/22197\">",
"           Clonazepam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/28/15813\">",
"           Clonidine and chlorthalidone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/7/20598\">",
"           Clonidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/11/21685\">",
"           Clopidogrel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/9/7317\">",
"           Clorazepate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/44/5828\">",
"           Clotrimazole (oral): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/37/41556\">",
"           Clotrimazole (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/38/38496\">",
"           Clotrimazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/37/25172\">",
"           Cloxacillin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/41/8854\">",
"           Clozapine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/36/26180\">",
"           Coal tar and salicylic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/51/13109\">",
"           Coal tar: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/44/14021\">",
"           Codeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/25/33172\">",
"           Colchicine and probenecid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/40/40580\">",
"           Colchicine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/39/23156\">",
"           Colesevelam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/17/1301\">",
"           Colestipol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/11/22708\">",
"           Colistin (colistimethate): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/53/6996\">",
"           Collagenase (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/6/31843\">",
"           Collagenase (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/18/26915\">",
"           Conivaptan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/17/41238\">",
"           Conjugated equine estrogens (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/48/17158\">",
"           Conjugated equine estrogens (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/62/39904\">",
"           Conjugated equine estrogens: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/0/11267\">",
"           Corticorelin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/48/1798\">",
"           Corticotropin injection gel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/18/19750\">",
"           Cortisone acetate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/12/197\">",
"           Cromolyn sodium (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/46/17124\">",
"           Cromolyn sodium (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/53/29524\">",
"           Cromolyn sodium (systemic therapy and oral inhalation): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/37/43600\">",
"           Cromolyn sodium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/38/12900\">",
"           Crotamiton: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/55/10099\">",
"           Cyanide antidote kit: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/16/35077\">",
"           Cyanocobalamin (vitamin B12): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/29/44499\">",
"           Cyclizine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/23/33140\">",
"           Cyclobenzaprine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/35/17972\">",
"           Cyclopentolate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/25/6550\">",
"           Cyclophosphamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/49/14100\">",
"           Cycloserine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/52/6980\">",
"           Cyclosporine (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/28/40390\">",
"           Cyclosporine (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/62/38880\">",
"           Cyclosporine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/28/35268\">",
"           Cyproheptadine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/55/9078\">",
"           Cyproterone and ethinyl estradiol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/15/6389\">",
"           Cyproterone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/39/38512\">",
"           Cysteamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/27/13749\">",
"           Cytarabine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/52/5956\">",
"           Cytomegalovirus immune globulin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/58/933\">",
"           Dabigatran: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/27/43444\">",
"           Dacarbazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/5/43092\">",
"           Dactinomycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/25/19860\">",
"           Dalfampridine (fampridine): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/17/2325\">",
"           Dalteparin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/30/36324\">",
"           Danaparoid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/54/32613\">",
"           Danazol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/9/2197\">",
"           Dantrolene: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/22/9573\">",
"           Dapsone (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/51/1844\">",
"           Dapsone (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/61/37840\">",
"           Dapsone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/60/11204\">",
"           Daptomycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/26/21925\">",
"           Darbepoetin alfa: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/30/28132\">",
"           Darifenacin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/26/33189\">",
"           Darunavir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/9/44181\">",
"           Dasatinib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/50/22309\">",
"           Daunorubicin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/33/26132\">",
"           Decitabine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/16/41221\">",
"           Deferasirox: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/59/949\">",
"           Deferoxamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/47/24308\">",
"           Degarelix: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/20/13636\">",
"           Delavirdine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/49/38676\">",
"           Demeclocycline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/31/27124\">",
"           Denileukin diftitox: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/38/3685\">",
"           Denosumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/62/8164\">",
"           Desflurane: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/24/27013\">",
"           Desipramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/0/26628\">",
"           Desirudin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/45/17109\">",
"           Desloratadine and pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/41/44692\">",
"           Desloratadine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/13/31957\">",
"           Desmopressin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/38/612\">",
"           Desonide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/3/41011\">",
"           Desoximetasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/57/6038\">",
"           Desvenlafaxine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/49/17172\">",
"           Dexamethasone (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/45/41686\">",
"           Dexamethasone (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/19/39216\">",
"           Dexamethasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/59/31668\">",
"           Dexchlorpheniramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/27/2485\">",
"           Dexlansoprazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/52/34627\">",
"           Dexmedetomidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/14/44261\">",
"           Dexmethylphenidate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/45/17107\">",
"           Dexpanthenol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/39/8820\">",
"           Dexrazoxane: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/12/33989\">",
"           Dextroamphetamine and amphetamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/15/28917\">",
"           Dextroamphetamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/54/1893\">",
"           Dextromethorphan and chlorpheniramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/51/41780\">",
"           Dextromethorphan and phenylephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/41/42644\">",
"           Dextromethorphan and quinidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/18/29988\">",
"           Dextromethorphan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/22/29027\">",
"           Diatrizoate meglumine and diatrizoate sodium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/49/27411\">",
"           Diatrizoate meglumine and iodipamide meglumine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/48/42755\">",
"           Diatrizoate meglumine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/58/25509\">",
"           Diazepam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/47/43763\">",
"           Diazoxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/23/2420\">",
"           Dibucaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/51/10036\">",
"           Diclofenac (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/32/20998\">",
"           Diclofenac (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/29/2518\">",
"           Diclofenac (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/60/27589\">",
"           Diclofenac and misoprostol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/60/41920\">",
"           Diclofenac: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/14/2276\">",
"           Dicloxacillin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/8/32900\">",
"           Dicyclomine (dicycloverine): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/13/38101\">",
"           Didanosine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/16/38148\">",
"           Diethylpropion: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/8/36996\">",
"           Difenoxin and atropine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/8/43139\">",
"           Diflorasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/33/41493\">",
"           Diflunisal: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/60/10180\">",
"           Difluprednate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/56/31619\">",
"           Digoxin immune Fab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/34/30245\">",
"           Digoxin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/55/6005\">",
"           Dihydrocodeine, aspirin, and caffeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/8/15493\">",
"           Dihydrocodeine, chlorpheniramine, and phenylephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/36/8773\">",
"           Dihydroergotamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/11/6326\">",
"           Diltiazem: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/50/34596\">",
"           Dimenhydrinate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/51/35635\">",
"           Dimercaprol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/31/10740\">",
"           Dimercaptosuccinic acid (succimer): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/2/33827\">",
"           Dimethyl sulfoxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/10/32932\">",
"           Dinoprostone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/57/12182\">",
"           Diphenhydramine (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/10/4260\">",
"           Diphenhydramine (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/25/23957\">",
"           Diphenhydramine and phenylephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/60/25537\">",
"           Diphenhydramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/39/11892\">",
"           Diphenoxylate and atropine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/30/10721\">",
"           Diphtheria and tetanus toxoid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/40/9858\">",
"           Diphtheria tetanus toxoids acellular pertussis inactivated poliovirus haemophilus influenzae type b conjugate vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/34/22049\">",
"           Diphtheria, tetanus toxoids, acellular pertussis, recombinant hepatitis B, and inactivated poliovirus vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/35/20017\">",
"           Diphtheria, tetanus toxoids, and acellular pertussis vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/29/14804\">",
"           Dipivefrin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/43/23220\">",
"           Dipyridamole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/8/1157\">",
"           Disopyramide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/30/25060\">",
"           Disulfiram: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/35/24115\">",
"           Dobutamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/15/12533\">",
"           Docetaxel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/57/30611\">",
"           Docosanol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/0/31747\">",
"           Docusate and senna: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/14/8420\">",
"           Docusate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/18/28964\">",
"           Dofetilide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/58/26532\">",
"           Dolasetron: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/5/18516\">",
"           Domperidone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/11/41140\">",
"           Donepezil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/24/32131\">",
"           Dopamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/43/37555\">",
"           Doripenem: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/46/19172\">",
"           Dornase alfa: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/53/5973\">",
"           Dorzolamide and timolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/25/26004\">",
"           Dorzolamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/2/44\">",
"           Doxazosin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/8/40069\">",
"           Doxepin (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/23/20852\">",
"           Doxepin (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/1/37904\">",
"           Doxepin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/9/20628\">",
"           Doxercalciferol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/52/30533\">",
"           Doxorubicin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/28/8644\">",
"           Doxycycline hyclate periodontal extended-release liquid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/10/36005\">",
"           Doxycycline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/17/42259\">",
"           Doxylamine and pyridoxine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/47/14068\">",
"           Doxylamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/27/13748\">",
"           Dronabinol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/32/9733\">",
"           Dronedarone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/48/26372\">",
"           Droperidol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/30/2534\">",
"           Drospirenone and estradiol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/42/9894\">",
"           Duloxetine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/8/43140\">",
"           Dutasteride and tamsulosin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/28/6596\">",
"           Dutasteride: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/45/32467\">",
"           Dyclonine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/12/18628\">",
"           Dyphylline and guaifenesin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/25/17812\">",
"           Dyphylline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/37/39508\">",
"           E. coli asparaginase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/7/34931\">",
"           Ecallantide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/8/19588\">",
"           Echothiophate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/30/31203\">",
"           Econazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/31/16885\">",
"           Eculizumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/17/276\">",
"           Edetate calcium disodium (calcium EDTA): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/57/916\">",
"           Edrophonium and atropine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/23/25973\">",
"           Efavirenz, tenofovir, and emtricitabine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/34/24101\">",
"           Efavirenz: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/14/1252\">",
"           Eflornithine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/21/12629\">",
"           Eletriptan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/19/4405\">",
"           Eltrombopag: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/42/5796\">",
"           Emedastine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/51/17205\">",
"           Emtricitabine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/51/27445\">",
"           Enalapril and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/31/30197\">",
"           Enalapril: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/57/8084\">",
"           Enflurane: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/33/21013\">",
"           Enfuvirtide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/51/26421\">",
"           Enoxaparin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/10/20644\">",
"           Entacapone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/49/11029\">",
"           Entecavir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/58/6053\">",
"           Ephedrine (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/29/8660\">",
"           Epinastine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/59/4020\">",
"           Epinephrine (adrenaline) (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/24/10630\">",
"           Epinephrine (adrenaline) (systemic therapy and oral inhalation): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/23/41328\">",
"           Epinephrine (adrenaline): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/21/36181\">",
"           Epirubicin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/49/23316\">",
"           Eplerenone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/12/25797\">",
"           Epoetin alfa: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/61/20436\">",
"           Epoprostenol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/6/32869\">",
"           Eprosartan and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/34/6693\">",
"           Eprosartan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/63/39923\">",
"           Eptifibatide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/3/13366\">",
"           Equine conjugated estrogens and medroxyprogesterone acetate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/16/10500\">",
"           Ergoloid mesylates: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/9/35988\">",
"           Ergotamine and caffeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/44/18116\">",
"           Ergotamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/14/29923\">",
"           Eribulin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/57/41877\">",
"           Erlotinib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/41/9876\">",
"           Ertapenem: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/61/4052\">",
"           Erythromycin (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/23/22901\">",
"           Erythromycin (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/47/756\">",
"           Erythromycin (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/61/34772\">",
"           Erythromycin and benzoyl peroxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/6/42080\">",
"           Erythromycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/1/44053\">",
"           Escitalopram: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/27/3508\">",
"           Esmolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/57/7062\">",
"           Esomeprazole and naproxen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/25/24981\">",
"           Esomeprazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/16/18692\">",
"           Estazolam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/9/8342\">",
"           Esterified estrogen and methyltestosterone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/56/7046\">",
"           Esterified estrogens: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/58/38824\">",
"           Estradiol (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/34/40485\">",
"           Estradiol (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/8/4230\">",
"           Estradiol and dienogest: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/30/13798\">",
"           Estradiol and levonorgestrel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/7/113\">",
"           Estradiol and norethindrone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/54/5990\">",
"           Estradiol and norgestimate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/2/27681\">",
"           Estradiol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/45/10965\">",
"           Estramustine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/34/13862\">",
"           Estropipate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/12/28868\">",
"           Eszopiclone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/34/36389\">",
"           Etanercept: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/36/40517\">",
"           Ethacrynic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/56/8068\">",
"           Ethambutol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/10/17574\">",
"           Ethinyl estradiol and desogestrel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/37/22102\">",
"           Ethinyl estradiol and drospirenone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/2/11302\">",
"           Ethinyl estradiol and ethynodiol diacetate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/39/37494\">",
"           Ethinyl estradiol and etonogestrel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/43/22198\">",
"           Ethinyl estradiol and levonorgestrel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/2/27686\">",
"           Ethinyl estradiol and norelgestromin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/19/311\">",
"           Ethinyl estradiol and norethindrone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/45/16086\">",
"           Ethinyl estradiol and norgestimate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/2/29734\">",
"           Ethinyl estradiol and norgestrel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/55/22390\">",
"           Ethinyl estradiol, drospirenone, and levomefolate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/2/26660\">",
"           Ethionamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/5/34901\">",
"           Ethosuximide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/20/9541\">",
"           Ethotoin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/62/6117\">",
"           Etidronate and calcium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/37/44628\">",
"           Etidronate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/34/20005\">",
"           Etodolac: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/22/32099\">",
"           Etomidate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/54/35684\">",
"           Etonogestrel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/43/40628\">",
"           Etoposide phosphate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/3/43061\">",
"           Etoposide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/56/10117\">",
"           Etravirine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/11/38070\">",
"           Everolimus: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/30/485\">",
"           Exemestane: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/59/26550\">",
"           Exenatide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/30/43493\">",
"           Ezetimibe and simvastatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/57/19348\">",
"           Ezetimibe: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/62/44003\">",
"           Factor XIII concentrates: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/9/16532\">",
"           Famciclovir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/41/19092\">",
"           Famotidine, calcium carbonate, and magnesium hydroxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/10/16549\">",
"           Famotidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/34/5668\">",
"           Fat emulsion: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/21/20820\">",
"           Febuxostat: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/1/12310\">",
"           Felbamate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/12/1221\">",
"           Felodipine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/61/38868\">",
"           Fenofibrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/3/30772\">",
"           Fenofibric acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/39/3702\">",
"           Fenoprofen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/47/43764\">",
"           Fenoterol and ipratropium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/29/472\">",
"           Fentanyl: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/39/39539\">",
"           Ferric gluconate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/10/10404\">",
"           Ferric hexacyanoferrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/20/2373\">",
"           Ferrous fumarate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/51/42804\">",
"           Ferrous gluconate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/22/5477\">",
"           Ferrous sulfate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/32/35331\">",
"           Ferumoxytol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/34/12836\">",
"           Fesoterodine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/63/22517\">",
"           Fexofenadine and pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/43/38580\">",
"           Fexofenadine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/22/21861\">",
"           Filgrastim: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/44/12996\">",
"           Finasteride: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/43/18101\">",
"           Fingolimod: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/34/4644\">",
"           Flavocoxid (plant flavonoids and zinc): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/34/14884\">",
"           Flavoxate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/40/4741\">",
"           Flecainide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/22/7525\">",
"           Floctafenine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/43/20148\">",
"           Floxuridine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/4/29765\">",
"           Fluconazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/22/15717\">",
"           Flucytosine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/41/37525\">",
"           Fludarabine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/11/38069\">",
"           Fludrocortisone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/60/36803\">",
"           Flumazenil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/6/8292\">",
"           Flunarizine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/30/4580\">",
"           Flunisolide (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/40/27265\">",
"           Flunisolide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/12/1220\">",
"           Fluocinolone (otic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/16/5380\">",
"           Fluocinolone (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/23/1397\">",
"           Fluocinolone, hydroquinone, and tretinoin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/33/38416\">",
"           Fluocinolone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/16/8452\">",
"           Fluocinonide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/37/6741\">",
"           Fluoride: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/55/25460\">",
"           Fluorometholone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/24/11653\">",
"           Fluorouracil (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/27/41396\">",
"           Fluorouracil (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/45/38608\">",
"           Fluorouracil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/58/30630\">",
"           Fluoxetine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/61/18388\">",
"           Fluoxymesterone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/5/24661\">",
"           Flupentixol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/6/26725\">",
"           Fluphenazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/24/12676\">",
"           Flurandrenolide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/47/33524\">",
"           Flurazepam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/3/38963\">",
"           Flurbiprofen (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/35/36405\">",
"           Flurbiprofen (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/55/38768\">",
"           Flurbiprofen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/53/12117\">",
"           Flutamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/5/28756\">",
"           Fluticasone (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/33/12822\">",
"           Fluticasone (oral inhalation): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/54/15204\">",
"           Fluticasone (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/16/8454\">",
"           Fluticasone and salmeterol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/1/42000\">",
"           Fluticasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/7/36980\">",
"           Fluvastatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/13/6358\">",
"           Fluvoxamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/16/260\">",
"           Folic acid, cyanocobalamin, and pyridoxine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/57/25492\">",
"           Folic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/14/29924\">",
"           Follitropin alfa (recombinant human follicle stimulating hormone): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/28/30148\">",
"           Follitropin beta (recombinant human follicle stimulating hormone): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/14/22755\">",
"           Fomepizole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/8/38020\">",
"           Fondaparinux: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/4/3142\">",
"           Formoterol and mometasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/56/23430\">",
"           Formoterol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/5/32853\">",
"           Fosamprenavir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/55/6004\">",
"           Fosaprepitant (intravenous aprepitant): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/11/37044\">",
"           Foscarnet: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/32/2564\">",
"           Fosfomycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/48/29445\">",
"           Fosinopril and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/39/15989\">",
"           Fosinopril: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/11/15540\">",
"           Fosphenytoin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/47/2803\">",
"           Fospropofol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/8/5253\">",
"           Frovatriptan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/51/36659\">",
"           Fructose, dextrose, and orthophosphoric acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/8/11396\">",
"           Fulvestrant: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/14/12518\">",
"           Furosemide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/4/37956\">",
"           Fusidic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/21/24916\">",
"           Gabapentin enacarbil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/8/2182\">",
"           Gabapentin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/63/34803\">",
"           Gadobenate dimeglumine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/57/31635\">",
"           Gadobutrol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/59/32691\">",
"           Gadodiamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/24/36227\">",
"           Gadofosveset: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/17/43283\">",
"           Gadopentetate dimeglumine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/38/28259\">",
"           Gadoteridol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/38/33379\">",
"           Gadoversetamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/3/14388\">",
"           Gadoxetate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/17/41236\">",
"           Galantamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/43/1716\">",
"           Gallium nitrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/59/5044\">",
"           Galsulfase (recombinant human N-acetylgalactosamine-4 sulfatase): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/53/41811\">",
"           Ganciclovir (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/18/31012\">",
"           Ganciclovir (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/48/38656\">",
"           Ganciclovir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/13/5332\">",
"           Ganirelix: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/31/44531\">",
"           Gatifloxacin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/20/34116\">",
"           Gefitinib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/42/677\">",
"           Gemcitabine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/21/31060\">",
"           Gemfibrozil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/19/22837\">",
"           Gemifloxacin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/23/28020\">",
"           Gentamicin (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/8/18564\">",
"           Gentamicin (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/59/38835\">",
"           Gentamicin (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/51/40752\">",
"           Gentamicin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/19/3380\">",
"           Gentian violet: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/23/32116\">",
"           Glatiramer acetate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/58/39844\">",
"           Gliclazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/30/38372\">",
"           Glimepiride: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/49/27413\">",
"           Glipizide and metformin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/19/16693\">",
"           Glipizide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/48/16131\">",
"           Glucagon: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/32/43523\">",
"           Glutamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/45/32469\">",
"           Glyburide and metformin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/38/15973\">",
"           Glyburide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/53/38739\">",
"           Glycerin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/0/44036\">",
"           Glycopyrrolate (glycopyrronium): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/11/34996\">",
"           Gold sodium thiomalate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/13/1238\">",
"           Golimumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/44/41667\">",
"           Gonadorelin acetate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/0/27652\">",
"           Goserelin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/53/1878\">",
"           Granisetron: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/56/38789\">",
"           Griseofulvin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/43/25268\">",
"           Guaifenesin and codeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/7/40052\">",
"           Guaifenesin and dextromethorphan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/38/613\">",
"           Guaifenesin and phenylephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/60/6085\">",
"           Guaifenesin and pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/44/7877\">",
"           Guaifenesin, dextromethorphan, and phenylephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/34/18981\">",
"           Guaifenesin, pseudoephedrine, and codeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/15/5365\">",
"           Guaifenesin, pseudoephedrine, and dextromethorphan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/55/26484\">",
"           Guaifenesin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/32/1541\">",
"           Guanfacine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/2/3108\">",
"           Guanidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/26/13729\">",
"           Haemophilus influenzae type b conjugate and hepatitis B vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/32/14849\">",
"           Haemophilus influenzae type b conjugate vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/52/32579\">",
"           Halcinonide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/35/24116\">",
"           Halobetasol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/63/37877\">",
"           Haloperidol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/20/18755\">",
"           Hemin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/20/325\">",
"           Heparin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/58/11169\">",
"           Hepatitis A vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/60/13249\">",
"           Hepatitis A virus and recombinant hepatitis B virus vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/42/28323\">",
"           Hepatitis B immune globulin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/38/10849\">",
"           Hepatitis B vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/47/19187\">",
"           Hetastarch: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/41/28307\">",
"           Hexachlorophene: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/16/22787\">",
"           Hexaminolevulinate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/28/11716\">",
"           Histrelin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/46/7908\">",
"           Homatropine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/15/31988\">",
"           Human chorionic gonadotropin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/9/4242\">",
"           Human papillomavirus bivalent (types 16, 18) recombinant vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/49/17169\">",
"           Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/29/30166\">",
"           Hyaluronate derivatives: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/37/4691\">",
"           Hyaluronidase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/40/8837\">",
"           Hydralazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/5/25685\">",
"           Hydrochlorothiazide and spironolactone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/51/24373\">",
"           Hydrochlorothiazide and triamterene: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/20/10565\">",
"           Hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/53/23381\">",
"           Hydrocodone and acetaminophen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/56/39812\">",
"           Hydrocodone and chlorpheniramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/24/30084\">",
"           Hydrocodone and homatropine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/6/42085\">",
"           Hydrocodone and ibuprofen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/36/35398\">",
"           Hydrocortisone (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/25/19861\">",
"           Hydrocortisone (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/9/39056\">",
"           Hydrocortisone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/48/14086\">",
"           Hydromorphone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/43/15028\">",
"           Hydroquinone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/49/1813\">",
"           Hydroxocobalamin (vitamin B12 supplement and cyanide antidote ): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/39/18037\">",
"           Hydroxychloroquine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/46/19171\">",
"           Hydroxyethyl starch (tetrastarch) 130/0.4: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/38/22116\">",
"           Hydroxyprogesterone caproate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/57/18323\">",
"           Hydroxypropyl cellulose: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/15/31987\">",
"           Hydroxypropyl methylcellulose: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/61/29653\">",
"           Hydroxyurea: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/45/3797\">",
"           Hydroxyzine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/38/18021\">",
"           Hyoscyamine, atropine, scopolamine, and phenobarbital: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/60/39877\">",
"           Hyoscyamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/62/5094\">",
"           Ibandronate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/20/18757\">",
"           Ibritumomab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/60/35781\">",
"           Ibuprofen and famotidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/43/30389\">",
"           Ibuprofen, pseudoephedrine, and chlorpheniramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/17/14614\">",
"           Ibuprofen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/19/26931\">",
"           Ibutilide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/42/23204\">",
"           Icodextrin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/40/29317\">",
"           Idarubicin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/47/8948\">",
"           Idursulfase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/46/19173\">",
"           Ifosfamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/40/32389\">",
"           Iloperidone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/56/34692\">",
"           Iloprost: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/49/3862\">",
"           Imatinib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/2/28707\">",
"           Imiglucerase (glucocerebrosidase): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/30/7652\">",
"           Imipenem and cilastatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/18/36133\">",
"           Imipramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/19/25908\">",
"           Imiquimod: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/54/16230\">",
"           Immune globulin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/7/4213\">",
"           IncobotulinumtoxinA (botulinum toxin type A, Xeomin): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/36/43588\">",
"           Indapamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/28/3525\">",
"           Indinavir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/34/550\">",
"           Indomethacin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/23/2422\">",
"           Infliximab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/53/16209\">",
"           Influenza virus vaccine (inactivated): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/43/11953\">",
"           Influenza virus vaccine (live attenuated): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/45/16084\">",
"           Instant glucose and intravenous dextrose: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/2/8229\">",
"           Insulin aspart protamine and insulin aspart: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/14/229\">",
"           Insulin aspart: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/8/6277\">",
"           Insulin detemir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/34/5669\">",
"           Insulin glargine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/24/389\">",
"           Insulin glulisine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/37/9813\">",
"           Insulin lispro protamine and insulin lispro: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/49/42772\">",
"           Insulin lispro: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/12/6341\">",
"           Insulin NPH and insulin regular: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/55/42868\">",
"           Insulin NPH: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/37/1621\">",
"           Insulin regular: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/61/14294\">",
"           Interferon alfa-2b: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/16/6406\">",
"           Interferon alfacon-1 (consensus interferon): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/54/30564\">",
"           Interferon alfa-n3: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/5/38997\">",
"           Interferon beta-1a: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/29/8661\">",
"           Interferon beta-1b: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/54/11109\">",
"           Interferon gamma-1b: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/44/29379\">",
"           Iobenguane: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/25/41363\">",
"           Iodipamide meglumine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/35/16948\">",
"           Iodixanol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/60/14276\">",
"           Iodoquinol and hydrocortisone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/61/40915\">",
"           Iodoquinol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/25/13716\">",
"           Iohexol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/33/2580\">",
"           Iopamidol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/24/3460\">",
"           Iopromide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/19/7476\">",
"           Iothalamate meglumine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/21/11604\">",
"           Ioversol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/18/3364\">",
"           Ioxaglate meglumine and ioxaglate sodium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/13/4308\">",
"           Ioxilan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/33/40468\">",
"           Ipilimumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/62/13284\">",
"           Ipratropium (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/51/39732\">",
"           Ipratropium (oral inhalation): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/33/35349\">",
"           Ipratropium and albuterol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/54/38752\">",
"           Ipratropium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/36/28229\">",
"           Irbesartan and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/16/17669\">",
"           Irbesartan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/44/1733\">",
"           Irinotecan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/15/33012\">",
"           Iron dextran: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/41/29331\">",
"           Iron sucrose: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/34/34341\">",
"           Isocarboxazid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/54/39780\">",
"           Isoflurane: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/5/8277\">",
"           Isoniazid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/46/8932\">",
"           Isoproterenol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/2/10277\">",
"           Isosorbide dinitrate and hydralazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/50/24356\">",
"           Isosorbide dinitrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/27/15796\">",
"           Isosorbide mononitrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/62/20451\">",
"           Isosulfan blue: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/34/33318\">",
"           Isotretinoin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/4/26692\">",
"           Isradipine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/17/34069\">",
"           Itraconazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/27/38320\">",
"           Ivermectin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/26/7589\">",
"           Ixabepilone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/56/14209\">",
"           Japanese encephalitis virus vaccine (inactivated): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/13/36051\">",
"           Kanamycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/36/10820\">",
"           Ketamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/30/2533\">",
"           Ketoconazole (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/51/34612\">",
"           Ketoconazole (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/52/38720\">",
"           Ketoconazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/59/30645\">",
"           Ketoprofen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/59/41909\">",
"           Ketorolac (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/0/19460\">",
"           Ketorolac (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/33/3606\">",
"           Ketorolac (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/34/41504\">",
"           Ketorolac: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/1/3092\">",
"           Ketotifen (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/21/20821\">",
"           Labetalol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/0/29701\">",
"           Lacosamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/60/39875\">",
"           Lactic acid with ammonium hydroxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/6/18532\">",
"           Lactobacillus: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/59/19380\">",
"           Lactulose: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/53/20309\">",
"           Lamivudine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/40/41605\">",
"           Lamotrigine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/35/18997\">",
"           Lanreotide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/49/33556\">",
"           Lansoprazole, amoxicillin, and clarithromycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/57/24469\">",
"           Lansoprazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/53/41812\">",
"           Lanthanum carbonate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/31/29173\">",
"           Lapatinib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/21/37203\">",
"           Laronidase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/22/29028\">",
"           Latanoprost and timolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/22/22884\">",
"           Latanoprost: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/10/28836\">",
"           L-carnitine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/42/24229\">",
"           Leflunomide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/39/11894\">",
"           Lenalidomide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/63/20468\">",
"           Lepirudin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/18/14629\">",
"           Letrozole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/48/9988\">",
"           Leucovorin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/48/774\">",
"           Leuprolide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/7/22645\">",
"           Levalbuterol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/38/35429\">",
"           Levetiracetam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/30/30180\">",
"           Levobunolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/55/43891\">",
"           Levocabastine (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/62/41955\">",
"           Levocabastine (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/7/13428\">",
"           Levocetirizine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/17/18709\">",
"           Levodopa-benserazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/63/24564\">",
"           Levofloxacin (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/32/13830\">",
"           Levofloxacin (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/60/38848\">",
"           Levofloxacin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/11/39091\">",
"           LEVOleucovorin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/24/15750\">",
"           Levonorgestrel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/62/20452\">",
"           Levorphanol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/20/13638\">",
"           Levothyroxine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/39/12915\">",
"           Lidocaine (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/58/36772\">",
"           Lidocaine (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/46/29413\">",
"           Lidocaine (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/23/9588\">",
"           Lidocaine and epinephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/0/18436\">",
"           Lidocaine and hydrocortisone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/17/4373\">",
"           Lidocaine and prilocaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/34/31267\">",
"           Lidocaine and tetracaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/0/41984\">",
"           Lidocaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/52/30532\">",
"           Linagliptin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/36/41539\">",
"           Lincomycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/37/37461\">",
"           Lindane: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/30/1510\">",
"           Linezolid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/27/44468\">",
"           Liothyronine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/14/27877\">",
"           Liotrix: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/57/5013\">",
"           Liposomal amphotericin B: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/14/25828\">",
"           Liposomal cytarabine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/21/25941\">",
"           Liposomal daunorubicin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/20/28997\">",
"           Liposomal doxorubicin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/37/41555\">",
"           Liposomal morphine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/42/43685\">",
"           Liraglutide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/44/31429\">",
"           Lisdexamfetamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/37/30294\">",
"           Lisinopril and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/32/9734\">",
"           Lisinopril: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/29/28117\">",
"           Lithium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/40/644\">",
"           Lodoxamide tromethamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/60/8133\">",
"           Lomustine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/27/22964\">",
"           Loperamide and simethicone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/33/41492\">",
"           Loperamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/13/30933\">",
"           Lopinavir and ritonavir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/57/19349\">",
"           Loratadine and pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/7/34932\">",
"           Loratadine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/13/19669\">",
"           Lorazepam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/40/31365\">",
"           Losartan and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/26/26021\">",
"           Losartan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/21/1364\">",
"           Loteprednol and tobramycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/58/20388\">",
"           Loteprednol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/16/10501\">",
"           Lovastatin and niacin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/61/6101\">",
"           Lovastatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/26/4517\">",
"           Loxapine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/28/1476\">",
"           Lubiprostone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/30/16869\">",
"           Lurasidone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/46/1764\">",
"           Lutropin alfa: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/41/38548\">",
"           Mafenide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/37/9812\">",
"           Magaldrate and simethicone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/13/2260\">",
"           Magnesium carbonate, calcium carbonate, and folic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/28/24004\">",
"           Magnesium chloride: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/57/15252\">",
"           Magnesium citrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/2/5156\">",
"           Magnesium glucoheptonate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/36/41540\">",
"           Magnesium gluconate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/32/12804\">",
"           Magnesium hydroxide and mineral oil emulsion: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/49/19220\">",
"           Magnesium hydroxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/38/11876\">",
"           Magnesium L-aspartate hydrochloride: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/35/44595\">",
"           Magnesium L-lactate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/33/12820\">",
"           Magnesium oxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/16/17668\">",
"           Magnesium salicylate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/3/13365\">",
"           Magnesium sulfate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/5/11348\">",
"           Malathion: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/10/25763\">",
"           Manganese: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/34/29221\">",
"           Mannitol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/38/4709\">",
"           Maprotiline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/15/43252\">",
"           Maraviroc: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/47/30452\">",
"           m-Cresyl acetate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/41/658\">",
"           Measles, mumps, and rubella vaccines (combined): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/20/14657\">",
"           Measles, mumps, rubella, and varicella virus vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/29/1492\">",
"           Mebendazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/5/22613\">",
"           Mechlorethamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/33/13844\">",
"           Meclizine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/18/17701\">",
"           Meclofenamate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/29/30164\">",
"           Medium chain triglycerides: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/25/36245\">",
"           Medroxyprogesterone acetate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/5/19541\">",
"           Mefenamic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/38/31333\">",
"           Mefloquine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/37/12885\">",
"           Megestrol acetate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/50/26405\">",
"           Meloxicam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/26/17830\">",
"           Melphalan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/61/21460\">",
"           Memantine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/38/11873\">",
"           Meningococcal polysaccharide vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/5/35923\">",
"           Meningococcal serogroup C conjugate vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/13/25812\">",
"           Menotropins: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/31/33267\">",
"           Menthol and zinc oxide (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/61/14292\">",
"           Mepenzolate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/46/24293\">",
"           Meperidine (pethidine): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/16/42243\">",
"           Mepivacaine (dental): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/1/34835\">",
"           Mepivacaine and levonordefrin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/7/42099\">",
"           Mepivacaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/17/15636\">",
"           Meprobamate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/4/30789\">",
"           Mercaptopurine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/47/40691\">",
"           Meropenem: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/34/33317\">",
"           Mesalamine (mesalazine): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/34/34340\">",
"           Mesna: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/47/3830\">",
"           Mestranol and norethindrone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/29/34260\">",
"           Metaproterenol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/33/41491\">",
"           Metaxalone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/22/358\">",
"           Metformin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/22/34147\">",
"           Methacholine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/13/4310\">",
"           Methadone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/1/12309\">",
"           Methamphetamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/0/20484\">",
"           Methazolamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/26/35236\">",
"           Methenamine and sodium acid phosphate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/7/5237\">",
"           Methenamine, phenyl salicylate, methylene blue, benzoic acid, and hyoscyamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/4/38981\">",
"           Methenamine, sodium biphosphate, phenyl salicylate, methylene blue, and hyoscyamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/26/23972\">",
"           Methenamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/53/16213\">",
"           Methimazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/1/23572\">",
"           Methocarbamol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/4/17476\">",
"           Methohexital: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/59/42934\">",
"           Methotrexate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/38/37477\">",
"           Methotrimeprazine (levomepromazine): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/41/24212\">",
"           Methoxsalen (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/5/2132\">",
"           Methoxsalen (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/41/38544\">",
"           Methoxsalen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/15/6388\">",
"           Methscopolamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/29/15829\">",
"           Methsuximide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/22/357\">",
"           Methyclothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/19/32051\">",
"           Methyl aminolevulinate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/55/13172\">",
"           Methyl salicylate and menthol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/14/14564\">",
"           Methylcellulose: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/33/534\">",
"           Methyldopa and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/6/29797\">",
"           Methyldopa: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/6/39012\">",
"           Methylene blue: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/42/7845\">",
"           Methylergonovine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/29/24019\">",
"           Methylfolate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/59/14260\">",
"           Methylnaltrexone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/43/7863\">",
"           Methylphenidate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/5/14422\">",
"           Methylprednisolone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/23/42356\">",
"           Methyltestosterone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/17/20756\">",
"           Metipranolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/45/34517\">",
"           Metoclopramide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/46/5861\">",
"           Metolazone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/37/36437\">",
"           Metoprolol and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/28/25030\">",
"           Metoprolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/48/19205\">",
"           Metronidazole (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/5/95\">",
"           Metronidazole (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/35/3636\">",
"           Metronidazole and nystatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/0/38912\">",
"           Metronidazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/23/18804\">",
"           Metyrosine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/14/31972\">",
"           Mexiletine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/42/8868\">",
"           Micafungin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/27/4533\">",
"           Miconazole (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/6/4197\">",
"           Midazolam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/26/43428\">",
"           Midodrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/15/2295\">",
"           Mifepristone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/14/22756\">",
"           Miglitol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/40/6788\">",
"           Miglustat: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/63/27637\">",
"           Milnacipran: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/22/20835\">",
"           Milrinone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/46/33508\">",
"           Mineral oil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/36/33347\">",
"           Minocycline hydrochloride periodontal microspheres: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/53/17237\">",
"           Minocycline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/26/24996\">",
"           Minoxidil (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/58/33699\">",
"           Minoxidil (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/20/38208\">",
"           Minoxidil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/45/33493\">",
"           Mirtazapine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/23/11636\">",
"           Misoprostol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/42/35488\">",
"           Mitomycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/59/29620\">",
"           Mitotane: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/4/1094\">",
"           Mitoxantrone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/10/13477\">",
"           Moclobemide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/26/28069\">",
"           Modafinil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/9/27797\">",
"           Moexipril and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/32/6661\">",
"           Moexipril: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/4/7236\">",
"           Mometasone (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/30/7654\">",
"           Mometasone (oral inhalation): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/61/13268\">",
"           Mometasone (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/57/41872\">",
"           Mometasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/5/38995\">",
"           Monobenzone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/18/13605\">",
"           Montelukast: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/33/14870\">",
"           Morphine sulfate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/45/9940\">",
"           Moxifloxacin (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/51/2870\">",
"           Moxifloxacin (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/61/38864\">",
"           Moxifloxacin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/54/37731\">",
"           Multiple vitamins (injectable): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/53/17236\">",
"           Multiple vitamins (prenatal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/30/24036\">",
"           Multiple vitamins: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/63/6132\">",
"           Mupirocin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/56/22406\">",
"           Mycophenolate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/8/29828\">",
"           Nabilone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/26/13733\">",
"           Nabiximols: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/56/23429\">",
"           Nabumetone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/18/18725\">",
"           Nadolol and bendroflumethiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/37/31317\">",
"           Nadolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/45/5845\">",
"           Nadroparin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/37/18005\">",
"           Nafarelin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/32/17924\">",
"           Nafcillin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/13/30931\">",
"           Naftifine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/46/43747\">",
"           Nalbuphine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/10/31907\">",
"           Naloxone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/53/27477\">",
"           Naltrexone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/52/40772\">",
"           Naphazoline (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/47/19188\">",
"           Naphazoline (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/60/9156\">",
"           Naphazoline and pheniramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/37/38480\">",
"           Naphazoline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/17/10517\">",
"           Naproxen and pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/35/44597\">",
"           Naproxen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/58/15269\">",
"           Naratriptan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/10/7333\">",
"           Natalizumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/45/7892\">",
"           Natamycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/1/32788\">",
"           Nateglinide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/14/17637\">",
"           Nebivolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/41/7828\">",
"           Nedocromil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/61/42965\">",
"           Nefazodone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/12/12485\">",
"           Nelarabine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/32/43524\">",
"           Nelfinavir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/5/34899\">",
"           Neomycin and polymyxin B: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/44/34499\">",
"           Neomycin, colistin, hydrocortisone, and thonzonium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/46/21220\">",
"           Neomycin, polymyxin B, and dexamethasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/61/27604\">",
"           Neomycin, polymyxin B, and gramicidin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/38/12901\">",
"           Neomycin, polymyxin B, and hydrocortisone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/63/36852\">",
"           Neomycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/38/28260\">",
"           Neostigmine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/5/26708\">",
"           Nepafenac: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/1/22547\">",
"           Nesiritide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/15/25845\">",
"           Nevirapine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/40/5765\">",
"           Niacin and simvastatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/10/12453\">",
"           Nicardipine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/20/9540\">",
"           Nicotinamide (niacinamide): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/29/25046\">",
"           Nicotine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/27/31157\">",
"           Nifedipine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/9/18582\">",
"           Nilotinib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/19/42292\">",
"           Nilutamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/45/3796\">",
"           Nimodipine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/46/31460\">",
"           Nisoldipine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/3/5172\">",
"           Nitazoxanide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/51/5940\">",
"           Nitisinone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/54/23396\">",
"           Nitrazepam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/30/44514\">",
"           Nitric oxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/5/14421\">",
"           Nitrofurantoin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/10/9382\">",
"           Nitroglycerin (glyceryl trinitrate): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/36/34371\">",
"           Nitroprusside: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/27/30131\">",
"           Nitrous oxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/58/31652\">",
"           Nizatidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/12/39107\">",
"           Nonoxynol 9: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/53/10067\">",
"           Norepinephrine (noradrenaline): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/56/41860\">",
"           Norethindrone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/7/28789\">",
"           Norfloxacin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/7/22643\">",
"           North American coral snake (Micrurus fulvius) antivenom: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/22/25957\">",
"           Nortriptyline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/63/40947\">",
"           Nystatin (oral): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/55/35700\">",
"           Nystatin (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/0/32771\">",
"           Nystatin and triamcinolone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/4/37952\">",
"           Nystatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/31/18934\">",
"           Octreotide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/54/18276\">",
"           Ofatumumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/20/30020\">",
"           Ofloxacin (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/6/16484\">",
"           Ofloxacin (otic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/29/30165\">",
"           Ofloxacin (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/32/41472\">",
"           Ofloxacin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/62/42981\">",
"           Olanzapine and fluoxetine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/16/28934\">",
"           Olanzapine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/8/31877\">",
"           Olmesartan and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/27/10677\">",
"           Olmesartan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/60/35779\">",
"           Olopatadine (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/2/8228\">",
"           Olopatadine (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/61/43984\">",
"           Olopatadine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/36/44611\">",
"           Olsalazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/15/34036\">",
"           Omalizumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/62/5093\">",
"           Omega-3-acid ethyl esters (fish oil): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/27/27061\">",
"           Omeprazole and sodium bicarbonate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/61/32725\">",
"           Omeprazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/55/16245\">",
"           OnabotulinumtoxinA (botulinum toxin type A, Botox): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/24/24965\">",
"           Ondansetron: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/19/26933\">",
"           Oprelvekin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/8/25732\">",
"           Orlistat: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/31/34292\">",
"           Orphenadrine, aspirin, and caffeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/11/29876\">",
"           Orphenadrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/16/1285\">",
"           Oseltamivir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/16/39171\">",
"           Ovine polyvalent crotalidae North and South American snake antivenom: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/56/900\">",
"           Oxacillin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/31/33269\">",
"           Oxaliplatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/53/9045\">",
"           Oxandrolone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/29/24021\">",
"           Oxaprozin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/29/31188\">",
"           Oxazepam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/38/39525\">",
"           Oxcarbazepine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/16/35075\">",
"           Oxiconazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/47/35574\">",
"           Oxybutynin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/53/20307\">",
"           Oxychlorosene: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/21/26965\">",
"           Oxycodone and acetaminophen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/48/32517\">",
"           Oxycodone and aspirin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/17/38165\">",
"           Oxycodone and ibuprofen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/3/6198\">",
"           Oxycodone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/25/23956\">",
"           Oxymetazoline (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/0/2052\">",
"           Oxymetazoline (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/1/38928\">",
"           Oxymetazoline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/3/9269\">",
"           Oxymetholone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/36/32325\">",
"           Oxymorphone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/30/18915\">",
"           Oxytocin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/24/22917\">",
"           Paclitaxel (nanoparticle albumin bound): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/26/17829\">",
"           Paclitaxel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/17/25875\">",
"           Palifermin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/42/3750\">",
"           Paliperidone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/57/36755\">",
"           Palonosetron: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/10/44196\">",
"           Pamidronate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/44/35524\">",
"           Pancrelipase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/24/34179\">",
"           Pancuronium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/26/26020\">",
"           Panitumumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/40/13957\">",
"           Pantoprazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/20/7492\">",
"           Papaverine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/19/21812\">",
"           Para-aminosalicylic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/46/4837\">",
"           Paregoric: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/36/17989\">",
"           Paricalcitol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/49/7956\">",
"           Paromomycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/12/17606\">",
"           Paroxetine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/5/20566\">",
"           Pazopanib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/19/22835\">",
"           Pegaptanib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/34/42532\">",
"           Pegaspargase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/44/32452\">",
"           Pegfilgrastim: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/29/40403\">",
"           Pegloticase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/29/44500\">",
"           Pegvisomant: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/16/44294\">",
"           Pegylated interferon (peginterferon) alfa-2a and ribavirin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/3/21558\">",
"           Pegylated interferon (peginterferon) alfa-2a: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/5/37974\">",
"           Pegylated interferon (peginterferon) alfa-2b and ribavirin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/8/30854\">",
"           Pegylated interferon (peginterferon) alfa-2b: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/11/23732\">",
"           Pemetrexed: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/38/42596\">",
"           Penbutolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/20/33091\">",
"           Penciclovir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/20/34117\">",
"           Penicillamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/23/43379\">",
"           Penicillin G (parenteral): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/18/22819\">",
"           Penicillin G benzathine and penicillin G procaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/41/44691\">",
"           Penicillin G benzathine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/10/32931\">",
"           Penicillin G procaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/32/18948\">",
"           Penicillin V potassium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/45/43731\">",
"           Pentafluoropropane and tetrafluoroethane: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/2/39973\">",
"           Pentamidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/48/23299\">",
"           Pentastarch: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/11/18613\">",
"           Pentazocine and acetaminophen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/36/40516\">",
"           Pentazocine and naloxone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/29/4564\">",
"           Pentazocine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/7/38003\">",
"           Pentobarbital: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/33/9748\">",
"           Pentosan polysulfate sodium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/41/16021\">",
"           Pentostatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/2/25636\">",
"           Pentoxifylline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/44/2756\">",
"           Perflutren lipid microspheres: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/22/38243\">",
"           Perflutren protein type A: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/57/18325\">",
"           Pericyazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/49/39701\">",
"           Perindopril and indapamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/13/17621\">",
"           Perindopril: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/6/30821\">",
"           Permethrin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/50/12069\">",
"           Perphenazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/44/11972\">",
"           Phenazopyridine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/10/3237\">",
"           Phendimetrazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/35/32309\">",
"           Phenelzine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/59/8117\">",
"           Phenobarbital: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/43/32436\">",
"           Phenol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/35/23092\">",
"           Phenoxybenzamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/41/20117\">",
"           Phentermine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/46/3812\">",
"           Phentolamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/52/21316\">",
"           Phenylephrine (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/50/37668\">",
"           Phenylephrine (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/59/33717\">",
"           Phenylephrine (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/36/20036\">",
"           Phenylephrine (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/24/5509\">",
"           Phenylephrine and pyrilamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/14/24804\">",
"           Phenylephrine and zinc sulfate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/16/15621\">",
"           Phenylephrine, pyrilamine, and dextromethorphan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/15/241\">",
"           Phenylephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/49/7958\">",
"           Phenytoin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/60/33731\">",
"           Physostigmine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/3/18484\">",
"           Pilocarpine (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/52/28484\">",
"           Pilocarpine (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/50/38688\">",
"           Pilocarpine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/7/3189\">",
"           Pimecrolimus: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/48/4869\">",
"           Pimozide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/49/20244\">",
"           Pinaverium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/21/43349\">",
"           Pindolol and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/31/5621\">",
"           Pindolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/58/41893\">",
"           Pioglitazone and glimepiride: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/19/19766\">",
"           Pioglitazone and metformin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/34/6694\">",
"           Pioglitazone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/20/40259\">",
"           Piperacillin and tazobactam sodium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/24/31107\">",
"           Piperacillin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/21/39252\">",
"           Pipotiazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/48/43780\">",
"           Pirbuterol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/0/18437\">",
"           Piroxicam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/61/17365\">",
"           Pitavastatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/28/4549\">",
"           Pizotifen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/37/8788\">",
"           Plerixafor: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/5/14417\">",
"           Pneumococcal polysaccharide vaccine (23-valent): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/28/35267\">",
"           Podofilox: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/60/17347\">",
"           Polidocanol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/17/11537\">",
"           Poliovirus vaccine (inactivated): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/55/9076\">",
"           Polyethylene glycol 3350: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/46/23268\">",
"           Polyethylene glycol electrolyte solution and bisacodyl: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/7/34933\">",
"           Polyethylene glycol electrolyte solution: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/31/15860\">",
"           Polymyxin B: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/52/42820\">",
"           Polysaccharide-iron complex, vitamin B12, and folic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/49/39700\">",
"           Polysaccharide-iron complex: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/10/13476\">",
"           Porfimer: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/7/20597\">",
"           Posaconazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/50/40739\">",
"           Potassium acetate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/13/23764\">",
"           Potassium bicarbonate and potassium chloride (effervescent): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/62/19428\">",
"           Potassium bicarbonate and potassium citrate (effervescent): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/13/19668\">",
"           Potassium bicarbonate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/8/14469\">",
"           Potassium chloride: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/14/37091\">",
"           Potassium citrate (powder or solution): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/35/32308\">",
"           Potassium citrate (tablet): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/41/11924\">",
"           Potassium gluconate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/6/34916\">",
"           Potassium iodide and iodine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/38/23141\">",
"           Potassium iodide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/24/24964\">",
"           Potassium phosphate and sodium phosphate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/30/1508\">",
"           Potassium phosphate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/35/43572\">",
"           Pralatrexate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/31/23027\">",
"           Pralidoxime: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/4/35908\">",
"           Pramipexole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/4/21573\">",
"           Pramlintide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/24/22916\">",
"           Pramoxine and hydrocortisone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/50/5925\">",
"           Prasugrel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/21/37204\">",
"           Pravastatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/16/24836\">",
"           Praziquantel: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/19/37172\">",
"           Prazosin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/30/3556\">",
"           Prednicarbate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/13/43220\">",
"           Prednisolone (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/12/29894\">",
"           Prednisolone (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/22/21860\">",
"           Prednisolone and gentamicin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/10/39072\">",
"           Prednisolone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/36/28230\">",
"           Prednisone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/55/22389\">",
"           Pregabalin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/47/36595\">",
"           Prilocaine and epinephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/29/30163\">",
"           Prilocaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/37/30292\">",
"           Primaquine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/5/15445\">",
"           Primidone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/57/36756\">",
"           Probenecid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/45/4820\">",
"           Procainamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/49/5909\">",
"           Procarbazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/50/33573\">",
"           Prochlorperazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/9/9364\">",
"           Procyclidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/14/35045\">",
"           Progesterone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/42/13989\">",
"           Promethazine and codeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/35/6709\">",
"           Promethazine and dextromethorphan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/21/14677\">",
"           Promethazine and phenylephrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/26/9638\">",
"           Promethazine, phenylephrine, and codeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/47/2806\">",
"           Promethazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/19/7478\">",
"           Propafenone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/27/6580\">",
"           Propantheline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/20/2372\">",
"           Proparacaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/57/39827\">",
"           Propofol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/24/1414\">",
"           Propranolol and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/4/43077\">",
"           Propranolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/31/30196\">",
"           Propylthiouracil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/62/25571\">",
"           Protamine sulfate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/51/31540\">",
"           Protein C concentrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/60/39876\">",
"           Protriptyline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/33/14869\">",
"           Pseudoephedrine and codeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/25/5525\">",
"           Pseudoephedrine and dextromethorphan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/63/8181\">",
"           Pseudoephedrine and ibuprofen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/63/10229\">",
"           Pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/23/21876\">",
"           Psyllium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/4/3140\">",
"           Pyrantel pamoate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/39/29300\">",
"           Pyrazinamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/20/326\">",
"           Pyrethrins: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/53/39764\">",
"           Pyridostigmine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/12/9413\">",
"           Pyrimethamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/2/16417\">",
"           Quadrivalent (A, C, Y, W-135) meningococcal conjugate vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/21/36180\">",
"           Quazepam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/29/15830\">",
"           Quetiapine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/32/8708\">",
"           Quinagolide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/7/16501\">",
"           Quinapril and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/24/15749\">",
"           Quinapril: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/17/23829\">",
"           Quinidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/0/13317\">",
"           Quinine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/36/16964\">",
"           Quinupristin and dalfopristin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/44/41668\">",
"           Rabeprazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/3/20531\">",
"           Rabies immune globulin (human): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/33/10769\">",
"           Rabies virus vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/42/18085\">",
"           Raloxifene: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/59/30644\">",
"           Raltegravir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/37/26196\">",
"           Raltitrexed: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/29/22996\">",
"           Ramelteon: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/63/20469\">",
"           Ramipril and felodipine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/3/22581\">",
"           Ramipril and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/12/23749\">",
"           Ramipril: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/10/30883\">",
"           Ranibizumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/56/22405\">",
"           Ranitidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/49/29460\">",
"           Ranolazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/45/18133\">",
"           Rasagiline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/30/20964\">",
"           Rasburicase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/36/580\">",
"           Recombinant human chorionic gonadotropin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/40/10884\">",
"           Recombinant human factor VIIa: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/32/22020\">",
"           Recombinant human factor VIII: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/39/20085\">",
"           Recombinant human growth hormone (somatropin): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/34/32291\">",
"           Regadenoson: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/41/38547\">",
"           Remifentanil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/29/5590\">",
"           Repaglinide and metformin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/58/35748\">",
"           Repaglinide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/7/6261\">",
"           Reserpine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/4/29763\">",
"           Retapamulin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/23/30067\">",
"           Reteplase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/38/8804\">",
"           Rho(D) immune globulin (intramuscular): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/17/37142\">",
"           Ribavirin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/32/40452\">",
"           Rifabutin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/42/37541\">",
"           Rifampin (rifampicin): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/13/27861\">",
"           Rifampin and isoniazid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/20/31045\">",
"           Rifampin, isoniazid, and pyrazinamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/2/27684\">",
"           Rifapentine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/41/43667\">",
"           Rifaximin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/6/24676\">",
"           Rilonacept: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/21/33108\">",
"           Riluzole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/58/14244\">",
"           RimabotulinumtoxinB (botulinum toxin type B, Myobloc): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/11/25780\">",
"           Rimantadine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/0/39940\">",
"           Rimexolone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/5/41045\">",
"           Risedronate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/27/21942\">",
"           Risperidone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/35/5686\">",
"           Ritonavir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/3/15414\">",
"           Rituximab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/41/13973\">",
"           Rivaroxaban: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/37/44629\">",
"           Rivastigmine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/47/37621\">",
"           Rizatriptan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/52/27459\">",
"           Rocuronium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/11/43188\">",
"           Roflumilast: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/53/15189\">",
"           Romidepsin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/16/1284\">",
"           Romiplostim: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/46/20196\">",
"           Ropinirole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/18/40227\">",
"           Ropivacaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/38/1638\">",
"           Rosiglitazone and glimepiride: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/42/15014\">",
"           Rosiglitazone and metformin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/50/806\">",
"           Rosiglitazone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/3/1077\">",
"           Rosuvastatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/5/18517\">",
"           Rufinamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/40/7812\">",
"           Saccharomyces boulardii: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/27/9652\">",
"           Sacrosidase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/25/40341\">",
"           Salmeterol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/33/43540\">",
"           Salsalate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/37/10836\">",
"           Sapropterin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/34/21029\">",
"           Saquinavir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/6/25700\">",
"           Sargramostim: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/59/4022\">",
"           Saxagliptin and metformin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/10/8357\">",
"           Saxagliptin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/8/4228\">",
"           Scopolamine (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/12/10437\">",
"           Scopolamine (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/47/38640\">",
"           Scopolamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/55/28532\">",
"           Secobarbital: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/24/17795\">",
"           Secretin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/52/18246\">",
"           Selegiline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/41/30356\">",
"           Selenium sulfide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/3/2100\">",
"           Selenium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/51/28468\">",
"           Senna: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/10/33955\">",
"           Sertaconazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/43/23222\">",
"           Sertraline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/1/22548\">",
"           Sevelamer: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/14/3300\">",
"           Sevoflurane: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/8/27781\">",
"           Sildenafil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/60/33732\">",
"           Silodosin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/28/43459\">",
"           Silver nitrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/48/42756\">",
"           Silver sulfadiazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/43/5812\">",
"           Simethicone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/17/11541\">",
"           Simvastatin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/26/16803\">",
"           Sincalide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/54/8036\">",
"           Sinecatechins: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/4/12356\">",
"           Sipuleucel-T: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/35/27190\">",
"           Sirolimus: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/2/9254\">",
"           Sitagliptin and metformin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/13/13525\">",
"           Sitagliptin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/37/2641\">",
"           Smallpox vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/16/13571\">",
"           Sodium acetate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/21/4437\">",
"           Sodium bicarbonate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/28/39366\">",
"           Sodium chloride preparations (saline and oral salt tablets): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/24/7556\">",
"           Sodium citrate and potassium citrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/6/1124\">",
"           Sodium citrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/20/30019\">",
"           Sodium hypochlorite solution: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/7/15476\">",
"           Sodium iodide I-131: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/4/4163\">",
"           Sodium lactate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/32/15875\">",
"           Sodium morrhuate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/37/34387\">",
"           Sodium nitrite and sodium thiosulfate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/32/31237\">",
"           Sodium oxybate (gamma hydroxybutyrate): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/33/33299\">",
"           Sodium phenylacetate and sodium benzoate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/59/22452\">",
"           Sodium phenylbutyrate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/15/19702\">",
"           Sodium phosphate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/62/22500\">",
"           Sodium polystyrene sulfonate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/53/40786\">",
"           Sodium tetradecyl: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/63/11251\">",
"           Sodium thiosulfate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/37/37460\">",
"           Sodium, potassium and magnesium sulfates bowel preparation kit: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/36/36420\">",
"           Solifenacin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/42/44709\">",
"           Sorafenib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/16/12548\">",
"           Sorbitol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/22/33125\">",
"           Sotalol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/9/2196\">",
"           Spinosad: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/63/4084\">",
"           Spiramycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/27/19893\">",
"           Spironolactone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/12/32965\">",
"           Stavudine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/48/40707\">",
"           Streptomycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/18/11557\">",
"           Streptozocin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/55/27507\">",
"           Strontium-89: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/31/31219\">",
"           Succinylcholine (suxamethonium): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/47/17140\">",
"           Sucralfate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/45/44755\">",
"           Sufentanil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/37/31315\">",
"           Sulconazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/56/43907\">",
"           Sulfabenzamide, sulfacetamide, and sulfathiazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/55/18292\">",
"           Sulfacetamide (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/37/40531\">",
"           Sulfacetamide (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/15/39156\">",
"           Sulfacetamide and prednisolone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/8/39040\">",
"           Sulfacetamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/25/43412\">",
"           Sulfadiazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/43/2742\">",
"           Sulfadoxine and pyrimethamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/29/32211\">",
"           Sulfanilamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/24/12677\">",
"           Sulfasalazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/14/38116\">",
"           Sulfur and sulfacetamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/30/29157\">",
"           Sulindac: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/20/37189\">",
"           Sumatriptan and naproxen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/37/15958\">",
"           Sumatriptan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/41/30358\">",
"           Sunitinib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/39/1654\">",
"           Synthetic conjugated estrogens A: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/20/42309\">",
"           Synthetic conjugated estrogens B: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/14/40165\">",
"           Tacrolimus (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/21/341\">",
"           Tacrolimus (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/24/38272\">",
"           Tacrolimus: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/38/9829\">",
"           Tadalafil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/55/39795\">",
"           Talc (sterile): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/28/5574\">",
"           Tamoxifen: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/39/30324\">",
"           Tamsulosin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/13/40149\">",
"           Tapentadol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/32/26116\">",
"           Tazarotene: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/19/24885\">",
"           Telaprevir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/48/38659\">",
"           Telavancin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/13/20693\">",
"           Telbivudine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/1/17429\">",
"           Telithromycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/21/19797\">",
"           Telmisartan and amlodipine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/59/29621\">",
"           Telmisartan and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/60/13253\">",
"           Telmisartan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/58/2981\">",
"           Temazepam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/60/32709\">",
"           Temozolomide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/31/43509\">",
"           Temsirolimus: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/2/21539\">",
"           Tenecteplase: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/17/36116\">",
"           Teniposide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/46/32485\">",
"           Tenofovir and emtricitabine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/4/36933\">",
"           Tenofovir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/31/33268\">",
"           Terazosin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/46/9957\">",
"           Terbinafine (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/53/39763\">",
"           Terbinafine (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/42/38560\">",
"           Terbinafine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/42/26277\">",
"           Terbutaline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/34/40483\">",
"           Terconazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/5/44116\">",
"           Teriparatide (recombinant human parathyroid hormone (1-34)): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/1/43028\">",
"           Tesamorelin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/27/22966\">",
"           Testosterone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/18/11555\">",
"           Tetanus immune globulin (human): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/5/12371\">",
"           Tetanus toxoid (adsorbed): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/15/13557\">",
"           Tetrabenazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/36/17987\">",
"           Tetracaine (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/8/38019\">",
"           Tetracaine (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/3/25652\">",
"           Tetracaine (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/52/41792\">",
"           Tetracaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/16/7429\">",
"           Tetracycline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/55/3956\">",
"           Tetrahydrozoline (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/62/6116\">",
"           Tetrahydrozoline (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/17/38160\">",
"           Tetrahydrozoline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/48/44805\">",
"           Thalidomide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/7/1141\">",
"           Theophylline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/33/3605\">",
"           Thioguanine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/19/37171\">",
"           Thiopental: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/36/19013\">",
"           Thioridazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/12/35012\">",
"           Thiotepa: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/31/10741\">",
"           Thiothixene: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/28/32197\">",
"           Thyroid extract (desiccated thyroid): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/43/29363\">",
"           Thyrotropin alfa (recombinant human thyrotropin): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/29/20949\">",
"           Tiagabine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/23/6517\">",
"           Tiaprofenic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/2/43043\">",
"           Ticarcillin and clavulanate potassium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/34/4645\">",
"           Ticlopidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/6/4196\">",
"           Tigecycline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/14/41188\">",
"           Tiludronate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/13/30932\">",
"           Timolol (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/60/22469\">",
"           Timolol (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/13/38096\">",
"           Timolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/59/15284\">",
"           Tincture of opium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/30/4581\">",
"           Tinidazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/61/16341\">",
"           Tinzaparin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/35/21044\">",
"           Tioconazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/50/20260\">",
"           Tiopronin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/7/36981\">",
"           Tiotropium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/46/20197\">",
"           Tipranavir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/2/24611\">",
"           Tirofiban: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/36/4677\">",
"           Tizanidine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/31/25076\">",
"           Tobramycin (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/45/15061\">",
"           Tobramycin (systemic therapy and oral inhalation): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/44/4805\">",
"           Tobramycin and dexamethasone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/49/39696\">",
"           Tobramycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/63/1013\">",
"           Tocilizumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/44/28356\">",
"           Tolazamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/22/34148\">",
"           Tolbutamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/60/34756\">",
"           Tolcapone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/38/16997\">",
"           Tolmetin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/62/39907\">",
"           Tolnaftate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/25/41364\">",
"           Tolterodine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/62/19429\">",
"           Tolvaptan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/38/32355\">",
"           Topical cocaine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/17/16663\">",
"           Topical salicylic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/50/14115\">",
"           Topical thrombin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/42/30372\">",
"           Topical tretinoin (topical all trans retinoic acid): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/31/8694\">",
"           Topiramate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/34/5670\">",
"           Topotecan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/39/13941\">",
"           Toremifene: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/44/37573\">",
"           Torsemide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/36/7749\">",
"           Tositumomab radioconjugate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/4/1092\">",
"           Total parenteral nutrition: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/16/39172\">",
"           Trabectedin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/32/6659\">",
"           Trace metals: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/5/30805\">",
"           Tramadol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/47/17141\">",
"           Trandolapril and verapamil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/23/9589\">",
"           Trandolapril: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/51/10037\">",
"           Tranexamic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/42/39589\">",
"           Tranylcypromine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/23/44404\">",
"           Trastuzumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/33/1556\">",
"           Travelers' diarrhea and cholera vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/60/23492\">",
"           Travoprost and timolol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/30/10724\">",
"           Travoprost: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/44/34501\">",
"           Trazodone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/48/14085\">",
"           Treprostinil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/10/16548\">",
"           Triamcinolone (nasal): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/31/19955\">",
"           Triamcinolone (ophthalmic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/49/5910\">",
"           Triamcinolone (systemic): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/46/36580\">",
"           Triamcinolone (topical): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/13/209\">",
"           Triamcinolone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/33/42516\">",
"           Triamterene: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/11/38068\">",
"           Triazolam: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/35/3635\">",
"           Trichloroacetic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/23/41331\">",
"           Trientine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/39/41588\">",
"           Trifluoperazine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/5/94\">",
"           Trifluridine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/30/39396\">",
"           Trihexyphenidyl: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/13/10452\">",
"           Trimebutine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/2/29732\">",
"           Trimethobenzamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/23/40307\">",
"           Trimethoprim and polymyxin B: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/9/146\">",
"           Trimethoprim: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/2/23589\">",
"           Trimethoprim-sulfamethoxazole (co-trimoxazole): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/18/21797\">",
"           Trimipramine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/13/18645\">",
"           Triprolidine and pseudoephedrine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/62/18405\">",
"           Triprolidine, pseudoephedrine, and codeine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/12/44227\">",
"           Triptorelin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/47/23284\">",
"           Trolamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/23/6515\">",
"           Tromethamine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/27/12724\">",
"           Tropicamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/9/13460\">",
"           Trospium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/60/11203\">",
"           Trypan blue: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/22/22883\">",
"           Trypsin, balsam peru, and castor oil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/2/15395\">",
"           Tuberculin skin test: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/59/10161\">",
"           Typhoid vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/36/22084\">",
"           Ulipristal: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/3/26676\">",
"           Unactivated prothrombin complex concentrates (3 factors: IX, II, X [and trace VII]): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/55/37747\">",
"           Unactivated prothrombin complex concentrates (4 factors: II, VII, IX, and X with proteins C and S): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/30/30179\">",
"           Undecylenic acid and derivatives: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/16/36099\">",
"           Urea and hydrocortisone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/6/19556\">",
"           Urea: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/1/28692\">",
"           Urofollitropin (purified human follicle stimulating hormone): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/34/25124\">",
"           Ursodiol: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/41/10900\">",
"           Ustekinumab: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/61/5076\">",
"           Vaccinia immune globulin (intravenous): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/45/35540\">",
"           Valacyclovir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/29/19925\">",
"           Valganciclovir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/35/11831\">",
"           Valproate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/34/33315\">",
"           Valrubicin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/24/29061\">",
"           Valsartan and hydrochlorothiazide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/15/21749\">",
"           Valsartan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/34/17957\">",
"           Vancomycin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/52/11078\">",
"           Vandetanib: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/36/13893\">",
"           Vardenafil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/9/9365\">",
"           Varenicline: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/40/10881\">",
"           Varicella virus vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/31/5620\">",
"           Vasopressin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/46/37603\">",
"           Vecuronium: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/15/20724\">",
"           Velaglucerase alfa (glucocerebrosidase): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/43/20150\">",
"           Venlafaxine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/53/5974\">",
"           Verapamil: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/3/6196\">",
"           Verteporfin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/38/614\">",
"           Vigabatrin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/55/34677\">",
"           Vilazodone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/60/17349\">",
"           Vinblastine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/7/42100\">",
"           Vincristine (conventional): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/8/8325\">",
"           Vinorelbine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/17/40208\">",
"           Vitamin A and vitamin D: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/34/11812\">",
"           Vitamin A: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/42/42659\">",
"           Vitamin B complex: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/53/18260\">",
"           Vitamin B1 (thiamine): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/34/27171\">",
"           Vitamin B2 (riboflavin): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/53/26452\">",
"           Vitamin B3 (niacin): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/21/38227\">",
"           Vitamin B5 (pantothenic acid): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/38/33380\">",
"           Vitamin B6 (pyridoxine): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/27/33205\">",
"           Vitamin C (ascorbic acid): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/13/36052\">",
"           Vitamin D2 (ergocalciferol): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/30/9701\">",
"           Vitamin D3 (cholecalciferol): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/45/40659\">",
"           Vitamin E: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/4/38980\">",
"           Vitamin K (phytonadione): Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/39/33397\">",
"           Voriconazole: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/8/36997\">",
"           Vorinostat: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/2/33830\">",
"           Warfarin: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/40/9857\">",
"           Yellow fever vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/57/37780\">",
"           Zafirlukast: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/51/6965\">",
"           Zaleplon: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/44/16068\">",
"           Zanamivir: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/55/19316\">",
"           Ziconotide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/1/32789\">",
"           Zidovudine and lamivudine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/25/22933\">",
"           Zidovudine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/1/14357\">",
"           Zileuton: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/19/36147\">",
"           Zinc acetate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/0/33795\">",
"           Zinc chloride: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/25/14740\">",
"           Zinc oxide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/38/4708\">",
"           Zinc sulfate: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/5/21590\">",
"           Ziprasidone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/4/8262\">",
"           Zoledronic acid: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/25/2454\">",
"           Zolmitriptan: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/44/21189\">",
"           Zolpidem: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/25/35221\">",
"           Zonisamide: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/11/40116\">",
"           Zopiclone: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/51/4913\">",
"           Zoster vaccine: Patient drug information",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/1/31765\">",
"           Zuclopenthixol: Patient drug information",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-14E9538FBE-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f42_37_43610=[""].join("\n");
var outline_f42_37_43610=null;
var title_f42_37_43611="Causes of insulin resistance";
var content_f42_37_43611=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F75383&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F75383&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of insulin resistance",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Inherited states of target cell resistance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leprechaunism (insulin-receptor mutations)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rabson-Mendenhall syndrome (insulin-receptor mutations)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Type A syndrome of insulin resistance (insulin-receptor mutations in some, unknown signalling defect in most)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Some lipodystrophies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Secondary insulin resistance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obesity (free fatty acids and adipocytokines may contribute)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Excess counterregulatory hormones (glucocorticoids, catecholamines, growth hormone, placental lactogen)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Type 2 diabetes mellitus (secondary to obesity and other factors)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inactivity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stress, infection (counterregulatory hormones)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pregnancy (placental lactogen)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Immune mediated (anti-insulin antibodies, anti-insulin receptor antibodies in type B syndrome)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Miscellaneous (starvation, uremia, cirrhosis, ketoacidosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Multifactorial etiology of insulin resistance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypertension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Polycystic ovary syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metabolic syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Most cases of type 2 diabetes mellitus",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_37_43611=[""].join("\n");
var outline_f42_37_43611=null;
var title_f42_37_43612="Strategies for assisting adolescents with smoking cessation";
var content_f42_37_43612=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Strategies for assisting adolescent patients with smoking cessation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Action",
"      </td>",
"      <td class=\"subtitle1\">",
"       Strategies for implementation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"4\">",
"       Help the patient with a quit plan",
"      </td>",
"      <td>",
"       Set a quit date. Ideally, the quit date should be within two weeks. For patients who have difficulty with this type of \"all-or-nothing\" approach, it is reasonable to develop a strategy of cutting down gradually, in anticipation of a quit date further in the future.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tell family, friends, and coworkers about quitting and request understanding and support.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Anticipate challenges to planned quit attempt, particularly during the critical first few weeks. These include nicotine withdrawal symptoms.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Remove tobacco products from your environment. Prior to quitting, avoid smoking in places where you spend a lot of time (eg, work, home, car).",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"5\">",
"       Provide practical counseling (problem solving/training)",
"      </td>",
"      <td>",
"       Abstinence - Total abstinence is essential. \"Not even a single puff after the quit date.\"",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Past quit experience - Review past quit attempts including identification of what helped during the quit attempt and what factors contributed to relapse.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Anticipate triggers or challenges in upcoming attempt - Discuss challenges/triggers (such as school pressures, parties, or feelings of boredom or depression) and how patient will successfully overcome them.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Alcohol, marijuana, and other drugs - Because these can cause relapse, the patient should consider limiting/abstaining from their use while quitting. Health care providers should discuss the use/abuse of these substances and plans for changing behavior.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Other smokers in the household - Quitting is more difficult when there is another smoker in the household. Patients should encourage family members or roommates to quit with them or not smoke in their presence.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Provide intra-treatment social support",
"      </td>",
"      <td>",
"       Provide a supportive clinical environment while encouraging the patient in his or her quit attempt. \"My office staff and I are available to assist you.\"",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Help the patient obtain extra-treatment social support",
"      </td>",
"      <td>",
"       Help the patient develop social support for his or her quit attempt in his or her environments outside of treatment. \"Ask your boyfriend/girlfriend, friends, and family to support you in your quit attempt.\"",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Recommend the use of approved pharmacotherapy, except in special circumstances",
"      </td>",
"      <td>",
"       Recommend the use of pharmacotherapies found to be effective. Explain how these medications increase smoking cessation success and reduce withdrawal symptoms. Discuss the proper use of these medications; review their use at future visits.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Provide supplementary materials",
"      </td>",
"      <td>",
"       Sources - Federal agencies, nonprofit agencies, or local/state health departments, eg, 1-800-QUITNOW (1800quitnow.cancer.gov), www.notobacco.org, or www.tobaccofree.org/children.htm.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Type - Have printed materials on hand in clinical setting; provide web addresses or Quitline phone numbers. Materials should be culturally, racially, educationally and age-appropriate for the patient.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Flore, MC, Bailey, WC, Cohen, SJ, et al. Treating Tobacco Use and Dependence. Public Health Service, US Dept of Health and Human Services, 2000.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_37_43612=[""].join("\n");
var outline_f42_37_43612=null;
var title_f42_37_43613="Contents: Upper respiratory infections";
var content_f42_37_43613=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?15/21/15710\">",
"       Infectious Diseases",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Upper respiratory infections",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Upper respiratory infections",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Bordetella pertussis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/37/13911\">",
"           Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/27/20918\">",
"           Microbiology, epidemiology, and pathogenesis of Bordetella pertussis infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/22/39271\">",
"           Treatment and prevention of Bordetella pertussis infection in adolescents and adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Diphtheria",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/50/11046\">",
"           Diagnosis and treatment of diphtheria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/38/29287\">",
"           Epidemiology, pathophysiology and clinical manifestations of diphtheria",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Haemophilus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/40/41608\">",
"           Microbiology, epidemiology and treatment of Haemophilus influenzae",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Moraxella catarrhalis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/36/22089\">",
"           Moraxella catarrhalis infections",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pharyngitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/38/6758\">",
"           Antibiotic failure in the treatment of streptococcal tonsillopharyngitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/30/27110\">",
"           Complications of streptococcal tonsillopharyngitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/38/5738\">",
"           Evaluation of acute pharyngitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/38/2666\">",
"           Treatment and prevention of streptococcal tonsillopharyngitis",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-74A20157D8-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f42_37_43613=[""].join("\n");
var outline_f42_37_43613=null;
var title_f42_37_43614="Thin blood smear 1";
var content_f42_37_43614=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F59913&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F59913&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Thin blood smear 1",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 359px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_37_43614=[""].join("\n");
var outline_f42_37_43614=null;
var title_f42_37_43615="Severe Vibrio vulnificus infection";
var content_f42_37_43615=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F55001&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F55001&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hemorrhagic lesions in severe Vibrio vulnificus infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 353px; height: 234px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Extensive bullous hemorrhagic lesions in a patient with Vibrio vulnificus septicemia and shock. Mortality in this condition exceeds 50 percent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Daniel J Sexton, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_37_43615=[""].join("\n");
var outline_f42_37_43615=null;
